Wiedemann-Rautenstrauch Syndrome

Mendelian MONDO:0009910 Pathograph 54 Show in embeddings browser Progeroid syndrome Congenital lipodystrophy

Wiedemann-Rautenstrauch syndrome (WRS), also called neonatal progeroid syndrome, is an ultra-rare autosomal recessive segmental progeroid disorder that is recognizable at birth. Affected infants show marked intrauterine and severe postnatal growth failure, generalized loss of subcutaneous fat with paradoxical localized fat pads (classically gluteal/suprabuttock and labial), a pseudohydrocephalic appearance produced by relative macrocephaly, widened fontanelles, sparse scalp hair and prominent scalp veins over a triangular face with a pinched or convex nose, small mouth and pointed chin, natal teeth and later hypodontia, thin skin, hypotonia, and variable intellectual disability. Survivors may develop progressive ataxia and tremor, and a subset show central white-matter abnormalities that overlap with the allelic POLR3A-related hypomyelinating leukodystrophy. The syndrome is caused by biallelic POLR3A variants that, taken together, leave residual RNA polymerase III activity: typically a recurrent intronic splice-affecting allele (most often c.3337-11T>C, or c.1909+18G>A) in trans with a null or missense allele. Patient fibroblasts and iPSCs show reduced wild-type POLR3A, nucleolar disruption, p53 activation and premature senescence, and patient progenitors differentiate poorly along osteogenic and chondrogenic lineages; how Pol III hypofunction produces the adipose and craniofacial phenotypes specifically is still inferred rather than demonstrated. Rare WRS-like presentations have been attributed to POLR3GL and POLR3B. Management is supportive, with no disease-modifying therapy.

Ask OpenScientist

Ask a research question about Wiedemann-Rautenstrauch Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
10
Pathophys.
48
Phenotypes
3
Hypotheses
3
Gaps
54
Pathograph
3
Genes
4
Variants
5
Medical Actions
4
Differentials
7
Models
37
References
1
Deep Research
👪

Inheritance

1
Autosomal recessive inheritance HP:0000007
Autosomal recessive, with affected sib pairs from unaffected parents reported before the gene was known and biallelic POLR3A variants (compound heterozygous far more often than homozygous) in molecularly confirmed cases. Expressivity is markedly variable, from death in the first months to survival into adulthood.
Autosomal recessive inheritance Expressivity: VARIABLE
Show evidence (4 references)
PMID:10607952 SUPPORT Human Clinical
"The fact that there are 2 pairs of sibs among the 5 patients further supports that NPS is an autosomal recessive condition."
Sib recurrence from unaffected parents in the largest pre-molecular series supports recessive inheritance.
PMID:21671373 SUPPORT Human Clinical
"Our findings support autosomal recessive inheritance in WRS and support the possibility of homozygocity mapping as a good approach to find the causative gene."
Three affected sibs born to unaffected, non-consanguineous parents.
PMID:30414627 SUPPORT Human Clinical
"Here we present seven additional infants, children, and adults with WRS and bi-allelic truncating and/or splicing variants in POLR3A."
Molecular confirmation that affected individuals carry biallelic POLR3A variants.
+ 1 more reference
◈

Mechanistic Hypotheses

3
Partial loss of RNA polymerase III function drives a multi-lineage developmental growth failure
canonical_pol3_partial_lof CANONICAL
Evidence balance 2 support
Biallelic POLR3A variants that jointly retain partial function reduce Pol III output of tRNAs and other small RNAs, limiting the proliferation and differentiation of progenitors in adipose, skeletal, craniofacial and oligodendroglial lineages. The genetic and cellular ends of this chain are established; the Pol III-output step is extrapolated from leukodystrophy alleles and the lineage-specific consequences are inferred from the phenotype.
Pathograph links
Biallelic POLR3A Variants with Residual Pol III Function -> Aberrant POLR3A Transcript Processing DIRECT Intronic and synonymous WRS alleles act by disturbing POLR3A pre-mRNA splicing.
Biallelic POLR3A Variants with Residual Pol III Function -> Reduced Wild-Type POLR3A Expression DIRECT Truncating and null alleles reduce the pool of wild-type POLR3A directly.
Aberrant POLR3A Transcript Processing -> Reduced Wild-Type POLR3A Expression DIRECT Aberrant isoforms lower the amount of correctly spliced, functional POLR3A transcript.
Reduced Wild-Type POLR3A Expression -> RNA Polymerase III Transcriptional Hypofunction DIRECT Less functional catalytic subunit lowers Pol III transcriptional output.
RNA Polymerase III Transcriptional Hypofunction -> Impaired Mesenchymal Progenitor Proliferation and Differentiation INDIRECT UNKNOWN INTERMEDIATES Reduced supply of translation-supporting small RNAs is the proposed reason that WRS progenitors proliferate and differentiate poorly; not directly demonstrated.
RNA Polymerase III Transcriptional Hypofunction -> Central Nervous System Hypomyelination INDIRECT UNKNOWN INTERMEDIATES Oligodendrocyte-lineage sensitivity to Pol III hypofunction is established in the allelic leukodystrophy and its cellular and mouse models, and is assumed to underlie the white-matter involvement seen in a subset of WRS patients.
Impaired Mesenchymal Progenitor Proliferation and Differentiation -> Generalized Subcutaneous Lipoatrophy with Localized Fat Pads INDIRECT UNKNOWN INTERMEDIATES Inferred failure of adipose progenitors to form or maintain fat depots. The paradoxical persistence of gluteal and labial pads is unexplained.
Impaired Mesenchymal Progenitor Proliferation and Differentiation -> Skeletal Undergrowth, Osteopenia and Craniofacial Dysmorphogenesis INDIRECT UNKNOWN INTERMEDIATES Reduced osteoblastic and chondrogenic differentiation is the proposed route to undermineralised bone, persistently open fontanelles and the craniofacial disproportion.
Impaired Mesenchymal Progenitor Proliferation and Differentiation -> Prenatal and Postnatal Growth Failure INDIRECT UNKNOWN INTERMEDIATES Global reduction in progenitor proliferation is the assumed basis of the growth failure that begins in utero and persists despite adequate caloric intake.
Show evidence (2 references)
PMID:30323018 SUPPORT Human Clinical
"Biallelic mutations in POLR3A, which encodes for the largest subunit of the DNA-dependent RNA polymerase III, underlie WRS."
The genetic anchor of the canonical model.
PMID:16097434 SUPPORT In Vitro
"Our data suggest a lack of cellular differentiation capacity in WRS patients, which may be responsible for the clinical appearance and symptoms of this rare disorder."
The progenitor-differentiation limb of the model.
Nucleolar stress, p53 activation and premature senescence produce the progeroid phenotype
senescence_driven_progeroid_phenotype EMERGING
Evidence balance 2 support
Mutant POLR3A accumulation causes nucleolar disruption, a p53/DNA-damage response and premature senescence in patient fibroblasts and iPSCs, and telomerase RNA is sequestered in nucleoli. On this model the progeroid features arise from senescence-driven exhaustion of progenitor pools, as in other segmental progerias. Supported by two cellular studies; no in vivo or rescue evidence.
Pathograph links
RNA Polymerase III Transcriptional Hypofunction -> Nucleolar Disruption, p53 Activation and Premature Senescence INDIRECT UNKNOWN INTERMEDIATES Mutant POLR3A accumulation in the nucleus is accompanied by nucleolar enlargement, p53 phosphorylation and senescence; the intermediates between Pol III hypofunction and the nucleolar stress response are not defined.
Nucleolar Disruption, p53 Activation and Premature Senescence -> Impaired Mesenchymal Progenitor Proliferation and Differentiation INDIRECT UNKNOWN INTERMEDIATES Hypothesised route in which p53-driven senescence of progenitors exhausts the mesenchymal pools needed for adipose, bone and cartilage formation. No study has connected the two observations in WRS cells.
Show evidence (2 references)
PMID:32976914 SUPPORT In Vitro
"All these changes were associated with premature senescence."
Premature senescence in WRS fibroblasts.
PMID:41081995 SUPPORT In Vitro
"HGPS and WRS patient fibroblasts showed similar signs of cellular aging; however, unlike HGPS, the causal link between the premature aging phenotype and WRS driving mutations is unclear."
Same cellular signature as HGPS, with the causal link explicitly flagged as open.
Specific allele combinations, not a functional site, decide WRS versus 4H leukodystrophy
allele_combination_determines_wrs_versus_4h EMERGING
Evidence balance 4 support 1 refute
WRS-specific recurrent haplotypes and the predominance of truncating or splice-affecting alleles in WRS, versus missense alleles in 4H leukodystrophy, suggest that the residual-function level set by the particular allele pair determines which POLR3A phenotype appears. Homozygous missense WRS families and shared intronic alleles between WRS and spastic ataxia show the rule is not absolute.
Show evidence (5 references)
PMID:30323018 SUPPORT Human Clinical
"We suggest that specific combinations of compound heterozygous variants must be present to cause the WRS phenotype."
The allele-combination proposal.
PMID:30323018 SUPPORT Human Clinical
"While biallelic POLR3A variants have been previously reported in 4H syndrome and adolescent-onset progressive spastic ataxia, recurrent haplotypes specifically occurring in individuals with WRS were detected."
WRS-specific recurrent haplotypes.
PMID:30414627 SUPPORT Human Clinical
"Bi-allelic missense variants in POLR3A have been associated with phenotypes distinct from WRS: hypogonadotropic hypogonadism and hypomyelinating leukodystrophy with or without oligodontia."
Variant-class contrast between WRS and the leukodystrophy phenotypes.
+ 2 more references
?

Discussions and Knowledge Gaps

3
How does partial loss of RNA polymerase III function abolish subcutaneous adipose tissue while sparing gluteal and labial fat pads?
KNOWLEDGE GAP OPEN wrs_adipose_mechanism_gap
Attached to
pathophysiology#Impaired Mesenchymal Progenitor Proliferation and Differentiation pathophysiology#Generalized Subcutaneous Lipoatrophy with Localized Fat Pads
Congenital generalized lipoatrophy is the defining tissue phenotype, yet no study has examined adipocyte differentiation, adipose progenitor number or lipid handling in WRS cells; the only differentiation data are osteogenic, chondrogenic and hematopoietic. The regional sparing of specific fat depots is unexplained by any global Pol III model and suggests depot-specific progenitor biology.
Show evidence (2 references)
PMID:16097434 SUPPORT In Vitro
"To date, there are no data about the differentiation capacity of WRS progenitor cells available in the literature."
States the gap that the osteogenic study only partly filled; adipogenic differentiation remains unassayed.
PMID:10607952 SUPPORT Human Clinical
"The neonatal progeroid syndrome (NPS), or Wiedemann-Rautenstrauch, is a rare autosomal recessive disorder comprised of generalized lipoatrophy except for fat pads in the suprabuttock areas, hypotrichosis of the scalp hair, eyebrows, and eyelashes, relative macrocephaly, triangular face, natal..."
The depot-sparing pattern that a mechanism must explain.
Is Pol III transcript output actually reduced in WRS cells, and does the WRS allele combination affect a different subset of Pol III transcripts than leukodystrophy alleles?
KNOWLEDGE GAP OPEN wrs_pol3_output_unmeasured
Attached to
pathophysiology#RNA Polymerase III Transcriptional Hypofunction mechanistic_hypotheses#allele_combination_determines_wrs_versus_4h
Reduced tRNA and BC200 levels have been shown for a leukodystrophy allele, and WRS fibroblasts show reduced wild-type POLR3A, but no study has profiled Pol III transcripts in WRS cells. Whether WRS and 4H alleles differ in the magnitude or transcript selectivity of Pol III hypofunction is the testable core of the allele-combination hypothesis.
Show evidence (1 reference)
PMID:30323018 SUPPORT Human Clinical
"No isolated functional sites in POLR3A explain the phenotype variability in POLR3A-related disorders."
Structural position alone does not explain which phenotype a genotype produces.
Can a mouse model of the WRS allele combination be built, given that the homozygous G672E leukodystrophy allele produces no phenotype and only lineage-restricted conditional alleles produce hypomyelination?
HUMAN MODEL MISMATCH OPEN wrs_no_animal_model
Attached to
pathophysiology#Central Nervous System Hypomyelination pathophysiology#Generalized Subcutaneous Lipoatrophy with Localized Fat Pads animal_models#Mouse
No animal model of WRS exists. The available Polr3a mice model the allelic leukodystrophy instead: a homozygous founder missense allele gives no neurological or myelin phenotype, and conditional Olig2-lineage expression of pathogenic alleles gives a mild hypomyelination without the systemic features. A WRS model would need a germline compound-heterozygous genotype with a splice-affecting allele whose leakiness in mouse is unknown, so the mouse negative results should not be read as evidence about the human mechanism.
Show evidence (2 references)
PMID:28407788 SUPPORT Model Organism
"We conclude that the first transgenic mice with a leukodystrophy-causing Polr3a mutation do not recapitulate the childhood-onset HLD observed in the majority of human patients with POLR3A mutations, and provide essential information to guide selection of Polr3a mutations for developing future..."
Direct evidence of a human-mouse mismatch for the closest available allele.
PMID:34583988 SUPPORT Model Organism
"These phenotypes reflect a subset of clinical features seen in patients."
Even the conditional model reproduces only part of the human leukodystrophy.
⚙

Pathophysiology

10
Biallelic POLR3A Variants with Residual Pol III Function
The initiating lesion is compound heterozygosity (occasionally homozygosity) for POLR3A variants that, considered as a pair, leave partial function of the catalytic subunit of RNA polymerase III. The characteristic WRS genotype pairs a recurrent intronic or synonymous splice-affecting allele with a truncating or missense allele; all WRS-associated amino-acid substitutions are predicted to perturb POLR3A structure. Which allele combinations produce WRS rather than 4H leukodystrophy is the central genotype-phenotype question for this gene.
Partial loss of RNA polymerase III function drives a multi-lineage developmental growth failure
POLR3A hgnc:30074 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves POLR3A (hgnc:30074). hgnc:30074 is a gene from the HUGO Gene Nomenclature Committee.
Genetic context POLR3A hgnc:30074 HUGO Gene Nomenclature Committee (hgnc) Relation: this genetic context concerns this gene This genetic context concerns POLR3A (hgnc:30074). hgnc:30074 is a gene from the HUGO Gene Nomenclature Committee. variant_origin: GERMLINE zygosity: COMPOUND_HETEROZYGOUS functional_impact_category: PARTIAL_LOSS_OF_FUNCTION
Most reported genotypes are compound heterozygous; homozygous missense genotypes occur in consanguineous families. Complete loss of both alleles is presumed lethal, so the allele pair retains partial function.
RNA polymerase III complex GO:0005666 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves RNA polymerase III complex (GO:0005666). GO:0005666 is a cellular component from the Gene Ontology.
Downstream
Aberrant POLR3A Transcript Processing Intronic and synonymous WRS alleles act by disturbing POLR3A pre-mRNA splicing. Partial loss of RNA polymerase III function drives a multi-lineage developmental growth failure
Reduced Wild-Type POLR3A Expression Truncating and null alleles reduce the pool of wild-type POLR3A directly. Partial loss of RNA polymerase III function drives a multi-lineage developmental growth failure
Show evidence (5 references)
PMID:30323018 SUPPORT Human Clinical
"Biallelic mutations in POLR3A, which encodes for the largest subunit of the DNA-dependent RNA polymerase III, underlie WRS."
Establishes the initiating molecular lesion.
PMID:31695177 SUPPORT Human Clinical
"All variants reported in the literature lead to at least a partial loss-of-function (when considering both alleles together)."
Supports classifying the allele pair as partial loss of function.
PMID:30323018 SUPPORT Computational
"All WRS-associated POLR3A amino acid changes were predicted to perturb substantially POLR3A structure/function."
In silico structural modelling of the missense alleles.
+ 2 more references
Aberrant POLR3A Transcript Processing
Deep-intronic, near-splice-site and synonymous WRS alleles produce aberrant POLR3A splice isoforms (exon skipping, intron retention, cryptic-site use), a proportion of which are frameshifted or degraded. Because splicing is leaky, some normally spliced transcript persists, which is one explanation for the residual function of the WRS allele pair.
Partial loss of RNA polymerase III function drives a multi-lineage developmental growth failure
POLR3A pre-mRNA splicing GO:0000398 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal POLR3A pre-mRNA splicing, annotated with mRNA splicing, via spliceosome (GO:0000398). GO:0000398 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Experimental models
POLR3A c.3342C>T minigene splicing reporter CELL LINE Shows that a synonymous WRS allele produces aberrant splice isoforms.
Downstream
Reduced Wild-Type POLR3A Expression Aberrant isoforms lower the amount of correctly spliced, functional POLR3A transcript. Partial loss of RNA polymerase III function drives a multi-lineage developmental growth failure
Show evidence (3 references)
PMID:38397171 SUPPORT Human Clinical
"Via the analysis of mRNA derived from fibroblasts, we reconfirmed the splicing-affecting nature of the c.3337-11T>C variant."
Patient-derived fibroblast mRNA analysis of the commonest WRS allele.
PMID:36385762 SUPPORT In Vitro
"Mini-gene reporter assays revealed that the synonymous variant of POLR3A and the missense variant of FANCA could affect pre-mRNA splicing of each gene."
Minigene assay showing that a synonymous WRS allele disrupts splicing.
PMID:40912518 SUPPORT Computational
"Splicing predictions using Human Splicing Finder (HSF) and SpliceAI suggested disruption of regulatory motifs and activation of a cryptic splice site."
In silico splicing prediction for a missense allele, suggesting a second, splice-level effect.
Reduced Wild-Type POLR3A Expression
WRS fibroblasts express less wild-type POLR3A mRNA and protein, with a reciprocal increase in mutant protein that accumulates in the nucleus; patient skin shows reduced POLR3A mRNA. The residual wild-type protein is what sustains Pol III assembly and activity in these cells.
Partial loss of RNA polymerase III function drives a multi-lineage developmental growth failure
skin fibroblast CL:0002620 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves skin fibroblast (CL:0002620). CL:0002620 is a cell type from the Cell Ontology.
RNA polymerase III complex GO:0005666 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves RNA polymerase III complex (GO:0005666). GO:0005666 is a cellular component from the Gene Ontology.
Experimental models
WRS patient primary dermal fibroblasts PRIMARY CELL CULTURE Quantifies wild-type versus mutant POLR3A transcript and protein in patient cells.
Downstream
RNA Polymerase III Transcriptional Hypofunction Less functional catalytic subunit lowers Pol III transcriptional output. Partial loss of RNA polymerase III function drives a multi-lineage developmental growth failure
Show evidence (3 references)
PMID:32976914 SUPPORT In Vitro
"The mutation caused a decrease in the expression of wildtype POLR3A mRNA and POLR3A protein and a sharp increase in mutant protein expression."
Direct measurement of wild-type versus mutant POLR3A in WRS patient fibroblasts.
PMID:32976914 SUPPORT In Vitro
"In addition, there was an increase in the nuclear localization of the mutant protein."
The truncated mutant protein is not excluded from the nucleus, so it may compete with wild-type subunit for complex assembly.
PMID:41549341 SUPPORT Human Clinical
"RT-qPCR analysis of skin tissue demonstrated a significant downregulation of POLR3A mRNA expression (p < 0.01)."
Reduced POLR3A transcript in patient skin in vivo.
RNA Polymerase III Transcriptional Hypofunction
POLR3A forms the catalytic centre of RNA polymerase III, which transcribes tRNAs, 5S rRNA, 7SL, 7SK, BC200 and other small non-coding RNAs that support translation, RNA processing and transcriptional regulation. Reduced functional POLR3A is expected to lower Pol III output. Direct quantification of Pol III transcripts in WRS cells has not been published; the reduction of tRNA and BC200 levels has been shown in cell lines and fibroblasts carrying leukodystrophy-associated POLR3A alleles, so this step is extrapolated from the allelic disorder.
Nucleolar stress, p53 activation and premature senescence produce the progeroid phenotype Partial loss of RNA polymerase III function drives a multi-lineage developmental growth failure
transcription by RNA polymerase III GO:0006383 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased transcription by RNA polymerase III (GO:0006383). GO:0006383 is a biological process from the Gene Ontology. ↓ DECREASED tRNA transcription by RNA polymerase III GO:0042797 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased tRNA transcription by RNA polymerase III (GO:0042797). GO:0042797 is a biological process from the Gene Ontology. ↓ DECREASED
DNA-directed RNA polymerase III activity GO:0003899 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves decreased DNA-directed RNA polymerase III activity, annotated with DNA-directed RNA polymerase activity (GO:0003899). GO:0003899 is a molecular function from the Gene Ontology. ↓ DECREASED
Experimental models
POLR3A p.M852V CRISPR-edited HEK293 and oligodendroglial cells CELL LINE Demonstrates that a hypomorphic POLR3A allele lowers tRNA and BC200 output, the step assumed but not measured in WRS.
Downstream
Nucleolar Disruption, p53 Activation and Premature Senescence Mutant POLR3A accumulation in the nucleus is accompanied by nucleolar enlargement, p53 phosphorylation and senescence; the intermediates between Pol III hypofunction and the nucleolar stress response are not defined. Nucleolar stress, p53 activation and premature senescence produce the progeroid phenotype
Impaired Mesenchymal Progenitor Proliferation and Differentiation Reduced supply of translation-supporting small RNAs is the proposed reason that WRS progenitors proliferate and differentiate poorly; not directly demonstrated. Partial loss of RNA polymerase III function drives a multi-lineage developmental growth failure
Central Nervous System Hypomyelination Oligodendrocyte-lineage sensitivity to Pol III hypofunction is established in the allelic leukodystrophy and its cellular and mouse models, and is assumed to underlie the white-matter involvement seen in a subset of WRS patients. Partial loss of RNA polymerase III function drives a multi-lineage developmental growth failure
Show evidence (3 references)
PMID:30414627 SUPPORT Human Clinical
"POLR3A, the largest subunit of RNA polymerase III, is a DNA-directed RNA polymerase that transcribes many small noncoding RNAs that regulate transcription, RNA processing, and translation."
States the enzymatic role that the WRS alleles compromise; background, not a measurement in WRS cells.
PMID:32976914 SUPPORT In Vitro
"POLR3A has important roles in transcription regulation of small RNAs, including tRNA, 5S rRNA, and 7SK rRNA."
Names the Pol III transcript classes at stake; the paper does not itself quantify them in WRS cells.
PMID:30898877 SUPPORT INDIRECT In Vitro
"Transcriptomic profiling uncovered a subset of transcripts vulnerable to Pol III hypofunction, including a global reduction in tRNA levels."
Demonstrates that a hypomorphic POLR3A allele lowers tRNA output; the allele studied (p.M852V) causes leukodystrophy, not WRS, so the support is by extrapolation.
Nucleolar Disruption, p53 Activation and Premature Senescence
WRS fibroblasts show increased nucleolar number and area, high phospho-p53 and phospho-H2AX, and premature replicative senescence; WRS iPSCs, in which POLR3A is upregulated during reprogramming, show nucleolar abnormalities with sequestration of the telomerase RNA component in nucleoli. Reduced fibroblast growth was already noted in the original 1977 description. These findings suggest a nucleolar-stress/p53 route to a progeroid cellular phenotype, but whether it drives the tissue phenotypes, rather than accompanying them, is untested.
Nucleolar stress, p53 activation and premature senescence produce the progeroid phenotype
skin fibroblast CL:0002620 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves skin fibroblast (CL:0002620). CL:0002620 is a cell type from the Cell Ontology.
cellular senescence GO:0090398 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased cellular senescence (GO:0090398). GO:0090398 is a biological process from the Gene Ontology. ↑ INCREASED nucleolus organization GO:0007000 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal nucleolus organization (GO:0007000). GO:0007000 is a biological process from the Gene Ontology. ⚠ ABNORMAL cell population proliferation GO:0008283 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased cell population proliferation (GO:0008283). GO:0008283 is a biological process from the Gene Ontology. ↓ DECREASED
Experimental models
WRS patient primary dermal fibroblasts PRIMARY CELL CULTURE Patient fibroblasts show the nucleolar, p53 and senescence phenotype that defines this node.
WRS patient-derived induced pluripotent stem cells IPSC DERIVED MODEL Reproduces nucleolar abnormality and adds TERC sequestration, but in a pluripotent state that overexpresses POLR3A.
Downstream
Impaired Mesenchymal Progenitor Proliferation and Differentiation Hypothesised route in which p53-driven senescence of progenitors exhausts the mesenchymal pools needed for adipose, bone and cartilage formation. No study has connected the two observations in WRS cells. Nucleolar stress, p53 activation and premature senescence produce the progeroid phenotype
Show evidence (5 references)
PMID:32976914 SUPPORT In Vitro
"These changes were associated with an increase in the number and area of nucleoli and to a high increase in the expression of pP53 and pH2AX."
Nucleolar and p53/DNA-damage-response readouts in WRS fibroblasts.
PMID:32976914 SUPPORT In Vitro
"All these changes were associated with premature senescence."
Premature senescence as the cellular outcome.
PMID:41081995 SUPPORT In Vitro
"Enhanced expression of mutant POLR3A in WRS iPSCs led to nucleolus abnormalities and telomerase RNA component (TERC) sequestration in the nucleoli in WRS iPSCs."
Independent iPSC model reproducing nucleolar abnormality and adding a telomerase-RNA sequestration readout.
+ 2 more references
Impaired Mesenchymal Progenitor Proliferation and Differentiation
Bone-marrow-derived progenitors from a WRS patient responded far less to osteoblastic differentiation stimuli and yielded fewer chondrocytes and hematopoietic cells than control progenitors, which the authors proposed as the cellular basis of the clinical picture. Adipocyte differentiation has not been assayed in WRS cells; failure of adipose development is inferred from the congenital lipoatrophy and is recorded as a knowledge gap.
Partial loss of RNA polymerase III function drives a multi-lineage developmental growth failure
mesenchymal stem cell CL:0000134 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves mesenchymal stem cell (CL:0000134). CL:0000134 is a cell type from the Cell Ontology. osteoblast CL:0000062 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves osteoblast (CL:0000062). CL:0000062 is a cell type from the Cell Ontology. chondrocyte CL:0000138 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves chondrocyte (CL:0000138). CL:0000138 is a cell type from the Cell Ontology.
osteoblast differentiation GO:0001649 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased osteoblast differentiation (GO:0001649). GO:0001649 is a biological process from the Gene Ontology. ↓ DECREASED cell population proliferation GO:0008283 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased cell population proliferation (GO:0008283). GO:0008283 is a biological process from the Gene Ontology. ↓ DECREASED
Experimental models
WRS bone-marrow-derived progenitor differentiation culture PRIMARY CELL CULTURE The only direct measurement of progenitor differentiation capacity in WRS.
Downstream
Generalized Subcutaneous Lipoatrophy with Localized Fat Pads Inferred failure of adipose progenitors to form or maintain fat depots. The paradoxical persistence of gluteal and labial pads is unexplained. Partial loss of RNA polymerase III function drives a multi-lineage developmental growth failure
Skeletal Undergrowth, Osteopenia and Craniofacial Dysmorphogenesis Reduced osteoblastic and chondrogenic differentiation is the proposed route to undermineralised bone, persistently open fontanelles and the craniofacial disproportion. Partial loss of RNA polymerase III function drives a multi-lineage developmental growth failure
Prenatal and Postnatal Growth Failure Global reduction in progenitor proliferation is the assumed basis of the growth failure that begins in utero and persists despite adequate caloric intake. Partial loss of RNA polymerase III function drives a multi-lineage developmental growth failure
Show evidence (3 references)
PMID:16097434 SUPPORT In Vitro
"It was shown, for the first time, that WRS cells showed a highly significant lower in vitro response to osteoblastic differentiation stimulus."
Osteogenic differentiation assay on patient bone-marrow progenitors.
PMID:16097434 SUPPORT In Vitro
"Furthermore, significantly fewer chondrocytes and hematopoietic cells were induced in WRS progenitors compared to the control group."
Reduced chondrogenic and hematopoietic output from the same progenitor culture.
PMID:16097434 SUPPORT In Vitro
"Our data suggest a lack of cellular differentiation capacity in WRS patients, which may be responsible for the clinical appearance and symptoms of this rare disorder."
The authors' proposed link from the differentiation defect to the clinical phenotype.
Generalized Subcutaneous Lipoatrophy with Localized Fat Pads
Near-absence of subcutaneous fat over the face, trunk and limbs from birth, producing thin, wrinkled skin with prominent superficial and scalp veins and the aged facial appearance, coexists with paradoxical fat accumulations over the buttocks/suprabuttock region and the labia or flanks. The lipoatrophy is congenital and persists; abnormal lipid and hormone profiles (hypertriglyceridemia, hyperprolactinemia) have been reported in a minority.
adipocyte CL:0000136 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves adipocyte (CL:0000136). CL:0000136 is a cell type from the Cell Ontology.
subcutaneous adipose tissue UBERON:0002190 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in subcutaneous adipose tissue (UBERON:0002190). UBERON:0002190 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Generalized lipodystrophy
Progeroid facial appearance
Prominent scalp veins
Thin skin
Hypertriglyceridemia
Show evidence (3 references)
PMID:10607952 SUPPORT Human Clinical
"The neonatal progeroid syndrome (NPS), or Wiedemann-Rautenstrauch, is a rare autosomal recessive disorder comprised of generalized lipoatrophy except for fat pads in the suprabuttock areas, hypotrichosis of the scalp hair, eyebrows, and eyelashes, relative macrocephaly, triangular face, natal..."
Defines the generalized lipoatrophy with spared suprabuttock fat pads.
PMID:30323018 SUPPORT Human Clinical
"Wiedemann-Rautenstrauch syndrome (WRS) is a form of segmental progeria presenting neonatally, characterised by growth retardation, sparse scalp hair, generalised lipodystrophy with characteristic local fatty tissue accumulations and unusual face."
The molecularly confirmed series describes the same lipodystrophy-with-local-accumulation pattern.
PMID:18717246 SUPPORT Human Clinical
"Our two patients had characteristic features of WRS, including intrauterine growth retardation, aged appearance, near absence of subcutaneous fat, gluteal fat pads, also labial pad in the first infant, wrinkled thin skin, sparse scalp hair, prominent scalp veins and facial dysmorphism."
Neonatal description of near-absent subcutaneous fat with gluteal and labial pads.
Skeletal Undergrowth, Osteopenia and Craniofacial Dysmorphogenesis
The craniofacial disproportion (relative macrocephaly with widely open fontanelles and sutures over a small, triangular face with micrognathia) and the dental anomalies (natal teeth, later hypodontia) are present at birth. Severe osteopenia with elevated urinary deoxypyridinoline, a bone-resorption marker, was documented in two neonates, and characteristic radiographic skeletal findings are described. Progressive kyphoscoliosis and joint contractures appear in survivors.
ossification GO:0001503 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased ossification (GO:0001503). GO:0001503 is a biological process from the Gene Ontology. ↓ DECREASED odontogenesis GO:0042476 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal odontogenesis (GO:0042476). GO:0042476 is a biological process from the Gene Ontology. ⚠ ABNORMAL
skull UBERON:0003129 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in skull (UBERON:0003129). UBERON:0003129 is an anatomical location from the Uberon multi-species anatomy ontology. skeletal system UBERON:0001434 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in skeletal system (UBERON:0001434). UBERON:0001434 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Pseudohydrocephalus
Wide anterior fontanel
Wide cranial sutures
Triangular face
Thin upper lip vermilion
Micrognathia
Natal teeth
Hypodontia
Osteopenia
Joint contracture
Scoliosis
Show evidence (3 references)
PMID:18717246 SUPPORT Human Clinical
"They also have severe osteopenia and elevated urinary deoxypyridinoline levels which have not been previously described in patients with WRS."
Bone-turnover evaluation in two neonates documents osteopenia with a raised resorption marker.
PMID:10607952 SUPPORT Human Clinical
"Skeletal findings in 2 of our patients demonstrated some new findings as well as the typical radiological abnormalities previously noted in NPS."
Confirms a recognizable radiographic skeletal pattern.
PMID:21671373 SUPPORT Human Clinical
"WRS patients are characterized by premature aging present at birth including pseudohydrocephalus, cranio-facial disproportion, reduced subcutaneous fat, thin skin, rigid and thick joints, and neonatal teeth in some cases."
Documents the craniofacial disproportion, joint stiffness and neonatal teeth.
Prenatal and Postnatal Growth Failure
Growth restriction is detectable on serial prenatal ultrasound, birth weight is low, and severe failure to thrive follows despite high-calorie enteral feeding, so the growth failure is intrinsic rather than nutritional. Short stature persists in survivors. Together with the lipoatrophy this produces the emaciated progeroid habitus.
multicellular organism growth GO:0035264 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased multicellular organism growth (GO:0035264). GO:0035264 is a biological process from the Gene Ontology. ↓ DECREASED
Downstream
Intrauterine growth retardation
Postnatal growth retardation
Failure to thrive
Short stature
Show evidence (3 references)
PMID:28447407 SUPPORT Human Clinical
"Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some..."
Growth retardation is listed first among the core manifestations of the 51-patient phenotype analysis.
PMID:1619643 SUPPORT Human Clinical
"During the pregnancy, growth retardation particularly in the biparietal and abdominal diameters but not the femoral length was detected through serial ultrasound scans."
Growth failure begins in utero and is detectable by ultrasound.
PMID:36596744 SUPPORT Human Clinical
"Nutritional support using high calorie milk and enteral tube was ineffective to gain weight due to frequent vomiting and aspiration."
Postnatal growth failure persisted despite enteral high-calorie feeding.
Central Nervous System Hypomyelination
White-matter involvement is variable in WRS. Some molecularly confirmed patients show delayed myelination or a hypomyelinating leukodystrophy pattern, one showed the striatal-variant pattern with the c.1771-6C>G allele, and adult survivors show superior cerebellar peduncle and midbrain T2/FLAIR hyperintensity together with ataxia, tremor, spasticity, dystonia or parkinsonism. This is the point of overlap with the allelic POLR3A-related (4H) leukodystrophy, in which diffuse hypomyelination is the defining feature.
oligodendrocyte CL:0000128 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves oligodendrocyte (CL:0000128). CL:0000128 is a cell type from the Cell Ontology.
myelination GO:0042552 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased myelination (GO:0042552). GO:0042552 is a biological process from the Gene Ontology. ↓ DECREASED central nervous system myelination GO:0022010 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased central nervous system myelination (GO:0022010). GO:0022010 is a biological process from the Gene Ontology. ↓ DECREASED
cerebral white matter UBERON:0002316 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cerebral white matter, annotated with white matter (UBERON:0002316). UBERON:0002316 is an anatomical location from the Uberon multi-species anatomy ontology.
Animal models
Polr3a G672E knock-in mouse Mouse fails to recapitulate A homozygous leukodystrophy allele does not produce hypomyelination in mouse.
Oligodendrocyte-lineage conditional Polr3a mutant mouse Mouse partially recapitulates Establishes that Pol III perturbation restricted to the oligodendrocyte lineage is sufficient for hypomyelination.
Downstream
CNS hypomyelination
Hypotonia
Ataxia
Tremor
Spasticity
Intellectual disability
Global developmental delay
Show evidence (3 references)
PMID:38348603 SUPPORT Human Clinical
"The patients have hallmark features such as prenatal and postnatal growth retardation, short stature, a progeroid appearance, hypotonia, facial dysmorphology, hypomyelination leukodystrophy, and mental impairment."
Consanguineous-family series in which hypomyelinating leukodystrophy was part of the presentation.
PMID:41549341 SUPPORT Human Clinical
"In addition to the classic Wiedemann-Rautenstrauch syndrome features-progressive diffuse alopecia, growth retardation, and abnormal white matter development-the patient presented with severe anemia and skin laxity, phenotypes not previously described in Wiedemann-Rautenstrauch syndrome."
Abnormal white matter development listed among the classic features in a 2026 case.
PMID:36825045 SUPPORT Human Clinical
"The most common brain MRI abnormality was T2-weighted/FLAIR hyperintensity of the superior cerebellar peduncles and midbrain."
Imaging correlate in a POLR3A movement-disorder series that includes a neonatal progeroid patient.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Wiedemann-Rautenstrauch Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

48
Blood 2
Anemia HP:0001903 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Anemia (HP:0001903). HP:0001903 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:41549341 SUPPORT Human Clinical
"In addition to the classic Wiedemann-Rautenstrauch syndrome features-progressive diffuse alopecia, growth retardation, and abnormal white matter development-the patient presented with severe anemia and skin laxity, phenotypes not previously described in Wiedemann-Rautenstrauch syndrome."
Severe anemia in a single POLR3A-confirmed patient.
PMID:36385762 NO_EVIDENCE Human Clinical
"For the mild anemia phenotype, the underlying causal genetic factors could be attributed to the compound heterozygous mutations in FANCA gene (c.2832dup, p.Ala945CysfsTer6 and c.1902 T > G, p.Asp634Glu)."
This patient's anemia was explained by a second recessive disorder, so the report does not bear on anemia as a POLR3A phenotype.
Thrombocytosis HP:0001894 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Persisting thrombocytosis, annotated with Thrombocytosis (HP:0001894). HP:0001894 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:18717246 SUPPORT Human Clinical
"Our first patient also has excessive joint contractures, persisting thrombocytosis and rectal prolapse."
Single-patient observation.
Ear 1
Hearing impairment HP:0000365 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Bilateral hearing loss, annotated with Hearing impairment (HP:0000365). HP:0000365 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:34611991 SUPPORT Human Clinical
"Over the years, above characteristic facial features, she showed severe postnatal growth retardation, global lipodystrophy, joint contractures, thoracic hypoplasia, scoliosis, anodontia, spastic quadriplegia, bilateral hearing loss, aphonia, hypogonadotropic hypogonadism, and cerebellar..."
Single adult survivor.
Endocrine 1
Hypogonadotropic hypogonadism HP:0000044 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypogonadotropic hypogonadism (HP:0000044). HP:0000044 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:34611991 SUPPORT Human Clinical
"Over the years, above characteristic facial features, she showed severe postnatal growth retardation, global lipodystrophy, joint contractures, thoracic hypoplasia, scoliosis, anodontia, spastic quadriplegia, bilateral hearing loss, aphonia, hypogonadotropic hypogonadism, and cerebellar..."
Single adult survivor.
Eye 1
Nystagmus HP:0000639 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Congenital nystagmus, annotated with Nystagmus (HP:0000639). HP:0000639 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:36596744 SUPPORT Human Clinical
"He had pectus excavatum and congenital nystagmus."
Single-patient observation.
Head and Neck 8
Triangular face VERY_FREQUENT HP:0000325 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Triangular face (HP:0000325). HP:0000325 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:28447407 SUPPORT Human Clinical
"Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some..."
Triangular face is part of the core facial gestalt; mapped to VERY_FREQUENT under the qualitative Pattern C table.
PMID:30414627 SUPPORT Human Clinical
"It has been proposed to be autosomal-recessive and is characterized by variable clinical features, such as intrauterine growth restriction and poor postnatal weight gain, characteristic facial features (triangular appearance to the face, convex nasal profile or pinched nose, and small mouth),..."
Triangular facial appearance in the molecular series.
Narrow mouth VERY_FREQUENT HP:0000160 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Small mouth, annotated with Narrow mouth (HP:0000160). HP:0000160 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:28447407 SUPPORT Human Clinical
"Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some..."
Small mouth listed within the core facial features.
PMID:28447407 SUPPORT Human Clinical
"the face characteristics sparse scalp hair, triangular face, small mouth with thin upper vermillion, natal teeth and a pointed chin, and the generalized lipodystrophy with local fatty tissue accumulations all go along together in almost all patients"
Small mouth is named in the group the 51-patient analysis says occur in "almost all patients", which maps to VERY_FREQUENT under the qualitative Pattern C table. Table 2 of the same paper records 16/18 for this feature in the WRS column.
Pointed chin VERY_FREQUENT HP:0000307 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pointed chin (HP:0000307). HP:0000307 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:28447407 SUPPORT Human Clinical
"Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some..."
Pointed chin listed within the core facial features.
PMID:28447407 SUPPORT Human Clinical
"the face characteristics sparse scalp hair, triangular face, small mouth with thin upper vermillion, natal teeth and a pointed chin, and the generalized lipodystrophy with local fatty tissue accumulations all go along together in almost all patients"
Pointed chin is named in the group the 51-patient analysis says occur in "almost all patients", which maps to VERY_FREQUENT under the qualitative Pattern C table. Table 2 of the same paper records 18/18 for this feature in the WRS column.
Micrognathia HP:0000347 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Micrognathia (HP:0000347). HP:0000347 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:10607952 SUPPORT Human Clinical
"The neonatal progeroid syndrome (NPS), or Wiedemann-Rautenstrauch, is a rare autosomal recessive disorder comprised of generalized lipoatrophy except for fat pads in the suprabuttock areas, hypotrichosis of the scalp hair, eyebrows, and eyelashes, relative macrocephaly, triangular face, natal..."
Micrognathia in the syndrome definition of the five-case series.
Pseudohydrocephalus Relative macrocephaly HP:0004482 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pseudohydrocephalus (relative macrocephaly with prominent scalp veins), annotated with Relative macrocephaly (HP:0004482). HP:0004482 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:569581 SUPPORT Human Clinical
"Two male infants with a pseudo-hydrocephalic progeroid syndrome with natal teeth are compared with two very similar female cases reported in the literature and interpreted as congenital progeria."
Wiedemann's 1979 delineation names the pseudohydrocephalic appearance as the defining feature.
PMID:30414627 SUPPORT Human Clinical
"It has been proposed to be autosomal-recessive and is characterized by variable clinical features, such as intrauterine growth restriction and poor postnatal weight gain, characteristic facial features (triangular appearance to the face, convex nasal profile or pinched nose, and small mouth),..."
Pseudohydrocephalus in the molecular series.
PMID:10607952 SUPPORT Human Clinical
"The neonatal progeroid syndrome (NPS), or Wiedemann-Rautenstrauch, is a rare autosomal recessive disorder comprised of generalized lipoatrophy except for fat pads in the suprabuttock areas, hypotrichosis of the scalp hair, eyebrows, and eyelashes, relative macrocephaly, triangular face, natal..."
Relative macrocephaly, the HP term chosen for the pseudohydrocephalic appearance.
Sparse scalp hair VERY_FREQUENT HP:0002209 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sparse scalp hair (HP:0002209). HP:0002209 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:28447407 SUPPORT Human Clinical
"Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some..."
Sparse hair is part of the core facial gestalt; mapped to VERY_FREQUENT under the qualitative Pattern C table.
PMID:30323018 SUPPORT Human Clinical
"Wiedemann-Rautenstrauch syndrome (WRS) is a form of segmental progeria presenting neonatally, characterised by growth retardation, sparse scalp hair, generalised lipodystrophy with characteristic local fatty tissue accumulations and unusual face."
Sparse scalp hair in the molecularly confirmed series.
Hypodontia FREQUENT HP:0000668 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypodontia (HP:0000668). HP:0000668 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:28447407 SUPPORT Human Clinical
"Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some..."
Hypodontia listed among the core dental anomalies.
PMID:34611991 SUPPORT Human Clinical
"Over the years, above characteristic facial features, she showed severe postnatal growth retardation, global lipodystrophy, joint contractures, thoracic hypoplasia, scoliosis, anodontia, spastic quadriplegia, bilateral hearing loss, aphonia, hypogonadotropic hypogonadism, and cerebellar..."
Anodontia, the extreme of the dental phenotype, in an adult survivor.
PMID:28447407 SUPPORT Human Clinical
"In addition we found that prominent scalp veins, wide cranial sutures, the presence of hypodontia, and the lower eyelid covering part of the cornea are also shared very often."
The 51-patient analysis reports hypodontia as "shared very often", mapped conservatively to FREQUENT as for the other features in that sentence.
Lagophthalmos HP:0030001 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Lagophthalmos (HP:0030001). HP:0030001 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:26691040 SUPPORT Human Clinical
"We report for the first time the findings of thin central corneas and lagophthalmos in WRS."
Single-patient ophthalmic report.
Integument 5
Progeroid facial appearance HP:0005328 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Progeroid facial appearance (HP:0005328). HP:0005328 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:27612211 SUPPORT Human Clinical
"Characteristic physical findings include neonatal progeroid appearance, sparse scalp hair, prominent scalp veins, and lipoatrophy; in addition, neonatal teeth are often a distinctive finding."
Neonatal progeroid appearance among the characteristic findings.
PMID:7823529 SUPPORT Human Clinical
"The diagnostic criteria of the neonatal progeroid syndrome (NPS) are: intrauterine and postnatal growth failure, hydrocephalic appearance, prominent scalp veins, old-looking face, absence of subcutaneous fat and neonatal teeth."
The old-looking face is one of the original diagnostic criteria, supporting diagnostic status.
Context-specific annotations (1)
Onset: CONGENITAL
Show evidence (1 reference)
PMID:319005 SUPPORT Human Clinical
"This report relates the case histories of two sisters who demonstrated the typical symptoms of progeria at birth."
The original 1977 description records progeroid features present at birth.
Prematurely aged appearance HP:0007495 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Prematurely aged appearance (HP:0007495). HP:0007495 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938095 SUPPORT Human Clinical
"The Wiedemann-Rautenstrauch syndrome (WRS, OMIM: 264090) characterizes a premature aging syndrome in which several features of aging are apparent at birth."
Defines the syndrome by its neonatal features of aging.
Alopecia HP:0001596 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Progressive diffuse alopecia, annotated with Alopecia (HP:0001596). HP:0001596 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:41549341 SUPPORT Human Clinical
"In addition to the classic Wiedemann-Rautenstrauch syndrome features-progressive diffuse alopecia, growth retardation, and abnormal white matter development-the patient presented with severe anemia and skin laxity, phenotypes not previously described in Wiedemann-Rautenstrauch syndrome."
Progressive diffuse alopecia listed among the classic features.
Thin skin HP:0000963 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Thin, wrinkled skin, annotated with Thin skin (HP:0000963). HP:0000963 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:21671373 SUPPORT Human Clinical
"WRS patients are characterized by premature aging present at birth including pseudohydrocephalus, cranio-facial disproportion, reduced subcutaneous fat, thin skin, rigid and thick joints, and neonatal teeth in some cases."
Thin skin in the three-sib family.
PMID:18717246 SUPPORT Human Clinical
"Our two patients had characteristic features of WRS, including intrauterine growth retardation, aged appearance, near absence of subcutaneous fat, gluteal fat pads, also labial pad in the first infant, wrinkled thin skin, sparse scalp hair, prominent scalp veins and facial dysmorphism."
Wrinkled thin skin in two neonates.
Cutis laxa HP:0000973 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Skin laxity, annotated with Cutis laxa (HP:0000973). HP:0000973 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:41549341 SUPPORT Human Clinical
"In addition to the classic Wiedemann-Rautenstrauch syndrome features-progressive diffuse alopecia, growth retardation, and abnormal white matter development-the patient presented with severe anemia and skin laxity, phenotypes not previously described in Wiedemann-Rautenstrauch syndrome."
Single-patient expansion of the cutaneous phenotype.
Limbs 1
Toe syndactyly HP:0001770 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Partial 2-3 toe syndactyly, annotated with Toe syndactyly (HP:0001770). HP:0001770 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:22585414 SUPPORT Human Clinical
"We describe a new patient with features of bilaterally pelvicalyceal ectasia and partial syndactyly on 2th and 3th toes, not previously described, to our knowledge."
Single variant case.
Metabolism 1
Hypertriglyceridemia HP:0002155 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypertriglyceridemia (HP:0002155). HP:0002155 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:18717246 SUPPORT Human Clinical
"Impaired lipid and hormone profiles including elevated prolactin and triglyceride level have been reported in patients with WRS."
Review statement in a case report summarizing prior laboratory findings.
PMID:10607952 SUPPORT Human Clinical
"Abnormalities in endocrine and lipid metabolism were found in 3 of 5 patients."
Lipid abnormalities in three of five patients; the abstract does not specify which analytes.
Musculoskeletal 5
Hypotonia HP:0001252 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypotonia (HP:0001252). HP:0001252 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:34289880 SUPPORT Human Clinical
"Wiedemann-Rautenstrauch syndrome (WRS) is a rare autosomal recessive neonatal progeroid disorder characterized by prenatal and postnatal growth retardation, short stature, a progeroid appearance, hypotonia, and mental impairment."
Hypotonia in the disease definition.
PMID:34611991 SUPPORT Human Clinical
"She presented at birth with intrauterine growth retardation, lipodystrophy, muscular hypotonia, and several WRS-like facial features, albeit without sparse hair and prominent scalp veins."
Muscular hypotonia at birth in a molecularly confirmed patient.
PMID:36596744 SUPPORT Human Clinical
"He was hypotonic and he could not control his head nor roll over his body."
Infantile hypotonia with motor delay.
Spasticity HP:0001257 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Spasticity (HP:0001257). HP:0001257 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:34611991 SUPPORT Human Clinical
"Over the years, above characteristic facial features, she showed severe postnatal growth retardation, global lipodystrophy, joint contractures, thoracic hypoplasia, scoliosis, anodontia, spastic quadriplegia, bilateral hearing loss, aphonia, hypogonadotropic hypogonadism, and cerebellar..."
Spastic quadriplegia in an adult survivor.
PMID:36825045 SUPPORT Human Clinical
"Patient 1 presented with a neonatal progeroid syndrome and developed parkinsonism, dystonia, ataxia, and spasticity."
Spasticity in a neonatal progeroid patient followed into later life.
Osteopenia HP:0000938 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Severe osteopenia, annotated with Osteopenia (HP:0000938). HP:0000938 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:18717246 SUPPORT Human Clinical
"They also have severe osteopenia and elevated urinary deoxypyridinoline levels which have not been previously described in patients with WRS."
Bone-mineral evaluation in two neonates.
Joint contracture HP:0034392 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Joint contractures, annotated with Joint contracture (HP:0034392). HP:0034392 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:18717246 SUPPORT Human Clinical
"Our first patient also has excessive joint contractures, persisting thrombocytosis and rectal prolapse."
Excessive joint contractures in a neonate.
PMID:34611991 SUPPORT Human Clinical
"Over the years, above characteristic facial features, she showed severe postnatal growth retardation, global lipodystrophy, joint contractures, thoracic hypoplasia, scoliosis, anodontia, spastic quadriplegia, bilateral hearing loss, aphonia, hypogonadotropic hypogonadism, and cerebellar..."
Joint contractures in an adult survivor.
Scoliosis HP:0002650 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Scoliosis (HP:0002650). HP:0002650 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:34611991 SUPPORT Human Clinical
"Over the years, above characteristic facial features, she showed severe postnatal growth retardation, global lipodystrophy, joint contractures, thoracic hypoplasia, scoliosis, anodontia, spastic quadriplegia, bilateral hearing loss, aphonia, hypogonadotropic hypogonadism, and cerebellar..."
Scoliosis in an adult survivor.
Nervous System 6
Intellectual disability FREQUENT HP:0001249 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Mild to moderate intellectual disability, annotated with Intellectual disability (HP:0001249). HP:0001249 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:10607952 SUPPORT Human Clinical
"It is apparent, based on the 21 cases, that mild to moderate mental retardation is common in NPS."
Author wording common maps to FREQUENT under the qualitative Pattern C table; based on 21 cases.
PMID:32555393 SUPPORT Human Clinical
"Neonatal progeroid syndrome or Wiedemann-Rautenstrauch syndrome (WRS; MIM 264090) is a rare genetic disorder that has clinical symptoms including premature aging, lipodystrophy, and variable mental impairment."
Variable mental impairment in the disease definition.
PMID:34611991 REFUTE Human Clinical
"She had no signs of developmental delay or intellectual disability."
A molecularly confirmed adult without intellectual disability, showing the feature is not obligate.
Global developmental delay HP:0001263 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Psychomotor developmental delay, annotated with Global developmental delay (HP:0001263). HP:0001263 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:7823529 SUPPORT Human Clinical
"With her a considerable atactic movement disturbance developed next to a psychomotoric retardation."
Psychomotor retardation in the long-term follow-up of the original patient.
PMID:36596744 SUPPORT Human Clinical
"He remains near bed-ridden state at 40 months despite constant physical rehabilitation."
Profound motor delay in a patient with striatal-variant brain involvement.
Ataxia OCCASIONAL HP:0001251 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Progressive ataxia, annotated with Ataxia (HP:0001251). HP:0001251 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:28447407 SUPPORT Human Clinical
"Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some..."
Author wording in some cases maps to OCCASIONAL under the qualitative Pattern C table.
PMID:7823529 SUPPORT Human Clinical
"With her a considerable atactic movement disturbance developed next to a psychomotoric retardation."
Ataxia emerging in the original patient by age 16.
PMID:36825045 SUPPORT Human Clinical
"Patient 1 presented with a neonatal progeroid syndrome and developed parkinsonism, dystonia, ataxia, and spasticity."
Ataxia as part of a later movement-disorder phenotype in a neonatal progeroid patient.
Context-specific annotations (1)
Onset: CHILDHOOD
Tremor OCCASIONAL HP:0001337 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Tremor (HP:0001337). HP:0001337 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:28447407 SUPPORT Human Clinical
"Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some..."
Author wording in some cases maps to OCCASIONAL under the qualitative Pattern C table.
Dystonia HP:0001332 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dystonia (HP:0001332). HP:0001332 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:36825045 SUPPORT Human Clinical
"Patient 1 presented with a neonatal progeroid syndrome and developed parkinsonism, dystonia, ataxia, and spasticity."
Single-patient report of dystonia.
Parkinsonism HP:0001300 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Parkinsonism (HP:0001300). HP:0001300 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:36825045 SUPPORT Human Clinical
"Patient 1 presented with a neonatal progeroid syndrome and developed parkinsonism, dystonia, ataxia, and spasticity."
Single-patient report of parkinsonism.
Growth 4
Intrauterine growth retardation VERY_FREQUENT HP:0001511 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Intrauterine growth retardation (HP:0001511). HP:0001511 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:28447407 SUPPORT Human Clinical
"Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some..."
Listed as a core manifestation across the 15 confirmed and 12 suggestive patients of the 51-patient analysis. Core manifestation is mapped to VERY_FREQUENT under the qualitative Pattern C table (equivalent to hallmark); no percentage was reported.
PMID:30414627 SUPPORT Human Clinical
"It has been proposed to be autosomal-recessive and is characterized by variable clinical features, such as intrauterine growth restriction and poor postnatal weight gain, characteristic facial features (triangular appearance to the face, convex nasal profile or pinched nose, and small mouth),..."
Intrauterine growth restriction in the molecularly confirmed cohort.
Context-specific annotations (1)
Onset: ANTENATAL
Show evidence (1 reference)
PMID:1619643 SUPPORT Human Clinical
"During the pregnancy, growth retardation particularly in the biparietal and abdominal diameters but not the femoral length was detected through serial ultrasound scans."
Antenatal detection of the growth restriction.
Postnatal growth retardation VERY_FREQUENT HP:0008897 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Postnatal growth retardation (HP:0008897). HP:0008897 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:28447407 SUPPORT Human Clinical
"Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some..."
Core manifestation, mapped to VERY_FREQUENT under the qualitative Pattern C table.
PMID:34611991 SUPPORT Human Clinical
"Over the years, above characteristic facial features, she showed severe postnatal growth retardation, global lipodystrophy, joint contractures, thoracic hypoplasia, scoliosis, anodontia, spastic quadriplegia, bilateral hearing loss, aphonia, hypogonadotropic hypogonadism, and cerebellar..."
Persistence of severe postnatal growth retardation in a 37-year-old survivor.
Failure to thrive HP:0001508 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Failure to thrive (HP:0001508). HP:0001508 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:36596744 SUPPORT Human Clinical
"WDRTS cases have distinct clinical features of congenital- or neonatal-onset failure to thrive and lipodystrophy."
Failure to thrive as a distinguishing feature from the allelic leukodystrophy.
PMID:30414627 SUPPORT Human Clinical
"It has been proposed to be autosomal-recessive and is characterized by variable clinical features, such as intrauterine growth restriction and poor postnatal weight gain, characteristic facial features (triangular appearance to the face, convex nasal profile or pinched nose, and small mouth),..."
Poor postnatal weight gain in the seven-patient molecular series.
Short stature HP:0004322 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Short stature (HP:0004322). HP:0004322 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:34289880 SUPPORT Human Clinical
"Wiedemann-Rautenstrauch syndrome (WRS) is a rare autosomal recessive neonatal progeroid disorder characterized by prenatal and postnatal growth retardation, short stature, a progeroid appearance, hypotonia, and mental impairment."
Short stature in the disease definition used by the POLR3B report.
Other 13
Generalized lipodystrophy VERY_FREQUENT HP:0009064 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Generalized lipoatrophy with localized fat pads, annotated with Generalized lipodystrophy (HP:0009064). HP:0009064 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:28447407 SUPPORT Human Clinical
"Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some..."
Core manifestation, mapped to VERY_FREQUENT under the qualitative Pattern C table.
PMID:38397171 SUPPORT Human Clinical
"This syndrome typically manifests neonatally and is characterized by growth retardation, evident generalized lipodystrophy with distinctively localized fat accumulations, sparse scalp hair, and atypical facial features."
Generalized lipodystrophy with localized accumulations in a molecularly confirmed patient.
PMID:18717246 SUPPORT Human Clinical
"Our two patients had characteristic features of WRS, including intrauterine growth retardation, aged appearance, near absence of subcutaneous fat, gluteal fat pads, also labial pad in the first infant, wrinkled thin skin, sparse scalp hair, prominent scalp veins and facial dysmorphism."
Neonatal near-absence of fat with gluteal and labial pads.
Context-specific annotations (1)
Onset: CONGENITAL
Convex nasal ridge HP:0000444 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Convex nasal profile or pinched (beaked) nose, annotated with Convex nasal ridge (HP:0000444). HP:0000444 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:30414627 SUPPORT Human Clinical
"It has been proposed to be autosomal-recessive and is characterized by variable clinical features, such as intrauterine growth restriction and poor postnatal weight gain, characteristic facial features (triangular appearance to the face, convex nasal profile or pinched nose, and small mouth),..."
Convex nasal profile or pinched nose among the characteristic facial features.
PMID:36159344 SUPPORT Human Clinical
"The face appeared progeroid and triangular with a beak-shaped nose, thin erythematous dry skin, bilateral entropion, hypoplastic mandibular rami, and a high palate"
Beak-shaped nose in a neonatal case.
Wide anterior fontanel HP:0000260 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Widened fontanelles, annotated with Wide anterior fontanel (HP:0000260). HP:0000260 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:30414627 SUPPORT Human Clinical
"It has been proposed to be autosomal-recessive and is characterized by variable clinical features, such as intrauterine growth restriction and poor postnatal weight gain, characteristic facial features (triangular appearance to the face, convex nasal profile or pinched nose, and small mouth),..."
Widened fontanelles among the characteristic features.
PMID:36159344 SUPPORT Human Clinical
"Physical examination showed an active crying baby with loss of subcutaneous fat, wide anterior fontanelle, sparse hair, and prominent scalp veins."
Wide anterior fontanelle on neonatal examination.
Wide cranial sutures FREQUENT HP:0010537 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Widely open cranial sutures, annotated with Wide cranial sutures (HP:0010537). HP:0010537 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:28447407 SUPPORT Human Clinical
"In addition we found that prominent scalp veins, wide cranial sutures, the presence of hypodontia, and the lower eyelid covering part of the cornea are also shared very often."
The 51-patient analysis reports wide cranial sutures as "shared very often", mapped conservatively to FREQUENT as for the other features in that sentence. This is a separate finding from the widened fontanelles recorded above.
Thin upper lip vermilion VERY_FREQUENT HP:0000219 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Thin upper vermillion, annotated with Thin upper lip vermilion (HP:0000219). HP:0000219 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:28447407 SUPPORT Human Clinical
"the face characteristics sparse scalp hair, triangular face, small mouth with thin upper vermillion, natal teeth and a pointed chin, and the generalized lipodystrophy with local fatty tissue accumulations all go along together in almost all patients"
Thin upper vermillion is named in the group the 51-patient analysis says occur in "almost all patients", which maps to VERY_FREQUENT under the qualitative Pattern C table. Table 2 of the same paper records 18/18 for this feature in the WRS column.
Sparse eyebrow HP:0045075 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sparse eyebrows, annotated with Sparse eyebrow (HP:0045075). HP:0045075 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:10607952 SUPPORT Human Clinical
"The neonatal progeroid syndrome (NPS), or Wiedemann-Rautenstrauch, is a rare autosomal recessive disorder comprised of generalized lipoatrophy except for fat pads in the suprabuttock areas, hypotrichosis of the scalp hair, eyebrows, and eyelashes, relative macrocephaly, triangular face, natal..."
Hypotrichosis of eyebrows in the syndrome definition.
Sparse eyelashes HP:0000653 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sparse eyelashes (HP:0000653). HP:0000653 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:10607952 SUPPORT Human Clinical
"The neonatal progeroid syndrome (NPS), or Wiedemann-Rautenstrauch, is a rare autosomal recessive disorder comprised of generalized lipoatrophy except for fat pads in the suprabuttock areas, hypotrichosis of the scalp hair, eyebrows, and eyelashes, relative macrocephaly, triangular face, natal..."
Hypotrichosis of eyelashes in the syndrome definition.
Prominent scalp veins FREQUENT HP:0001043 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Prominent scalp veins (HP:0001043). HP:0001043 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:7823529 SUPPORT Human Clinical
"The diagnostic criteria of the neonatal progeroid syndrome (NPS) are: intrauterine and postnatal growth failure, hydrocephalic appearance, prominent scalp veins, old-looking face, absence of subcutaneous fat and neonatal teeth."
Prominent scalp veins among the original diagnostic criteria.
PMID:27612211 SUPPORT Human Clinical
"Characteristic physical findings include neonatal progeroid appearance, sparse scalp hair, prominent scalp veins, and lipoatrophy; in addition, neonatal teeth are often a distinctive finding."
Prominent scalp veins in the first molecularly solved case.
PMID:28447407 SUPPORT Human Clinical
"In addition we found that prominent scalp veins, wide cranial sutures, the presence of hypodontia, and the lower eyelid covering part of the cornea are also shared very often."
The 51-patient analysis reports prominent scalp veins as "shared very often". That wording sits between the "often" (FREQUENT) and "almost all" (VERY_FREQUENT) rows of the Pattern C table, so the band is set conservatively to FREQUENT; Table 2 of the same paper records 17/18 in the WRS column, which would support the higher band.
Natal teeth VERY_FREQUENT Natal tooth HP:0000695 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Natal teeth, annotated with Natal tooth (HP:0000695). HP:0000695 is a phenotype from the Human Phenotype Ontology.
Show evidence (4 references)
PMID:27612211 SUPPORT Human Clinical
"Characteristic physical findings include neonatal progeroid appearance, sparse scalp hair, prominent scalp veins, and lipoatrophy; in addition, neonatal teeth are often a distinctive finding."
Author wording often maps to FREQUENT under the qualitative Pattern C table. Other sources describe natal teeth as present in some patients or as a core manifestation, so the band is uncertain.
PMID:569581 SUPPORT Human Clinical
"Two male infants with a pseudo-hydrocephalic progeroid syndrome with natal teeth are compared with two very similar female cases reported in the literature and interpreted as congenital progeria."
Natal teeth in the original delineation.
PMID:22585414 SUPPORT Human Clinical
"The syndrome is characterized by progeroid appearance, decreased subcutaneous fat, hypotrichosis, macrocephaly, and in some natal teeth."
An older single case report using weaker wording. It is kept for the association but is superseded for the frequency band by the 18-patient series below, which counts natal teeth among the features present in almost all patients.
+ 1 more reference
Context-specific annotations (1)
Onset: CONGENITAL
CNS hypomyelination HP:0003429 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypomyelination or abnormal white matter, annotated with CNS hypomyelination (HP:0003429). HP:0003429 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:38348603 SUPPORT Human Clinical
"The patients have hallmark features such as prenatal and postnatal growth retardation, short stature, a progeroid appearance, hypotonia, facial dysmorphology, hypomyelination leukodystrophy, and mental impairment."
Hypomyelinating leukodystrophy in three consanguineous families; not universal across the literature, so no frequency is assigned.
PMID:41549341 SUPPORT Human Clinical
"In addition to the classic Wiedemann-Rautenstrauch syndrome features-progressive diffuse alopecia, growth retardation, and abnormal white matter development-the patient presented with severe anemia and skin laxity, phenotypes not previously described in Wiedemann-Rautenstrauch syndrome."
Abnormal white matter development in a 2026 case.
Entropion HP:0000621 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Congenital upper eyelid entropion (tarsal kink), annotated with Entropion (HP:0000621). HP:0000621 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:28468175 SUPPORT Human Clinical
"He had tarsal kink in upper eyelids in both eyes."
Bilateral congenital tarsal kink, a form of upper-lid entropion.
PMID:36159344 SUPPORT Human Clinical
"The face appeared progeroid and triangular with a beak-shaped nose, thin erythematous dry skin, bilateral entropion, hypoplastic mandibular rami, and a high palate"
Bilateral entropion on neonatal examination.
Decreased corneal thickness HP:0100689 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Thin central cornea, annotated with Decreased corneal thickness (HP:0100689). HP:0100689 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:26691040 SUPPORT Human Clinical
"We report for the first time the findings of thin central corneas and lagophthalmos in WRS."
Single-patient ophthalmic report.
Hydronephrosis HP:0000126 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Bilateral pelvicalyceal ectasia, annotated with Hydronephrosis (HP:0000126). HP:0000126 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:22585414 SUPPORT Human Clinical
"We describe a new patient with features of bilaterally pelvicalyceal ectasia and partial syndactyly on 2th and 3th toes, not previously described, to our knowledge."
Single variant case; hydronephrosis is the closest HP term to pelvicalyceal ectasia.
🧬

Genetic Associations

3
POLR3A (Causative)
Gene: POLR3A hgnc:30074 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is POLR3A (hgnc:30074). hgnc:30074 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Show evidence (8 references)
PMID:27612211 SUPPORT Human Clinical
"Here we report an infant with the characteristic phenotypic features of Wiedemann-Rautenstrauch syndrome in whom exome sequencing identified two pathogenic variants in POLR3A: c.1909+18G>A; p.(Y637Cfs*23) and c.2617C>T; p.(R873*)."
First report of biallelic POLR3A variants in WRS, including the recurrent c.1909+18G>A intronic allele.
PMID:30414627 SUPPORT Human Clinical
"Our findings confirm the association of bi-allelic POLR3A variants with WRS, expand the clinical phenotype of WRS, and suggest specific POLR3A genotypes associated with WRS and hypomyelinating leukodystrophy."
Independent seven-patient replication establishing POLR3A as the WRS gene.
PMID:30323018 SUPPORT Human Clinical
"Biallelic POLR3A variants were identified in eight affected individuals and monoallelic variants of the same gene in four other individuals."
Twelve-family series; biallelic variants in every individual with sufficient material.
+ 5 more references
Variants (4)
POLR3A c.3337-11T>C Pathogenic
Recurrent intronic variant that perturbs POLR3A splicing; the commonest WRS allele, found in trans with truncating or missense alleles and, in one patient, in cis with c.1909+22G>A on the same haplotype.
Show evidence (2 references)
PMID:38397171 SUPPORT Human Clinical
"Via the analysis of mRNA derived from fibroblasts, we reconfirmed the splicing-affecting nature of the c.3337-11T>C variant."
Patient-fibroblast mRNA analysis confirming the splicing effect of the recurrent allele.
PMID:32555393 SUPPORT Human Clinical
"One of the reported variations in our patient, c.3568C>T, p.(Gln1190Ter), is a novel variation that was not reported before."
Example of the recurrent intronic allele paired in trans with a novel nonsense allele.
POLR3A c.1909+18G>A Pathogenic
Intronic variant predicted to cause a frameshift, p.(Y637Cfs*23), reported in trans with a nonsense allele in the first molecularly solved WRS proband.
Show evidence (1 reference)
PMID:27612211 SUPPORT Human Clinical
"This proband is notable because she had two null pathogenic variants."
The authors treat both alleles, including c.1909+18G>A, as null.
POLR3A c.1771-6C>G / c.1771-7C>G Pathogenic
Adjacent intron-13 variants shared with the striatal and hereditary spastic ataxia presentations of POLR3A-related disease; c.1771-7C>G was found in trans with p.(Arg669Ter) in an Indian WRS patient, and c.1771-6C>G in a Korean WRS patient with striatal-variant brain involvement.
Show evidence (2 references)
PMID:33559318 SUPPORT Human Clinical
"The variant c.1771-7C>G was earlier found to be associated with hereditary spastic ataxia."
The same intronic allele underlies a distinct POLR3A phenotype depending on its partner allele.
PMID:36596744 SUPPORT Human Clinical
"Our patient has a c.1771-6C>G variant and also showed profound neurodevelopmental problem and striatal involvement."
c.1771-6C>G in a WRS patient with the striatal-variant neurologic phenotype.
POLR3A c.3342C>T (p.Ser1114=) Likely Pathogenic
Synonymous exonic variant shown by minigene assay to generate aberrant splice isoforms; an example of a "silent" WRS allele that is pathogenic through transcript processing.
Show evidence (1 reference)
PMID:36385762 SUPPORT In Vitro
"For POLR3A, the synonymous mutation (c.3342C > T, p.Ser1114=) generated three types of aberrant isoforms."
Minigene reporter assay demonstrating aberrant splicing from the synonymous change.
POLR3GL (Candidate second locus (single patient, WRS-like variant phenotype))
Gene: POLR3GL hgnc:28466 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is POLR3GL (hgnc:28466). hgnc:28466 is a gene from the HUGO Gene Nomenclature Committee. variant_origin: GERMLINE
Show evidence (2 references)
PMID:31695177 SUPPORT Human Clinical
"Here, we describe an individual with several clinical features of neonatal progeroid syndrome in whom exome sequencing revealed a homozygous nonsense variant in POLR3GL (NM_032305.2:c.358C>T; p.(Arg120Ter))."
Single-patient report of a POLR3GL nonsense variant with a WRS-like phenotype.
PMID:31695177 SUPPORT Human Clinical
"we propose POLR3GL as a gene causing a variant of neonatal progeroid syndrome and therefore expand the phenotype associated with POLR3GL variants."
The authors themselves frame POLR3GL as causing a variant form rather than classical WRS.
POLR3B (Candidate second locus (single family; variants of uncertain significance))
Gene: POLR3B hgnc:30348 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is POLR3B (hgnc:30348). hgnc:30348 is a gene from the HUGO Gene Nomenclature Committee. variant_origin: GERMLINE
Show evidence (2 references)
PMID:34289880 SUPPORT Human Clinical
"Whole-exome sequencing (WES) of the patient was performed, and POLR3B compound heterozygous variants-c.2191G > C:p.E731Q and c.3046G > A:p.V1016M-were identified in the patient."
The only report linking POLR3B to a WRS diagnosis.
PMID:34289880 SUPPORT Human Clinical
"The American College of Medical Genetics and Genomics guidelines predicted the two variants as variants of uncertain significance (Table 1)."
The report's own ACMG classification limits the strength of the POLR3B claim.
🗃️

External Assertions

1
OMIM Wiedemann-Rautenstrauch syndrome record
OMIM disease record OMIM:264090
OMIM phenotype identifier for Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome).
💊

Medical Actions

5
Multidisciplinary supportive care
Category: Therapeutic Action: Supportive CareNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Supportive Care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. NCIT:C15747
There is no disease-modifying therapy. Care is supportive and symptom directed, covering feeding support, infection management, monitoring of renal and electrolyte status in the neonatal period, careful handling because of osteopenia, ophthalmic protection where lagophthalmos or entropion is present, dental care, and developmental and neurological follow-up in survivors.
Target Phenotypes: Failure to thrive HP:0001508 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Failure to thrive (HP:0001508). HP:0001508 is a phenotype from the Human Phenotype Ontology. Osteopenia HP:0000938 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Osteopenia (HP:0000938). HP:0000938 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:18717246 SUPPORT Human Clinical
"We evaluated bone mineral findings in our two patients with WRS and recommend caution when handling children with WRS."
Handling precautions because of severe neonatal osteopenia.
PMID:36159344 SUPPORT Human Clinical
"We reported a case of a three-days old male neonate with features of WRS presented with fatal hyperkalemic renal failure which is a unique presentation not reported before in the cases affected with this syndrome."
Justifies neonatal renal and electrolyte surveillance as part of supportive care.
Nutritional support
Category: Therapeutic Action: High-calorie enteral nutritional supportNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is High-calorie enteral nutritional support, annotated with Nutritional Support (NCIT:C15433). NCIT:C15433 is a clinical intervention from the NCI Thesaurus. Ontology label: Nutritional Support NCIT:C15433
Platform: Behavioral / lifestyle
High-calorie formula and enteral tube feeding are used for failure to thrive, but weight gain is often poor because the growth failure is intrinsic and vomiting and aspiration complicate feeding.
Target Phenotypes: Failure to thrive HP:0001508 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Failure to thrive (HP:0001508). HP:0001508 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:36596744 SUPPORT Human Clinical
"Nutritional support using high calorie milk and enteral tube was ineffective to gain weight due to frequent vomiting and aspiration."
Documents the intervention and its limited effectiveness in one patient.
Physical rehabilitation
Category: Therapeutic Action: Physical therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Physical therapy (NCIT:C15302). NCIT:C15302 is a clinical intervention from the NCI Thesaurus. Ontology label: Physical Therapy NCIT:C15302
Platform: Behavioral / lifestyle
Physiotherapy for hypotonia, motor delay and contractures; benefit is limited in patients with progressive neurological involvement.
Target Phenotypes: Hypotonia HP:0001252 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Hypotonia (HP:0001252). HP:0001252 is a phenotype from the Human Phenotype Ontology. Global developmental delay HP:0001263 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Global developmental delay (HP:0001263). HP:0001263 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:36596744 SUPPORT Human Clinical
"He remains near bed-ridden state at 40 months despite constant physical rehabilitation."
Documents use of rehabilitation and its limited effect in a severely affected patient.
Eyelid surgery for congenital tarsal kink
Category: Therapeutic Action: Everting-suture correction of upper eyelid tarsal kinkNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Everting-suture correction of upper eyelid tarsal kink, annotated with Ophthalmologic Surgical Procedure (NCIT:C15331). NCIT:C15331 is a clinical intervention from the NCI Thesaurus. Ontology label: Ophthalmologic Surgical Procedure NCIT:C15331
Platform: Surgery
Bilateral upper-lid tarsal kink was corrected with everting sutures via a transconjunctival approach under local anesthesia.
Target Phenotypes: Entropion HP:0000621 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Entropion (HP:0000621). HP:0000621 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:28468175 SUPPORT Human Clinical
"The authors treated bilateral tarsal kink with an everting suture via a transconjunctival approach under local anesthesia."
Single-patient surgical report.
Genetic counseling and prenatal diagnosis
Category: Counseling / Informational Action: Genetic CounselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Genetic Counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. NCIT:C15240
Autosomal recessive inheritance gives a 25% recurrence risk per pregnancy. Molecular prenatal diagnosis is possible when both familial POLR3A variants are known; serial ultrasound detected growth restriction in a recurrence pregnancy before the gene was identified.
Show evidence (1 reference)
PMID:1619643 SUPPORT Human Clinical
"When the woman became pregnant again, in spite of having been assessed as having a 25% risk of recurrence, the prenatal findings seen in her previous pregnancy led us to suggest sequential echography and a similar pattern of growth retardation was shown."
Recurrence-risk counseling and ultrasound-based prenatal diagnosis in a second pregnancy.
🔬

Biochemical Markers

3
Urinary deoxypyridinoline (ELEVATED)
Context: Bone-resorption marker measured in two neonates with severe osteopenia.
Show evidence (1 reference)
PMID:18717246 SUPPORT Human Clinical
"They also have severe osteopenia and elevated urinary deoxypyridinoline levels which have not been previously described in patients with WRS."
Elevated urinary deoxypyridinoline as a readout of increased bone resorption.
Serum prolactin (ELEVATED)
Context: Reported in a minority of patients; mechanism unexplained.
Show evidence (1 reference)
PMID:18717246 SUPPORT Human Clinical
"Impaired lipid and hormone profiles including elevated prolactin and triglyceride level have been reported in patients with WRS."
Review statement summarizing prior hormone findings.
Serum triglycerides (ELEVATED)
Context: Reported in a minority of patients, consistent with the generalized lipodystrophy.
Show evidence (1 reference)
PMID:18717246 SUPPORT Human Clinical
"Impaired lipid and hormone profiles including elevated prolactin and triglyceride level have been reported in patients with WRS."
Review statement summarizing prior lipid findings.
🔬

Diagnosis

4
Molecular genetic testing of POLR3A
Diagnosis is confirmed by identifying biallelic POLR3A variants. Because many WRS alleles are deep-intronic or synonymous and are missed by coding-only filters, clinical suspicion must drive targeted intronic analysis and, where possible, RNA studies.
POLR3A sequencing including intronic regions NCIT:C15709 NCI Thesaurus (NCIT)
Results: Biallelic POLR3A variants, typically a recurrent intronic allele in trans with a truncating or missense allele.
Show evidence (2 references)
PMID:30323018 SUPPORT Human Clinical
"Multiple variants were found to affect POLR3A transcript processing and were mostly located in deep intronic regions, making clinical suspicion fundamental to detection."
Deep-intronic alleles make targeted, suspicion-driven testing essential.
PMID:38397171 SUPPORT Human Clinical
"Utilizing whole-exome sequencing (WES), we identified a novel missense variant c.3677T>C (p.Leu1226Pro) in the POLR3A gene (NM_007055.4) alongside two cis intronic variants c.1909+22G>A and c.3337-11T>C."
Exome sequencing with attention to near-exon intronic variants resolved the diagnosis.
Whole-exome sequencing
Trio or singleton exome sequencing has been the discovery and diagnostic modality in most molecularly confirmed cases.
Whole exome sequencing NCIT:C101295 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:34289880 SUPPORT Human Clinical
"Our study not only identified a novel WRS-associated gene, POLR3B, but also broadened the mutational and phenotypic spectra of POLR3B."
Exome sequencing as the route to a molecular diagnosis in a progeroid proband.
Prenatal ultrasound
In a family with a previous affected child, serial ultrasound showing growth retardation of the biparietal and abdominal diameters with preserved femoral length identified a second affected pregnancy before molecular testing was available.
Serial prenatal ultrasound NCIT:C222238 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:1619643 SUPPORT Human Clinical
"This case shows that ultrasound examination can be a useful tool in the prenatal diagnosis of this rare, autosomal recessive syndrome."
Ultrasound-based prenatal recognition in a recurrence pregnancy.
Brain magnetic resonance imaging
Brain MRI evaluates white-matter involvement; delayed myelination, striatal involvement and superior cerebellar peduncle or midbrain hyperintensity have been reported in POLR3A-related disease including WRS.
Brain MRI NCIT:C16809 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:36825045 SUPPORT Human Clinical
"The most common brain MRI abnormality was T2-weighted/FLAIR hyperintensity of the superior cerebellar peduncles and midbrain."
Imaging sign suggestive of POLR3A-related disease.
📈

Progression

3
Neonatal period and infancy
Age: Birth to 1 year
The period of highest mortality. In the 18-patient gold-standard series six of the patients whose outcome is recorded died within the first year, four of them in the first weeks of life. Death is usually attributed to malnutrition or infection rather than to a single organ failure, and one neonate died of hyperkalemic renal failure on day three.
Show evidence (3 references)
PMID:28447407 SUPPORT Human Clinical
"Four patients have died within the 1st weeks of life, 2 other in the 1st year, 4 between 5 and 10 years of age, 1 at 17 years, but 2 are still alive at age 20 years."
Gives the age-at-death distribution for the molecularly and photographically confirmed WRS patients.
PMID:36159344 SUPPORT Human Clinical
"The average survival in WRS is seven months, although survival into the third decade of life has been reported"
States the reported average survival, which falls inside this phase.
PMID:36159344 SUPPORT Human Clinical
"WRS patients have a short life expectancy due to malnutrition"
Identifies malnutrition as a proximate cause of the early mortality.
Late infancy and childhood
Age: 1 to 10 years
Survivors of infancy develop and then accumulate neurological signs, chiefly tremor, hypertonia and ataxia, which is what makes WRS a progressive rather than a purely static congenital disorder. Growth failure and lipoatrophy persist unchanged. Four of the recorded deaths fall between 5 and 10 years.
Show evidence (2 references)
PMID:28447407 SUPPORT Human Clinical
"These symptoms arise typically in late infancy or childhood."
Dates the onset of the progressive neurological signs to this phase.
PMID:28447407 SUPPORT Human Clinical
"showed a clear progression in signs and symptoms with time, especially with respect of neurological signs as tremor, hypertonia, and ataxia"
Establishes that the neurological phenotype progresses rather than remaining static.
Adolescence and adulthood
Age: Second and third decade
A minority reach adolescence or adulthood. In the confirmed series one patient was alive at 17 years and two at 20 years, and survival into the third decade is reported. These survivors carry the accumulated neurological burden of the previous phase; ataxia and tremor increase with age.
Show evidence (2 references)
PMID:28447407 SUPPORT Human Clinical
"1 at 17 years, but 2 are still alive at age 20 years"
Documents the long-surviving minority within the confirmed series.
PMID:28447407 SUPPORT Human Clinical
"the progressive nature of WRS became clear in the increase with age of ataxia and tremor in some of the patients"
Describes what continues to change in the patients who survive longest.
📊

Prevalence

1
Worldwide
Cases In Literature Ultra Rare
No population prevalence has been measured. Fewer than 40 patients had been reported by 2016 and "over 50" by 2022; Orphanet classes the disorder as <1/1,000,000 but its ORPHA:3455 record is not in the structured cache, so that figure is not cited as evidence here.
Show evidence (2 references)
PMID:27612211 SUPPORT Human Clinical
"Wiedemann-Rautenstrauch syndrome, also known as neonatal progeroid syndrome, is a rare condition with fewer than 40 patients reported in the literature."
Literature case count as of 2016.
PMID:36385762 SUPPORT Human Clinical
"Currently, over 50 cases with variable phenotypes of WDRTS have been reported."
Literature case count as of 2022, consistent with an ultra-rare disorder.
⚖️

Clinical Burden

High
WRS is frequently lethal in the first year of life and imposes lifelong multi-system disability on those who survive. Of the confirmed patients whose outcome is recorded, six died within the first year and four more before age ten, with reported average survival of seven months. Survivors face feeding failure that does not respond to high-calorie enteral support, progressive ataxia, tremor and spasticity, intellectual disability in most, and dental, ophthalmic and skeletal complications. No disease-modifying therapy exists, so the entire burden is met with supportive care.
Show evidence (3 references)
PMID:28447407 SUPPORT Human Clinical
"Four patients have died within the 1st weeks of life, 2 other in the 1st year, 4 between 5 and 10 years of age, 1 at 17 years, but 2 are still alive at age 20 years."
Quantifies the mortality that dominates the burden assessment.
PMID:36159344 SUPPORT Human Clinical
"The average survival in WRS is seven months, although survival into the third decade of life has been reported"
Reported average survival supports a HIGH rather than VARIABLE burden level.
PMID:36596744 SUPPORT Human Clinical
"Nutritional support using high calorie milk and enteral tube was ineffective to gain weight due to frequent vomiting and aspiration."
Illustrates the refractory feeding burden carried by survivors.
🔀

Differential Diagnoses

4

Conditions with similar clinical presentations that must be differentiated from Wiedemann-Rautenstrauch Syndrome:

Hutchinson-Gilford progeria syndrome MONDO:0008310
Overlapping Features The prototypic progeria, caused by a recurrent de novo LMNA variant, presents after the first year with progressive loss of fat and hair and vascular disease; it lacks the neonatal onset, natal teeth and pseudohydrocephalus of WRS, and LMNA is normal in WRS.
Distinguishing Features
  • Onset after infancy in HGPS versus at birth in WRS
  • LMNA G608G in HGPS; no LMNA variants in WRS
  • Sporadic dominant in HGPS versus recessive in WRS
Show evidence (2 references)
PMID:19938095 SUPPORT Human Clinical
"We did not find mutations in Lamin A/C (LMNA) gene in four WRS patients, and in particular, we did not find the G608G mutation (GGC > GGT transition) which is associated with most cases with Hutchinson-Gilford progeria (OMIM 176670)."
Molecular exclusion of HGPS in clinically diagnosed WRS.
PMID:30450527 SUPPORT Human Clinical
"Thus, we suggest that POLR3A mutations are causal for a portion of under-diagnosed early-onset segmental progeroid syndromes."
POLR3A testing resolves LMNA-negative progeroid cases.
Marfanoid-progeroid-lipodystrophy syndrome MONDO:0014831
Overlapping Features Neonatal progeroid appearance with congenital generalized lipodystrophy caused by 3-prime FBN1 truncating variants; repeatedly diagnosed at birth as WRS. The marfanoid habitus, ectopia lentis and aortic dilation that emerge later, dominant de novo inheritance and the FBN1 genotype distinguish it.
Distinguishing Features
  • Later marfanoid skeletal and ocular features and aortic root dilation
  • De novo heterozygous 3-prime FBN1 variant rather than biallelic POLR3A variants
  • Normal intellect and preserved insulin sensitivity
Show evidence (1 reference)
PMID:24613577 SUPPORT Human Clinical
"We report a 16-year-old girl with neonatal progeroid features and congenital lipodystrophy who was considered at birth as a possible variant of Wiedemann-Rautenstrauch syndrome."
Documents the neonatal misdiagnosis that makes this the leading non-POLR3A differential.
POLR3A striatal variant
Overlapping Features Biallelic POLR3A genotypes including c.1771-6C>G or c.1771-7C>G produce an early-onset, rapidly progressive neurologic disorder with focal striatal involvement rather than diffuse hypomyelination. One WRS patient carried c.1771-6C>G and showed both the progeroid and lipodystrophic phenotype and striatal involvement, so the two can coincide.
Distinguishing Features
  • Striatal MRI involvement and profound neurodevelopmental impairment
  • Absence of lipodystrophy and progeroid face in the classic striatal variant
Show evidence (2 references)
PMID:36596744 SUPPORT Human Clinical
"Our patient has a c.1771-6C>G variant and also showed profound neurodevelopmental problem and striatal involvement."
Overlap case linking WRS with the striatal-variant allele and imaging pattern.
PMID:33559318 SUPPORT Human Clinical
"The variant c.1771-7C>G was earlier found to be associated with hereditary spastic ataxia."
The neighbouring intronic allele is shared with another POLR3A neurologic phenotype.
🧫

Experimental Models

5
WRS patient primary dermal fibroblasts PRIMARY_CELL_CULTURE
Primary skin fibroblasts from one WRS patient carrying the truncating allele c.3772_3773delCT (p.Leu1258Glyfs*12), compared with a control line.
skin fibroblast CL:0002620 Cell Ontology (CL) Relation: this experimental model uses this cell type This experimental model uses skin fibroblast (CL:0002620). CL:0002620 is a cell type from the Cell Ontology.
Organism
human NCBITaxon:9606 NCBI Taxonomy (NCBITaxon) Relation: this experimental model is built in this organism This experimental model is built in human, annotated with Homo sapiens (NCBITaxon:9606). NCBITaxon:9606 is an organism from the NCBI Taxonomy.
Publication
PMID:32976914
Pathograph links
Reduced Wild-Type POLR3A Expression measures fidelity: moderate Quantifies wild-type versus mutant POLR3A transcript and protein in patient cells.
Limitations: A single patient; only one allele was characterized in the report, so the contribution of the second allele to the residual wild-type pool is unknown.
Readouts
Wild-type POLR3A mRNA and protein
Direction: DECREASED
Interpretation: Less wild-type catalytic subunit is available for Pol III assembly.
Show evidence (1 reference)
PMID:32976914 SUPPORT In Vitro
"The mutation caused a decrease in the expression of wildtype POLR3A mRNA and POLR3A protein and a sharp increase in mutant protein expression."
The measurement behind this readout.
Show evidence (1 reference)
PMID:32976914 SUPPORT In Vitro
"The mutation caused a decrease in the expression of wildtype POLR3A mRNA and POLR3A protein and a sharp increase in mutant protein expression."
Establishes that this model measures the wild-type POLR3A level that defines the target node.
Nucleolar Disruption, p53 Activation and Premature Senescence recapitulates fidelity: moderate Patient fibroblasts show the nucleolar, p53 and senescence phenotype that defines this node.
Limitations: Cultured fibroblasts from one patient; in vitro passaging itself induces senescence, and the phenotype has not been shown in the affected tissues such as adipose, bone or brain.
Readouts
Nucleolar number and area
Direction: INCREASED
Interpretation: Nucleolar stress readout.
Show evidence (1 reference)
PMID:32976914 SUPPORT In Vitro
"These changes were associated with an increase in the number and area of nucleoli and to a high increase in the expression of pP53 and pH2AX."
Reports the nucleolar measurement.
Phospho-p53 and phospho-H2AX expression
Direction: INCREASED
Interpretation: DNA-damage-response and p53 activation readout.
Show evidence (1 reference)
PMID:32976914 SUPPORT In Vitro
"These changes were associated with an increase in the number and area of nucleoli and to a high increase in the expression of pP53 and pH2AX."
Reports the pP53 and pH2AX measurement.
Premature senescence
Direction: INCREASED
Interpretation: Cellular outcome of the nucleolar and p53 response.
Show evidence (1 reference)
PMID:32976914 SUPPORT In Vitro
"All these changes were associated with premature senescence."
Reports the senescence outcome.
Show evidence (1 reference)
PMID:32976914 SUPPORT In Vitro
"The present observations add to our understanding of the differences between Hutchinson-Gilford progeria syndrome and WRS and opens new alternatives to study cell senesce and human aging."
The authors position the fibroblast model as informative for WRS senescence biology.
Show evidence (1 reference)
PMID:32976914 SUPPORT In Vitro
"We aim to describe the cellular and molecular features of WRS fibroblasts."
The study's stated purpose is to characterize patient-derived WRS fibroblasts, which is what this model is.
WRS patient-derived induced pluripotent stem cells IPSC_DERIVED_MODEL
iPSCs reprogrammed by a non-integrating episomal method from fibroblasts of a WRS patient with biallelic POLR3A variants, alongside an HGPS iPSC line.
Organism
human NCBITaxon:9606 NCBI Taxonomy (NCBITaxon) Relation: this experimental model is built in this organism This experimental model is built in human, annotated with Homo sapiens (NCBITaxon:9606). NCBITaxon:9606 is an organism from the NCBI Taxonomy.
Publication
PMID:41081995
Pathograph links
Nucleolar Disruption, p53 Activation and Premature Senescence partially recapitulates fidelity: low Reproduces nucleolar abnormality and adds TERC sequestration, but in a pluripotent state that overexpresses POLR3A.
Limitations: POLR3A is upregulated during reprogramming, so mutant POLR3A is expressed above the level found in differentiated patient cells; pluripotent cells do not senesce, so the senescence limb of the node cannot be modelled here.
Readouts
Nucleolar morphology and TERC localization
Direction: ALTERED
Interpretation: Nucleolar abnormality with telomerase RNA sequestration.
Show evidence (1 reference)
PMID:41081995 SUPPORT In Vitro
"Enhanced expression of mutant POLR3A in WRS iPSCs led to nucleolus abnormalities and telomerase RNA component (TERC) sequestration in the nucleoli in WRS iPSCs."
Reports the nucleolar and TERC measurement.
Show evidence (1 reference)
PMID:41081995 SUPPORT In Vitro
"Whereas lamin A is downregulated in iPSCs, allowing for regeneration of HGPS iPSCs, we found that POLR3A is upregulated during reprogramming."
Explains why the model exaggerates mutant POLR3A expression.
Show evidence (1 reference)
PMID:41081995 SUPPORT In Vitro
"using a non-integrative episomal approach we reprogrammed iPSCs from cells of a patient suffering from Wiedemann-Rautenstrauch Syndrome (WRS), which is caused by bi-allelic pathogenic mutations of the RNA polymerase III subunit A gene (POLR3A)"
Establishes the derivation and genotype of this patient iPSC model.
WRS bone-marrow-derived progenitor differentiation culture PRIMARY_CELL_CULTURE
Bone-marrow-derived stem cells from a 16-year-old WRS patient, stimulated toward osteoblastic and chondroblastic differentiation with dexamethasone, ascorbic acid and beta-glycerophosphate over 21 days, compared with a healthy donor.
mesenchymal stem cell CL:0000134 Cell Ontology (CL) Relation: this experimental model uses this cell type This experimental model uses mesenchymal stem cell (CL:0000134). CL:0000134 is a cell type from the Cell Ontology.
Organism
human NCBITaxon:9606 NCBI Taxonomy (NCBITaxon) Relation: this experimental model is built in this organism This experimental model is built in human, annotated with Homo sapiens (NCBITaxon:9606). NCBITaxon:9606 is an organism from the NCBI Taxonomy.
Publication
PMID:16097434
Pathograph links
Impaired Mesenchymal Progenitor Proliferation and Differentiation recapitulates fidelity: moderate The only direct measurement of progenitor differentiation capacity in WRS.
Limitations: A single patient predating molecular diagnosis, so the POLR3A genotype is unknown; one control donor; an in vitro differentiation assay rather than tissue formation.
Readouts
Osteoblastic differentiation response
Direction: DECREASED
Interpretation: Reduced osteogenic capacity of patient progenitors.
Show evidence (1 reference)
PMID:16097434 SUPPORT In Vitro
"It was shown, for the first time, that WRS cells showed a highly significant lower in vitro response to osteoblastic differentiation stimulus."
Reports the osteoblastic readout.
Chondrocyte and hematopoietic cell induction
Direction: DECREASED
Interpretation: Reduced chondrogenic and hematopoietic output.
Show evidence (1 reference)
PMID:16097434 SUPPORT In Vitro
"Furthermore, significantly fewer chondrocytes and hematopoietic cells were induced in WRS progenitors compared to the control group."
Reports the chondrocyte and hematopoietic readouts.
Show evidence (1 reference)
PMID:16097434 SUPPORT In Vitro
"Bone marrow-derived stem cells of a 16-year-old WRS patient were cultivated and stimulated by dexamethasone, ascorbic acid and beta-glycerolphosphate (DAG) over 21 days."
Describes the progenitor culture system.
Show evidence (1 reference)
PMID:16097434 SUPPORT In Vitro
"To elucidate the osteoblastic and chondroblastic regeneration potential in WRS, a progenitor cell culture system was used."
States what the progenitor culture system was built to measure.
POLR3A c.3342C>T minigene splicing reporter CELL_LINE
A pEGFP-N1 minigene spanning POLR3A exons 25 to 27 carrying the synonymous c.3342C>T (p.Ser1114=) variant, transfected into HEK293 or HeLa cells to test the effect on pre-mRNA splicing.
Organism
human NCBITaxon:9606 NCBI Taxonomy (NCBITaxon) Relation: this experimental model is built in this organism This experimental model is built in human, annotated with Homo sapiens (NCBITaxon:9606). NCBITaxon:9606 is an organism from the NCBI Taxonomy.
Publication
PMID:36385762
Pathograph links
Aberrant POLR3A Transcript Processing recapitulates fidelity: moderate Shows that a synonymous WRS allele produces aberrant splice isoforms.
Limitations: A minigene reports splicing of a three-exon fragment in heterologous cells, not the full POLR3A transcript in patient tissue; isoform proportions may differ in vivo.
Readouts
Aberrant splice isoforms from the c.3342C>T minigene
Direction: INCREASED
Interpretation: The synonymous variant disrupts normal splicing.
Show evidence (1 reference)
PMID:36385762 SUPPORT In Vitro
"For POLR3A, the synonymous mutation (c.3342C > T, p.Ser1114=) generated three types of aberrant isoforms."
Reports the isoform readout.
Show evidence (1 reference)
PMID:36385762 SUPPORT In Vitro
"for minigene splicing reporter assays to test their effects on pre-mRNA splicing"
Establishes the minigene reporter as the assay system used for this variant.
POLR3A p.M852V CRISPR-edited HEK293 and oligodendroglial cells CELL_LINE
HEK293 clones carrying the leukodystrophy-causing POLR3A c.2554A>G (p.M852V) allele, homozygous or in trans with a frameshift, plus MO3.13 oligodendroglial cells, profiled for Pol III transcript output.
Organism
human NCBITaxon:9606 NCBI Taxonomy (NCBITaxon) Relation: this experimental model is built in this organism This experimental model is built in human, annotated with Homo sapiens (NCBITaxon:9606). NCBITaxon:9606 is an organism from the NCBI Taxonomy.
Publication
PMID:30898877
Pathograph links
RNA Polymerase III Transcriptional Hypofunction partially recapitulates fidelity: low Demonstrates that a hypomorphic POLR3A allele lowers tRNA and BC200 output, the step assumed but not measured in WRS.
Limitations: The allele studied causes 4H leukodystrophy, not WRS; WRS allele combinations have not been profiled, so the magnitude and transcript selectivity of Pol III hypofunction in WRS is extrapolated.
Readouts
Precursor and mature tRNA levels
Direction: DECREASED
Interpretation: Global reduction of tRNA output from hypomorphic Pol III.
Show evidence (1 reference)
PMID:30898877 SUPPORT In Vitro
"Transcriptomic profiling uncovered a subset of transcripts vulnerable to Pol III hypofunction, including a global reduction in tRNA levels."
Reports the tRNA measurement.
Show evidence (1 reference)
PMID:30898877 SUPPORT INDIRECT In Vitro
"The brain cytoplasmic BC200 RNA (BCYRN1), involved in translation regulation, was consistently affected in all our cellular models, including patient-derived fibroblasts."
Supports Pol III hypofunction as a consequence of pathogenic POLR3A variants; patients here have leukodystrophy, not WRS.
Show evidence (1 reference)
PMID:30898877 SUPPORT In Vitro
"we used CRISPR-Cas9 to introduce the POLR3A mutation"
Establishes the CRISPR-edited cell lines as the model system.
🐁

Animal Models

2
Polr3a G672E knock-in mouse
Mice carrying the French-Canadian founder 4H-leukodystrophy allele, either homozygous or over a null allele, are viable and fertile with normal motor behaviour, normal myelin staining and protein levels, and no significant change in brain Pol III transcripts. No mouse model of WRS exists; this leukodystrophy model is recorded because it is the closest available and because its negative result bears on what a WRS model would need.
Species
Mouse
Genotype
Polr3a c.2015G>A (p.G672E) homozygous knock-in, and knock-in over null
Genes
POLR3A hgnc:30074 HUGO Gene Nomenclature Committee (hgnc) Relation: this experimental model concerns this gene This experimental model concerns POLR3A (hgnc:30074). hgnc:30074 is a gene from the HUGO Gene Nomenclature Committee.
Publication
PMID:28407788
Pathograph links
Central Nervous System Hypomyelination fails to recapitulate fidelity: low A homozygous leukodystrophy allele does not produce hypomyelination in mouse.
Limitations: Leukodystrophy allele rather than a WRS genotype; the G672E allele may be too mild in mouse, and rodent oligodendrogenesis may tolerate Pol III perturbation better than human. The absence of a phenotype in this model is not evidence against Pol III-dependent hypomyelination in humans.
Readouts
Luxol Fast Blue myelin staining and myelin protein levels
Direction: UNCHANGED
Interpretation: Myelination not overtly impaired.
Show evidence (1 reference)
PMID:28407788 SUPPORT Model Organism
"Cerebral and cerebellar Luxol Fast Blue staining and measurement of levels of myelin proteins showed no significant differences between the three groups, suggesting that myelination is not overtly impaired in Polr3a KI/KI and KI/KO mice."
Reports the myelin measurement.
Show evidence (1 reference)
PMID:28407788 SUPPORT Model Organism
"We conclude that the first transgenic mice with a leukodystrophy-causing Polr3a mutation do not recapitulate the childhood-onset HLD observed in the majority of human patients with POLR3A mutations, and provide essential information to guide selection of Polr3a mutations for developing future..."
The authors' own statement that the model fails to recapitulate the human disease.
Show evidence (1 reference)
PMID:28407788 SUPPORT Model Organism
"we introduced the French Canadian founder Polr3a mutation c.2015G > A (p.G672E) in mice, generating homozygous knock-in (KI/KI) as well as compound heterozygous mice for one Polr3a KI and one null allele (KI/KO)."
Establishes the genotypes of the two mouse lines described here.
Oligodendrocyte-lineage conditional Polr3a mutant mouse
Conditional expression of pathogenic Polr3a mutations in the Olig2 lineage produces impaired growth, developmental delay, cognitive and sensorimotor deficits and cerebral and spinal hypomyelination, with fewer mature oligodendrocytes and thinner myelin; cerebellar hypomyelination and gross motor deficits are absent.
Species
Mouse
Genotype
Pathogenic Polr3a alleles expressed conditionally in Olig2-expressing cells
Genes
POLR3A hgnc:30074 HUGO Gene Nomenclature Committee (hgnc) Relation: this experimental model concerns this gene This experimental model concerns POLR3A (hgnc:30074). hgnc:30074 is a gene from the HUGO Gene Nomenclature Committee.
Publication
PMID:34583988
Pathograph links
Central Nervous System Hypomyelination partially recapitulates fidelity: moderate Establishes that Pol III perturbation restricted to the oligodendrocyte lineage is sufficient for hypomyelination.
Limitations: Leukodystrophy alleles restricted to one lineage; the systemic WRS phenotype of lipodystrophy, craniofacial dysmorphogenesis and growth failure cannot be assessed, and cerebellar hypomyelination is not reproduced.
Readouts
Myelination of cerebrum and spinal cord
Direction: DECREASED
Interpretation: Hypomyelination from lineage-restricted Pol III perturbation.
Show evidence (1 reference)
PMID:34583988 SUPPORT Model Organism
"Here we show that mice expressing pathogenic mutations in the largest Pol III subunit, Polr3a, specifically in Olig2-expressing cells, have impaired growth and developmental delay, deficits in cognitive, sensory, and fine sensorimotor function, and hypomyelination in multiple regions of the..."
Reports the hypomyelination measurement.
Show evidence (1 reference)
PMID:34583988 SUPPORT Model Organism
"In contrast, the gross motor defects and cerebellar hypomyelination that are common features of severely affected patients are absent in the mice, suggesting a relatively mild form of the disease in this conditional model."
The authors' own account of what the model does and does not reproduce.
Show evidence (1 reference)
PMID:34583988 SUPPORT Model Organism
"Our results show that disease pathogenesis in the mice involves defects that reduce both the number of mature myelinating oligodendrocytes and the ability of these cells to produce a myelin sheath of normal thickness."
States the cellular defect this conditional mouse model demonstrates.
{ }

Source YAML

click to show 
name: Wiedemann-Rautenstrauch Syndrome
creation_date: "2026-09-05T06:37:27Z"
category: Mendelian
description: >-
  Wiedemann-Rautenstrauch syndrome (WRS), also called neonatal progeroid syndrome,
  is an ultra-rare autosomal recessive segmental progeroid disorder that is
  recognizable at birth. Affected infants show marked intrauterine and severe
  postnatal growth failure, generalized loss of subcutaneous fat with paradoxical
  localized fat pads (classically gluteal/suprabuttock and labial), a
  pseudohydrocephalic appearance produced by relative macrocephaly, widened
  fontanelles, sparse scalp hair and prominent scalp veins over a triangular face
  with a pinched or convex nose, small mouth and pointed chin, natal teeth and
  later hypodontia, thin skin, hypotonia, and variable intellectual disability.
  Survivors may develop progressive ataxia and tremor, and a subset show central
  white-matter abnormalities that overlap with the allelic POLR3A-related
  hypomyelinating leukodystrophy.

  The syndrome is caused by biallelic POLR3A variants that, taken together,
  leave residual RNA polymerase III activity: typically a recurrent intronic
  splice-affecting allele (most often c.3337-11T>C, or c.1909+18G>A) in trans
  with a null or missense allele. Patient fibroblasts and iPSCs show reduced
  wild-type POLR3A, nucleolar disruption, p53 activation and premature
  senescence, and patient progenitors differentiate poorly along osteogenic and
  chondrogenic lineages; how Pol III hypofunction produces the adipose and
  craniofacial phenotypes specifically is still inferred rather than
  demonstrated. Rare WRS-like presentations have been attributed to POLR3GL and
  POLR3B. Management is supportive, with no disease-modifying therapy.
disease_term:
  preferred_term: Wiedemann-Rautenstrauch syndrome
  term:
    id: MONDO:0009910
    label: Wiedemann-Rautenstrauch syndrome
synonyms:
- WRS
- WDRTS
- Neonatal progeroid syndrome
- NPS
- Neonatal pseudohydrocephalic progeroid syndrome
- Congenital pseudohydrocephalic progeroid syndrome
- Progeroid syndrome, neonatal
parents:
- Progeroid syndrome
- Congenital lipodystrophy
external_assertions:
- name: OMIM Wiedemann-Rautenstrauch syndrome record
  source: OMIM
  assertion_type: disease_record
  external_id: OMIM:264090
  description: OMIM phenotype identifier for Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome).
inheritance:
- name: Autosomal recessive inheritance
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  expressivity: VARIABLE
  description: >-
    Autosomal recessive, with affected sib pairs from unaffected parents reported
    before the gene was known and biallelic POLR3A variants (compound
    heterozygous far more often than homozygous) in molecularly confirmed cases.
    Expressivity is markedly variable, from death in the first months to
    survival into adulthood.
  evidence:
  - reference: PMID:10607952
    reference_title: "Neonatal progeroid (Wiedemann-Rautenstrauch) syndrome: report of five new cases and review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The fact that there are 2 pairs of sibs among the 5 patients further supports that NPS is an autosomal recessive condition."
    explanation: Sib recurrence from unaffected parents in the largest pre-molecular series supports recessive inheritance.
  - reference: PMID:21671373
    reference_title: "Neonatal progeroid syndrome (Wiedemann-Rautenstrauch syndrome): report of three affected sibs."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our findings support autosomal recessive inheritance in WRS and support the possibility of homozygocity mapping as a good approach to find the causative gene."
    explanation: Three affected sibs born to unaffected, non-consanguineous parents.
  - reference: PMID:30414627
    reference_title: "Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here we present seven additional infants, children, and adults with WRS and bi-allelic truncating and/or splicing variants in POLR3A."
    explanation: Molecular confirmation that affected individuals carry biallelic POLR3A variants.
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Patients reported to date demonstrate a remarkable variability in phenotype, which hampers diagnostics."
    explanation: Supports the VARIABLE expressivity classification.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    No population prevalence has been measured. Fewer than 40 patients had been
    reported by 2016 and "over 50" by 2022; Orphanet classes the disorder as
    <1/1,000,000 but its ORPHA:3455 record is not in the structured cache, so
    that figure is not cited as evidence here.
  evidence:
  - reference: PMID:27612211
    reference_title: "Neonatal progeriod syndrome associated with biallelic truncating variants in POLR3A."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Wiedemann-Rautenstrauch syndrome, also known as neonatal progeroid syndrome, is a rare condition with fewer than 40 patients reported in the literature."
    explanation: Literature case count as of 2016.
  - reference: PMID:36385762
    reference_title: "A synonymous variant contributes to a rare Wiedemann-Rautenstrauch syndrome complicated with mild anemia via affecting pre-mRNA splicing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Currently, over 50 cases with variable phenotypes of WDRTS have been reported."
    explanation: Literature case count as of 2022, consistent with an ultra-rare disorder.
progression:
- phase: Neonatal period and infancy
  age_range: Birth to 1 year
  notes: >-
    The period of highest mortality. In the 18-patient gold-standard series six
    of the patients whose outcome is recorded died within the first year, four
    of them in the first weeks of life. Death is usually attributed to
    malnutrition or infection rather than to a single organ failure, and one
    neonate died of hyperkalemic renal failure on day three.
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Four patients have died within the 1st weeks of life, 2 other in the 1st year, 4 between 5 and 10 years of age, 1 at 17 years, but 2 are still alive at age 20 years."
    explanation: Gives the age-at-death distribution for the molecularly and photographically confirmed WRS patients.
  - reference: PMID:36159344
    reference_title: "A Case of Wiedemann-Rautenstrauch Syndrome With Fatal Hyperkalemic Renal Faliure."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The average survival in WRS is seven months, although survival into the third decade of life has been reported"
    explanation: States the reported average survival, which falls inside this phase.
  - reference: PMID:36159344
    reference_title: "A Case of Wiedemann-Rautenstrauch Syndrome With Fatal Hyperkalemic Renal Faliure."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "WRS patients have a short life expectancy due to malnutrition"
    explanation: Identifies malnutrition as a proximate cause of the early mortality.
- phase: Late infancy and childhood
  age_range: 1 to 10 years
  notes: >-
    Survivors of infancy develop and then accumulate neurological signs, chiefly
    tremor, hypertonia and ataxia, which is what makes WRS a progressive rather
    than a purely static congenital disorder. Growth failure and lipoatrophy
    persist unchanged. Four of the recorded deaths fall between 5 and 10 years.
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "These symptoms arise typically in late infancy or childhood."
    explanation: Dates the onset of the progressive neurological signs to this phase.
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "showed a clear progression in signs and symptoms with time, especially with respect of neurological signs as tremor, hypertonia, and ataxia"
    explanation: Establishes that the neurological phenotype progresses rather than remaining static.
- phase: Adolescence and adulthood
  age_range: Second and third decade
  notes: >-
    A minority reach adolescence or adulthood. In the confirmed series one
    patient was alive at 17 years and two at 20 years, and survival into the
    third decade is reported. These survivors carry the accumulated neurological
    burden of the previous phase; ataxia and tremor increase with age.
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "1 at 17 years, but 2 are still alive at age 20 years"
    explanation: Documents the long-surviving minority within the confirmed series.
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the progressive nature of WRS became clear in the increase with age of ataxia and tremor in some of the patients"
    explanation: Describes what continues to change in the patients who survive longest.
clinical_burden:
  burden_level: HIGH
  rationale: >-
    WRS is frequently lethal in the first year of life and imposes lifelong
    multi-system disability on those who survive. Of the confirmed patients
    whose outcome is recorded, six died within the first year and four more
    before age ten, with reported average survival of seven months. Survivors
    face feeding failure that does not respond to high-calorie enteral support,
    progressive ataxia, tremor and spasticity, intellectual disability in most,
    and dental, ophthalmic and skeletal complications. No disease-modifying
    therapy exists, so the entire burden is met with supportive care.
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Four patients have died within the 1st weeks of life, 2 other in the 1st year, 4 between 5 and 10 years of age, 1 at 17 years, but 2 are still alive at age 20 years."
    explanation: Quantifies the mortality that dominates the burden assessment.
  - reference: PMID:36159344
    reference_title: "A Case of Wiedemann-Rautenstrauch Syndrome With Fatal Hyperkalemic Renal Faliure."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The average survival in WRS is seven months, although survival into the third decade of life has been reported"
    explanation: Reported average survival supports a HIGH rather than VARIABLE burden level.
  - reference: PMID:36596744
    reference_title: "Biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome with atypical brain involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Nutritional support using high calorie milk and enteral tube was ineffective to gain weight due to frequent vomiting and aspiration."
    explanation: Illustrates the refractory feeding burden carried by survivors.

genetic:
- name: POLR3A
  gene_term:
    preferred_term: POLR3A
    term:
      id: hgnc:30074
      label: POLR3A
  association: Causative
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  features: >-
    Biallelic variants in POLR3A, encoding the largest (catalytic) subunit of RNA
    polymerase III. WRS genotypes are dominated by compound heterozygosity for a
    truncating or missense allele in trans with a recurrent intronic
    splice-affecting allele, most often c.3337-11T>C (also c.1909+18G>A and
    c.1771-6C>G / c.1771-7C>G), and by synonymous or deep-intronic variants that
    perturb transcript processing; homozygous missense variants have been reported
    in consanguineous families. Two null alleles have been reported in a single
    proband. Considered together, the allele pairs are believed to leave partial
    Pol III function, in contrast to the missense-dominated genotypes of 4H
    leukodystrophy.
  evidence:
  - reference: PMID:27612211
    reference_title: "Neonatal progeriod syndrome associated with biallelic truncating variants in POLR3A."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here we report an infant with the characteristic phenotypic features of Wiedemann-Rautenstrauch syndrome in whom exome sequencing identified two pathogenic variants in POLR3A: c.1909+18G>A; p.(Y637Cfs*23) and c.2617C>T; p.(R873*)."
    explanation: First report of biallelic POLR3A variants in WRS, including the recurrent c.1909+18G>A intronic allele.
  - reference: PMID:30414627
    reference_title: "Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our findings confirm the association of bi-allelic POLR3A variants with WRS, expand the clinical phenotype of WRS, and suggest specific POLR3A genotypes associated with WRS and hypomyelinating leukodystrophy."
    explanation: Independent seven-patient replication establishing POLR3A as the WRS gene.
  - reference: PMID:30323018
    reference_title: "Specific combinations of biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Biallelic POLR3A variants were identified in eight affected individuals and monoallelic variants of the same gene in four other individuals."
    explanation: Twelve-family series; biallelic variants in every individual with sufficient material.
  - reference: PMID:30323018
    reference_title: "Specific combinations of biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Multiple variants were found to affect POLR3A transcript processing and were mostly located in deep intronic regions, making clinical suspicion fundamental to detection."
    explanation: Documents the deep-intronic, splice-affecting character of many WRS alleles.
  - reference: PMID:30450527
    reference_title: "Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Furthermore, we firmly establish biallelic mutations in POLR3A as the genetic cause of a recognizable, neonatal, Wiedemann-Rautenstrauch-like progeroid syndrome."
    explanation: Third independent cohort confirming the gene-disease relationship.
  - reference: PMID:32555393
    reference_title: "Unique combination and in silico modeling of biallelic POLR3A variants as a cause of Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The other variant, c.3337-11T>C, was previously shown in WRS patients in trans with other variations."
    explanation: Documents c.3337-11T>C as the recurrent WRS allele found in trans with a second variant.
  - reference: PMID:38348603
    reference_title: "Further delineation of Wiedemann-Rautenstrauch syndrome linked with POLR3A."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Using whole-exome sequencing, we identified one novel homozygous missense variant (NM_007055: c.2456C>T; p. Pro819Leu) in two Omani families and one novel homozygous variant (c.1895G>T; p Cys632Phe) in Saudi family that segregates with the disease in the POLR3A gene."
    explanation: Homozygous missense genotypes in consanguineous families, showing that WRS is not restricted to compound heterozygosity.
  - reference: PMID:33559318
    reference_title: "Wiedemann-Rautenstrauch syndrome in an Indian patient with biallelic pathogenic variants in POLR3A."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Till date, 19 families are reported with WRS due to variants in POLR3A."
    explanation: Family count for the POLR3A-WRS association as of 2021.
  variants:
  - name: POLR3A c.3337-11T>C
    description: >-
      Recurrent intronic variant that perturbs POLR3A splicing; the commonest WRS
      allele, found in trans with truncating or missense alleles and, in one
      patient, in cis with c.1909+22G>A on the same haplotype.
    clinical_significance: PATHOGENIC
    evidence:
    - reference: PMID:38397171
      reference_title: "The Genetic Basis of the First Patient with Wiedemann-Rautenstrauch Syndrome in the Russian Federation."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Via the analysis of mRNA derived from fibroblasts, we reconfirmed the splicing-affecting nature of the c.3337-11T>C variant."
      explanation: Patient-fibroblast mRNA analysis confirming the splicing effect of the recurrent allele.
    - reference: PMID:32555393
      reference_title: "Unique combination and in silico modeling of biallelic POLR3A variants as a cause of Wiedemann-Rautenstrauch syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "One of the reported variations in our patient, c.3568C>T, p.(Gln1190Ter), is a novel variation that was not reported before."
      explanation: Example of the recurrent intronic allele paired in trans with a novel nonsense allele.
  - name: POLR3A c.1909+18G>A
    description: >-
      Intronic variant predicted to cause a frameshift, p.(Y637Cfs*23), reported in
      trans with a nonsense allele in the first molecularly solved WRS proband.
    clinical_significance: PATHOGENIC
    evidence:
    - reference: PMID:27612211
      reference_title: "Neonatal progeriod syndrome associated with biallelic truncating variants in POLR3A."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "This proband is notable because she had two null pathogenic variants."
      explanation: The authors treat both alleles, including c.1909+18G>A, as null.
  - name: POLR3A c.1771-6C>G / c.1771-7C>G
    description: >-
      Adjacent intron-13 variants shared with the striatal and hereditary spastic
      ataxia presentations of POLR3A-related disease; c.1771-7C>G was found in trans
      with p.(Arg669Ter) in an Indian WRS patient, and c.1771-6C>G in a Korean WRS
      patient with striatal-variant brain involvement.
    clinical_significance: PATHOGENIC
    evidence:
    - reference: PMID:33559318
      reference_title: "Wiedemann-Rautenstrauch syndrome in an Indian patient with biallelic pathogenic variants in POLR3A."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The variant c.1771-7C>G was earlier found to be associated with hereditary spastic ataxia."
      explanation: The same intronic allele underlies a distinct POLR3A phenotype depending on its partner allele.
    - reference: PMID:36596744
      reference_title: "Biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome with atypical brain involvement."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Our patient has a c.1771-6C>G variant and also showed profound neurodevelopmental problem and striatal involvement."
      explanation: c.1771-6C>G in a WRS patient with the striatal-variant neurologic phenotype.
  - name: POLR3A c.3342C>T (p.Ser1114=)
    description: >-
      Synonymous exonic variant shown by minigene assay to generate aberrant splice
      isoforms; an example of a "silent" WRS allele that is pathogenic through
      transcript processing.
    clinical_significance: LIKELY_PATHOGENIC
    evidence:
    - reference: PMID:36385762
      reference_title: "A synonymous variant contributes to a rare Wiedemann-Rautenstrauch syndrome complicated with mild anemia via affecting pre-mRNA splicing."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "For POLR3A, the synonymous mutation (c.3342C > T, p.Ser1114=) generated three types of aberrant isoforms."
      explanation: Minigene reporter assay demonstrating aberrant splicing from the synonymous change.
- name: POLR3GL
  gene_term:
    preferred_term: POLR3GL
    term:
      id: hgnc:28466
      label: POLR3GL
  association: Candidate second locus (single patient, WRS-like variant phenotype)
  variant_origin: GERMLINE
  notes: >-
    A homozygous nonsense POLR3GL variant with RNA evidence of nonsense-mediated
    decay was reported in one individual with several, not all, features of
    neonatal progeroid syndrome; the authors describe the presentation as a
    variant of the syndrome. POLR3GL encodes another Pol III subunit. Treated here
    as a candidate gene rather than a second established WRS gene; no
    relationship_type is asserted.
  evidence:
  - reference: PMID:31695177
    reference_title: "A variant of neonatal progeroid syndrome, or Wiedemann-Rautenstrauch syndrome, is associated with a nonsense variant in POLR3GL."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here, we describe an individual with several clinical features of neonatal progeroid syndrome in whom exome sequencing revealed a homozygous nonsense variant in POLR3GL (NM_032305.2:c.358C>T; p.(Arg120Ter))."
    explanation: Single-patient report of a POLR3GL nonsense variant with a WRS-like phenotype.
  - reference: PMID:31695177
    reference_title: "A variant of neonatal progeroid syndrome, or Wiedemann-Rautenstrauch syndrome, is associated with a nonsense variant in POLR3GL."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we propose POLR3GL as a gene causing a variant of neonatal progeroid syndrome and therefore expand the phenotype associated with POLR3GL variants."
    explanation: The authors themselves frame POLR3GL as causing a variant form rather than classical WRS.
- name: POLR3B
  gene_term:
    preferred_term: POLR3B
    term:
      id: hgnc:30348
      label: POLR3B
  association: Candidate second locus (single family; variants of uncertain significance)
  variant_origin: GERMLINE
  notes: >-
    Compound heterozygous POLR3B missense variants segregated with a progeroid
    phenotype in one proband and an affected fetus. The variants were classified
    as variants of uncertain significance by ACMG criteria in the report itself,
    so POLR3B is recorded as a candidate rather than a causative WRS gene.
  evidence:
  - reference: PMID:34289880
    reference_title: "Whole-exome sequencing reveals POLR3B variants associated with progeria-related Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Whole-exome sequencing (WES) of the patient was performed, and POLR3B compound heterozygous variants-c.2191G > C:p.E731Q and c.3046G > A:p.V1016M-were identified in the patient."
    explanation: The only report linking POLR3B to a WRS diagnosis.
  - reference: PMID:34289880
    reference_title: "Whole-exome sequencing reveals POLR3B variants associated with progeria-related Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The American College of Medical Genetics and Genomics guidelines predicted the two variants as variants of uncertain significance (Table 1)."
    explanation: The report's own ACMG classification limits the strength of the POLR3B claim.
pathophysiology:
- name: Biallelic POLR3A Variants with Residual Pol III Function
  description: >-
    The initiating lesion is compound heterozygosity (occasionally homozygosity)
    for POLR3A variants that, considered as a pair, leave partial function of the
    catalytic subunit of RNA polymerase III. The characteristic WRS genotype pairs
    a recurrent intronic or synonymous splice-affecting allele with a truncating
    or missense allele; all WRS-associated amino-acid substitutions are predicted
    to perturb POLR3A structure. Which allele combinations produce WRS rather than
    4H leukodystrophy is the central genotype-phenotype question for this gene.
  biological_scale: MOLECULAR
  mechanism_confidence: ESTABLISHED
  gene:
    preferred_term: POLR3A
    term:
      id: hgnc:30074
      label: POLR3A
  genetic_context:
    gene:
      preferred_term: POLR3A
      term:
        id: hgnc:30074
        label: POLR3A
    variant_origin: GERMLINE
    zygosity: COMPOUND_HETEROZYGOUS
    functional_impact_category: PARTIAL_LOSS_OF_FUNCTION
    description: >-
      Most reported genotypes are compound heterozygous; homozygous missense
      genotypes occur in consanguineous families. Complete loss of both alleles is
      presumed lethal, so the allele pair retains partial function.
  cellular_components:
  - preferred_term: RNA polymerase III complex
    term:
      id: GO:0005666
      label: RNA polymerase III complex
  evidence:
  - reference: PMID:30323018
    reference_title: "Specific combinations of biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Biallelic mutations in POLR3A, which encodes for the largest subunit of the DNA-dependent RNA polymerase III, underlie WRS."
    explanation: Establishes the initiating molecular lesion.
  - reference: PMID:31695177
    reference_title: "A variant of neonatal progeroid syndrome, or Wiedemann-Rautenstrauch syndrome, is associated with a nonsense variant in POLR3GL."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All variants reported in the literature lead to at least a partial loss-of-function (when considering both alleles together)."
    explanation: Supports classifying the allele pair as partial loss of function.
  - reference: PMID:30323018
    reference_title: "Specific combinations of biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: "All WRS-associated POLR3A amino acid changes were predicted to perturb substantially POLR3A structure/function."
    explanation: In silico structural modelling of the missense alleles.
  - reference: PMID:38348603
    reference_title: "Further delineation of Wiedemann-Rautenstrauch syndrome linked with POLR3A."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: "In silico homology modeling of wild-type and mutated proteins revealed a substantial change in the structure and stability of both proteins, demonstrating a possible effect on function."
    explanation: Homology modelling of the homozygous missense alleles p.Pro819Leu and p.Cys632Phe.
  - reference: PMID:40912518
    reference_title: "Clinical and molecular insights into Wiedemann-Rautenstrauch syndrome: A case report and genetic analysis of the c.2707G>A variant in the POLR3A gene."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: "To find potential structural consequences, molecular modeling of the wild-type and mutant RNA polymerase III complex (PDB: 7DN3) was performed using PyMOL, while DynaMut analysis revealed destabilizing effects, decreased residue flexibility, and steric clashes that could impair complex function."
    explanation: Structural modelling of p.Gly903Arg within the Pol III complex.
  downstream:
  - target: Aberrant POLR3A Transcript Processing
    causal_link_type: DIRECT
    hypothesis_groups:
    - canonical_pol3_partial_lof
    description: Intronic and synonymous WRS alleles act by disturbing POLR3A pre-mRNA splicing.
    evidence:
    - reference: PMID:30323018
      reference_title: "Specific combinations of biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Multiple variants were found to affect POLR3A transcript processing and were mostly located in deep intronic regions, making clinical suspicion fundamental to detection."
      explanation: Transcript-processing analyses in the twelve-family series link the variants to aberrant splicing.
  - target: Reduced Wild-Type POLR3A Expression
    causal_link_type: DIRECT
    hypothesis_groups:
    - canonical_pol3_partial_lof
    description: Truncating and null alleles reduce the pool of wild-type POLR3A directly.
- name: Aberrant POLR3A Transcript Processing
  description: >-
    Deep-intronic, near-splice-site and synonymous WRS alleles produce aberrant
    POLR3A splice isoforms (exon skipping, intron retention, cryptic-site use),
    a proportion of which are frameshifted or degraded. Because splicing is
    leaky, some normally spliced transcript persists, which is one explanation for
    the residual function of the WRS allele pair.
  biological_scale: MOLECULAR
  mechanism_confidence: ESTABLISHED
  biological_processes:
  - preferred_term: POLR3A pre-mRNA splicing
    term:
      id: GO:0000398
      label: mRNA splicing, via spliceosome
    modifier: ABNORMAL
  evidence:
  - reference: PMID:38397171
    reference_title: "The Genetic Basis of the First Patient with Wiedemann-Rautenstrauch Syndrome in the Russian Federation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Via the analysis of mRNA derived from fibroblasts, we reconfirmed the splicing-affecting nature of the c.3337-11T>C variant."
    explanation: Patient-derived fibroblast mRNA analysis of the commonest WRS allele.
  - reference: PMID:36385762
    reference_title: "A synonymous variant contributes to a rare Wiedemann-Rautenstrauch syndrome complicated with mild anemia via affecting pre-mRNA splicing."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Mini-gene reporter assays revealed that the synonymous variant of POLR3A and the missense variant of FANCA could affect pre-mRNA splicing of each gene."
    explanation: Minigene assay showing that a synonymous WRS allele disrupts splicing.
  - reference: PMID:40912518
    reference_title: "Clinical and molecular insights into Wiedemann-Rautenstrauch syndrome: A case report and genetic analysis of the c.2707G>A variant in the POLR3A gene."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: "Splicing predictions using Human Splicing Finder (HSF) and SpliceAI suggested disruption of regulatory motifs and activation of a cryptic splice site."
    explanation: In silico splicing prediction for a missense allele, suggesting a second, splice-level effect.
  downstream:
  - target: Reduced Wild-Type POLR3A Expression
    causal_link_type: DIRECT
    hypothesis_groups:
    - canonical_pol3_partial_lof
    description: Aberrant isoforms lower the amount of correctly spliced, functional POLR3A transcript.
- name: Reduced Wild-Type POLR3A Expression
  description: >-
    WRS fibroblasts express less wild-type POLR3A mRNA and protein, with a
    reciprocal increase in mutant protein that accumulates in the nucleus; patient
    skin shows reduced POLR3A mRNA. The residual wild-type protein is what
    sustains Pol III assembly and activity in these cells.
  biological_scale: MOLECULAR
  mechanism_confidence: ESTABLISHED
  cell_types:
  - preferred_term: skin fibroblast
    term:
      id: CL:0002620
      label: skin fibroblast
  cellular_components:
  - preferred_term: RNA polymerase III complex
    term:
      id: GO:0005666
      label: RNA polymerase III complex
  evidence:
  - reference: PMID:32976914
    reference_title: "Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann-Rautenstrauch syndrome fibroblasts."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The mutation caused a decrease in the expression of wildtype POLR3A mRNA and POLR3A protein and a sharp increase in mutant protein expression."
    explanation: Direct measurement of wild-type versus mutant POLR3A in WRS patient fibroblasts.
  - reference: PMID:32976914
    reference_title: "Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann-Rautenstrauch syndrome fibroblasts."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "In addition, there was an increase in the nuclear localization of the mutant protein."
    explanation: The truncated mutant protein is not excluded from the nucleus, so it may compete with wild-type subunit for complex assembly.
  - reference: PMID:41549341
    reference_title: "Novel POLR3A Gene Mutation Results in Wiedemann-Rautenstrauch Syndrome With Striking Cutis Laxa and Myelofibrosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "RT-qPCR analysis of skin tissue demonstrated a significant downregulation of POLR3A mRNA expression (p < 0.01)."
    explanation: Reduced POLR3A transcript in patient skin in vivo.
  downstream:
  - target: RNA Polymerase III Transcriptional Hypofunction
    causal_link_type: DIRECT
    hypothesis_groups:
    - canonical_pol3_partial_lof
    description: Less functional catalytic subunit lowers Pol III transcriptional output.
- name: RNA Polymerase III Transcriptional Hypofunction
  description: >-
    POLR3A forms the catalytic centre of RNA polymerase III, which transcribes
    tRNAs, 5S rRNA, 7SL, 7SK, BC200 and other small non-coding RNAs that support
    translation, RNA processing and transcriptional regulation. Reduced functional
    POLR3A is expected to lower Pol III output. Direct quantification of Pol III
    transcripts in WRS cells has not been published; the reduction of tRNA and
    BC200 levels has been shown in cell lines and fibroblasts carrying
    leukodystrophy-associated POLR3A alleles, so this step is extrapolated from the
    allelic disorder.
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  molecular_functions:
  - preferred_term: DNA-directed RNA polymerase III activity
    term:
      id: GO:0003899
      label: DNA-directed RNA polymerase activity
    modifier: DECREASED
  biological_processes:
  - preferred_term: transcription by RNA polymerase III
    term:
      id: GO:0006383
      label: transcription by RNA polymerase III
    modifier: DECREASED
  - preferred_term: tRNA transcription by RNA polymerase III
    term:
      id: GO:0042797
      label: tRNA transcription by RNA polymerase III
    modifier: DECREASED
  evidence:
  - reference: PMID:30414627
    reference_title: "Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "POLR3A, the largest subunit of RNA polymerase III, is a DNA-directed RNA polymerase that transcribes many small noncoding RNAs that regulate transcription, RNA processing, and translation."
    explanation: States the enzymatic role that the WRS alleles compromise; background, not a measurement in WRS cells.
  - reference: PMID:32976914
    reference_title: "Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann-Rautenstrauch syndrome fibroblasts."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "POLR3A has important roles in transcription regulation of small RNAs, including tRNA, 5S rRNA, and 7SK rRNA."
    explanation: Names the Pol III transcript classes at stake; the paper does not itself quantify them in WRS cells.
  - reference: PMID:30898877
    reference_title: "Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: IN_VITRO
    snippet: "Transcriptomic profiling uncovered a subset of transcripts vulnerable to Pol III hypofunction, including a global reduction in tRNA levels."
    explanation: Demonstrates that a hypomorphic POLR3A allele lowers tRNA output; the allele studied (p.M852V) causes leukodystrophy, not WRS, so the support is by extrapolation.
  downstream:
  - target: Nucleolar Disruption, p53 Activation and Premature Senescence
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - senescence_driven_progeroid_phenotype
    description: >-
      Mutant POLR3A accumulation in the nucleus is accompanied by nucleolar
      enlargement, p53 phosphorylation and senescence; the intermediates between
      Pol III hypofunction and the nucleolar stress response are not defined.
  - target: Impaired Mesenchymal Progenitor Proliferation and Differentiation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - canonical_pol3_partial_lof
    description: >-
      Reduced supply of translation-supporting small RNAs is the proposed reason
      that WRS progenitors proliferate and differentiate poorly; not directly
      demonstrated.
  - target: Central Nervous System Hypomyelination
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - canonical_pol3_partial_lof
    description: >-
      Oligodendrocyte-lineage sensitivity to Pol III hypofunction is established in
      the allelic leukodystrophy and its cellular and mouse models, and is assumed
      to underlie the white-matter involvement seen in a subset of WRS patients.
    evidence:
    - reference: PMID:30898877
      reference_title: "Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: IN_VITRO
      snippet: "Upon differentiation, mRNA levels of the MBP gene, encoding myelin basic protein, were significantly decreased in POLR3A-mutant cells."
      explanation: Links POLR3A hypofunction to reduced myelin gene expression in oligodendroglial cells carrying a leukodystrophy allele.
    - reference: PMID:34583988
      reference_title: "Defective myelination in an RNA polymerase III mutant leukodystrophic mouse."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: MODEL_ORGANISM
      snippet: "The findings suggest unique sensitivities of oligodendrogenesis and myelination to perturbations of Pol III transcription."
      explanation: Conditional Polr3a-mutant mice show that Pol III perturbation in the oligodendrocyte lineage is sufficient for hypomyelination.
- name: Nucleolar Disruption, p53 Activation and Premature Senescence
  description: >-
    WRS fibroblasts show increased nucleolar number and area, high phospho-p53 and
    phospho-H2AX, and premature replicative senescence; WRS iPSCs, in which
    POLR3A is upregulated during reprogramming, show nucleolar abnormalities with
    sequestration of the telomerase RNA component in nucleoli. Reduced fibroblast
    growth was already noted in the original 1977 description. These findings
    suggest a nucleolar-stress/p53 route to a progeroid cellular phenotype, but
    whether it drives the tissue phenotypes, rather than accompanying them, is
    untested.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  cell_types:
  - preferred_term: skin fibroblast
    term:
      id: CL:0002620
      label: skin fibroblast
  biological_processes:
  - preferred_term: cellular senescence
    term:
      id: GO:0090398
      label: cellular senescence
    modifier: INCREASED
  - preferred_term: nucleolus organization
    term:
      id: GO:0007000
      label: nucleolus organization
    modifier: ABNORMAL
  - preferred_term: cell population proliferation
    term:
      id: GO:0008283
      label: cell population proliferation
    modifier: DECREASED
  evidence:
  - reference: PMID:32976914
    reference_title: "Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann-Rautenstrauch syndrome fibroblasts."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "These changes were associated with an increase in the number and area of nucleoli and to a high increase in the expression of pP53 and pH2AX."
    explanation: Nucleolar and p53/DNA-damage-response readouts in WRS fibroblasts.
  - reference: PMID:32976914
    reference_title: "Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann-Rautenstrauch syndrome fibroblasts."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "All these changes were associated with premature senescence."
    explanation: Premature senescence as the cellular outcome.
  - reference: PMID:41081995
    reference_title: "POLR3A mutations cause nucleolus abnormalities and aberrant telomerase RNA metabolism in induced pluripotent stem cells from Wiedemann-Rautenstrauch premature aging syndrome patient."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Enhanced expression of mutant POLR3A in WRS iPSCs led to nucleolus abnormalities and telomerase RNA component (TERC) sequestration in the nucleoli in WRS iPSCs."
    explanation: Independent iPSC model reproducing nucleolar abnormality and adding a telomerase-RNA sequestration readout.
  - reference: PMID:319005
    reference_title: "Progeria: a cell culture study and clinical report of familial incidence."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The examination of the cultured skin fibroblasts from the younger child showed a clear decrease in cell growth."
    explanation: The original 1977 report already documented reduced fibroblast growth.
  - reference: PMID:41081995
    reference_title: "POLR3A mutations cause nucleolus abnormalities and aberrant telomerase RNA metabolism in induced pluripotent stem cells from Wiedemann-Rautenstrauch premature aging syndrome patient."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "HGPS and WRS patient fibroblasts showed similar signs of cellular aging; however, unlike HGPS, the causal link between the premature aging phenotype and WRS driving mutations is unclear."
    explanation: Records the authors' own caution that causality from the cellular aging phenotype to the disease is not established.
  downstream:
  - target: Impaired Mesenchymal Progenitor Proliferation and Differentiation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - senescence_driven_progeroid_phenotype
    description: >-
      Hypothesised route in which p53-driven senescence of progenitors exhausts
      the mesenchymal pools needed for adipose, bone and cartilage formation. No
      study has connected the two observations in WRS cells.
- name: Impaired Mesenchymal Progenitor Proliferation and Differentiation
  description: >-
    Bone-marrow-derived progenitors from a WRS patient responded far less to
    osteoblastic differentiation stimuli and yielded fewer chondrocytes and
    hematopoietic cells than control progenitors, which the authors proposed as
    the cellular basis of the clinical picture. Adipocyte differentiation has not
    been assayed in WRS cells; failure of adipose development is inferred from the
    congenital lipoatrophy and is recorded as a knowledge gap.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  cell_types:
  - preferred_term: mesenchymal stem cell
    term:
      id: CL:0000134
      label: mesenchymal stem cell
  - preferred_term: osteoblast
    term:
      id: CL:0000062
      label: osteoblast
  - preferred_term: chondrocyte
    term:
      id: CL:0000138
      label: chondrocyte
  biological_processes:
  - preferred_term: osteoblast differentiation
    term:
      id: GO:0001649
      label: osteoblast differentiation
    modifier: DECREASED
  - preferred_term: cell population proliferation
    term:
      id: GO:0008283
      label: cell population proliferation
    modifier: DECREASED
  evidence:
  - reference: PMID:16097434
    reference_title: "In vitro osteogenic differentiation is affected in Wiedemann-Rautenstrauch-Syndrome (WRS)."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "It was shown, for the first time, that WRS cells showed a highly significant lower in vitro response to osteoblastic differentiation stimulus."
    explanation: Osteogenic differentiation assay on patient bone-marrow progenitors.
  - reference: PMID:16097434
    reference_title: "In vitro osteogenic differentiation is affected in Wiedemann-Rautenstrauch-Syndrome (WRS)."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Furthermore, significantly fewer chondrocytes and hematopoietic cells were induced in WRS progenitors compared to the control group."
    explanation: Reduced chondrogenic and hematopoietic output from the same progenitor culture.
  - reference: PMID:16097434
    reference_title: "In vitro osteogenic differentiation is affected in Wiedemann-Rautenstrauch-Syndrome (WRS)."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Our data suggest a lack of cellular differentiation capacity in WRS patients, which may be responsible for the clinical appearance and symptoms of this rare disorder."
    explanation: The authors' proposed link from the differentiation defect to the clinical phenotype.
  downstream:
  - target: Generalized Subcutaneous Lipoatrophy with Localized Fat Pads
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - canonical_pol3_partial_lof
    description: >-
      Inferred failure of adipose progenitors to form or maintain fat depots. The
      paradoxical persistence of gluteal and labial pads is unexplained.
  - target: Skeletal Undergrowth, Osteopenia and Craniofacial Dysmorphogenesis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - canonical_pol3_partial_lof
    description: >-
      Reduced osteoblastic and chondrogenic differentiation is the proposed route
      to undermineralised bone, persistently open fontanelles and the
      craniofacial disproportion.
  - target: Prenatal and Postnatal Growth Failure
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - canonical_pol3_partial_lof
    description: >-
      Global reduction in progenitor proliferation is the assumed basis of the
      growth failure that begins in utero and persists despite adequate caloric
      intake.
- name: Generalized Subcutaneous Lipoatrophy with Localized Fat Pads
  description: >-
    Near-absence of subcutaneous fat over the face, trunk and limbs from birth,
    producing thin, wrinkled skin with prominent superficial and scalp veins and
    the aged facial appearance, coexists with paradoxical fat accumulations over
    the buttocks/suprabuttock region and the labia or flanks. The lipoatrophy is
    congenital and persists; abnormal lipid and hormone profiles
    (hypertriglyceridemia, hyperprolactinemia) have been reported in a minority.
  biological_scale: TISSUE
  mechanism_confidence: ESTABLISHED
  locations:
  - preferred_term: subcutaneous adipose tissue
    term:
      id: UBERON:0002190
      label: subcutaneous adipose tissue
  cell_types:
  - preferred_term: adipocyte
    term:
      id: CL:0000136
      label: adipocyte
  evidence:
  - reference: PMID:10607952
    reference_title: "Neonatal progeroid (Wiedemann-Rautenstrauch) syndrome: report of five new cases and review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The neonatal progeroid syndrome (NPS), or Wiedemann-Rautenstrauch, is a rare autosomal recessive disorder comprised of generalized lipoatrophy except for fat pads in the suprabuttock areas, hypotrichosis of the scalp hair, eyebrows, and eyelashes, relative macrocephaly, triangular face, natal teeth, and micrognathia."
    explanation: Defines the generalized lipoatrophy with spared suprabuttock fat pads.
  - reference: PMID:30323018
    reference_title: "Specific combinations of biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Wiedemann-Rautenstrauch syndrome (WRS) is a form of segmental progeria presenting neonatally, characterised by growth retardation, sparse scalp hair, generalised lipodystrophy with characteristic local fatty tissue accumulations and unusual face."
    explanation: The molecularly confirmed series describes the same lipodystrophy-with-local-accumulation pattern.
  - reference: PMID:18717246
    reference_title: "Clinical and laboratory findings of two newborns with Wiedemann-Rautenstrauch syndrome: additional features, evaluation of bone turnover and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our two patients had characteristic features of WRS, including intrauterine growth retardation, aged appearance, near absence of subcutaneous fat, gluteal fat pads, also labial pad in the first infant, wrinkled thin skin, sparse scalp hair, prominent scalp veins and facial dysmorphism."
    explanation: Neonatal description of near-absent subcutaneous fat with gluteal and labial pads.
  downstream:
  - target: Generalized lipodystrophy
    causal_link_type: DIRECT
  - target: Progeroid facial appearance
    causal_link_type: DIRECT
  - target: Prominent scalp veins
    causal_link_type: DIRECT
  - target: Thin skin
    causal_link_type: DIRECT
  - target: Hypertriglyceridemia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Skeletal Undergrowth, Osteopenia and Craniofacial Dysmorphogenesis
  description: >-
    The craniofacial disproportion (relative macrocephaly with widely open
    fontanelles and sutures over a small, triangular face with micrognathia) and
    the dental anomalies (natal teeth, later hypodontia) are present at birth.
    Severe osteopenia with elevated urinary deoxypyridinoline, a bone-resorption
    marker, was documented in two neonates, and characteristic radiographic
    skeletal findings are described. Progressive kyphoscoliosis and joint
    contractures appear in survivors.
  biological_scale: TISSUE
  mechanism_confidence: ESTABLISHED
  locations:
  - preferred_term: skull
    term:
      id: UBERON:0003129
      label: skull
  - preferred_term: skeletal system
    term:
      id: UBERON:0001434
      label: skeletal system
  biological_processes:
  - preferred_term: ossification
    term:
      id: GO:0001503
      label: ossification
    modifier: DECREASED
  - preferred_term: odontogenesis
    term:
      id: GO:0042476
      label: odontogenesis
    modifier: ABNORMAL
  evidence:
  - reference: PMID:18717246
    reference_title: "Clinical and laboratory findings of two newborns with Wiedemann-Rautenstrauch syndrome: additional features, evaluation of bone turnover and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "They also have severe osteopenia and elevated urinary deoxypyridinoline levels which have not been previously described in patients with WRS."
    explanation: Bone-turnover evaluation in two neonates documents osteopenia with a raised resorption marker.
  - reference: PMID:10607952
    reference_title: "Neonatal progeroid (Wiedemann-Rautenstrauch) syndrome: report of five new cases and review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Skeletal findings in 2 of our patients demonstrated some new findings as well as the typical radiological abnormalities previously noted in NPS."
    explanation: Confirms a recognizable radiographic skeletal pattern.
  - reference: PMID:21671373
    reference_title: "Neonatal progeroid syndrome (Wiedemann-Rautenstrauch syndrome): report of three affected sibs."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "WRS patients are characterized by premature aging present at birth including pseudohydrocephalus, cranio-facial disproportion, reduced subcutaneous fat, thin skin, rigid and thick joints, and neonatal teeth in some cases."
    explanation: Documents the craniofacial disproportion, joint stiffness and neonatal teeth.
  downstream:
  - target: Pseudohydrocephalus
    causal_link_type: DIRECT
  - target: Wide anterior fontanel
    causal_link_type: DIRECT
  - target: Wide cranial sutures
    causal_link_type: DIRECT
  - target: Triangular face
    causal_link_type: DIRECT
  - target: Thin upper lip vermilion
    causal_link_type: DIRECT
  - target: Micrognathia
    causal_link_type: DIRECT
  - target: Natal teeth
    causal_link_type: DIRECT
  - target: Hypodontia
    causal_link_type: DIRECT
  - target: Osteopenia
    causal_link_type: DIRECT
  - target: Joint contracture
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Scoliosis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Prenatal and Postnatal Growth Failure
  description: >-
    Growth restriction is detectable on serial prenatal ultrasound, birth weight
    is low, and severe failure to thrive follows despite high-calorie enteral
    feeding, so the growth failure is intrinsic rather than nutritional. Short
    stature persists in survivors. Together with the lipoatrophy this produces
    the emaciated progeroid habitus.
  biological_scale: ORGANISM
  mechanism_confidence: ESTABLISHED
  biological_processes:
  - preferred_term: multicellular organism growth
    term:
      id: GO:0035264
      label: multicellular organism growth
    modifier: DECREASED
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some cases-progressive ataxia and tremor."
    explanation: Growth retardation is listed first among the core manifestations of the 51-patient phenotype analysis.
  - reference: PMID:1619643
    reference_title: "Two sibs with Wiedemann-Rautenstrauch syndrome: possibilities of prenatal diagnosis by ultrasound."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "During the pregnancy, growth retardation particularly in the biparietal and abdominal diameters but not the femoral length was detected through serial ultrasound scans."
    explanation: Growth failure begins in utero and is detectable by ultrasound.
  - reference: PMID:36596744
    reference_title: "Biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome with atypical brain involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Nutritional support using high calorie milk and enteral tube was ineffective to gain weight due to frequent vomiting and aspiration."
    explanation: Postnatal growth failure persisted despite enteral high-calorie feeding.
  downstream:
  - target: Intrauterine growth retardation
    causal_link_type: DIRECT
  - target: Postnatal growth retardation
    causal_link_type: DIRECT
  - target: Failure to thrive
    causal_link_type: DIRECT
  - target: Short stature
    causal_link_type: DIRECT
- name: Central Nervous System Hypomyelination
  conforms_to: "cns_myelin_failure#Deficient or Unstable CNS Myelin Sheath"
  description: >-
    White-matter involvement is variable in WRS. Some molecularly confirmed
    patients show delayed myelination or a hypomyelinating leukodystrophy pattern,
    one showed the striatal-variant pattern with the c.1771-6C>G allele, and
    adult survivors show superior cerebellar peduncle and midbrain T2/FLAIR
    hyperintensity together with ataxia, tremor, spasticity, dystonia or
    parkinsonism. This is the point of overlap with the allelic POLR3A-related
    (4H) leukodystrophy, in which diffuse hypomyelination is the defining
    feature.
  biological_scale: TISSUE
  mechanism_confidence: ESTABLISHED
  cell_types:
  - preferred_term: oligodendrocyte
    term:
      id: CL:0000128
      label: oligodendrocyte
  locations:
  - preferred_term: cerebral white matter
    term:
      id: UBERON:0002316
      label: white matter
  biological_processes:
  - preferred_term: myelination
    term:
      id: GO:0042552
      label: myelination
    modifier: DECREASED
  - preferred_term: central nervous system myelination
    term:
      id: GO:0022010
      label: central nervous system myelination
    modifier: DECREASED
  evidence:
  - reference: PMID:38348603
    reference_title: "Further delineation of Wiedemann-Rautenstrauch syndrome linked with POLR3A."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The patients have hallmark features such as prenatal and postnatal growth retardation, short stature, a progeroid appearance, hypotonia, facial dysmorphology, hypomyelination leukodystrophy, and mental impairment."
    explanation: Consanguineous-family series in which hypomyelinating leukodystrophy was part of the presentation.
  - reference: PMID:41549341
    reference_title: "Novel POLR3A Gene Mutation Results in Wiedemann-Rautenstrauch Syndrome With Striking Cutis Laxa and Myelofibrosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition to the classic Wiedemann-Rautenstrauch syndrome features-progressive diffuse alopecia, growth retardation, and abnormal white matter development-the patient presented with severe anemia and skin laxity, phenotypes not previously described in Wiedemann-Rautenstrauch syndrome."
    explanation: Abnormal white matter development listed among the classic features in a 2026 case.
  - reference: PMID:36825045
    reference_title: "Spectrum of Pediatric to Early Adulthood POLR3A-Associated Movement Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The most common brain MRI abnormality was T2-weighted/FLAIR hyperintensity of the superior cerebellar peduncles and midbrain."
    explanation: Imaging correlate in a POLR3A movement-disorder series that includes a neonatal progeroid patient.
  downstream:
  - target: CNS hypomyelination
    causal_link_type: DIRECT
  - target: Hypotonia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Ataxia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Tremor
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Spasticity
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Intellectual disability
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Global developmental delay
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
mechanistic_hypotheses:
- hypothesis_group_id: canonical_pol3_partial_lof
  hypothesis_label: Partial loss of RNA polymerase III function drives a multi-lineage developmental growth failure
  status: CANONICAL
  description: >-
    Biallelic POLR3A variants that jointly retain partial function reduce Pol III
    output of tRNAs and other small RNAs, limiting the proliferation and
    differentiation of progenitors in adipose, skeletal, craniofacial and
    oligodendroglial lineages. The genetic and cellular ends of this chain are
    established; the Pol III-output step is extrapolated from leukodystrophy
    alleles and the lineage-specific consequences are inferred from the phenotype.
  evidence:
  - reference: PMID:30323018
    reference_title: "Specific combinations of biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Biallelic mutations in POLR3A, which encodes for the largest subunit of the DNA-dependent RNA polymerase III, underlie WRS."
    explanation: The genetic anchor of the canonical model.
  - reference: PMID:16097434
    reference_title: "In vitro osteogenic differentiation is affected in Wiedemann-Rautenstrauch-Syndrome (WRS)."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Our data suggest a lack of cellular differentiation capacity in WRS patients, which may be responsible for the clinical appearance and symptoms of this rare disorder."
    explanation: The progenitor-differentiation limb of the model.
- hypothesis_group_id: senescence_driven_progeroid_phenotype
  hypothesis_label: Nucleolar stress, p53 activation and premature senescence produce the progeroid phenotype
  status: EMERGING
  description: >-
    Mutant POLR3A accumulation causes nucleolar disruption, a p53/DNA-damage
    response and premature senescence in patient fibroblasts and iPSCs, and
    telomerase RNA is sequestered in nucleoli. On this model the progeroid
    features arise from senescence-driven exhaustion of progenitor pools, as in
    other segmental progerias. Supported by two cellular studies; no in vivo or
    rescue evidence.
  evidence:
  - reference: PMID:32976914
    reference_title: "Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann-Rautenstrauch syndrome fibroblasts."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "All these changes were associated with premature senescence."
    explanation: Premature senescence in WRS fibroblasts.
  - reference: PMID:41081995
    reference_title: "POLR3A mutations cause nucleolus abnormalities and aberrant telomerase RNA metabolism in induced pluripotent stem cells from Wiedemann-Rautenstrauch premature aging syndrome patient."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "HGPS and WRS patient fibroblasts showed similar signs of cellular aging; however, unlike HGPS, the causal link between the premature aging phenotype and WRS driving mutations is unclear."
    explanation: Same cellular signature as HGPS, with the causal link explicitly flagged as open.
- hypothesis_group_id: allele_combination_determines_wrs_versus_4h
  hypothesis_label: Specific allele combinations, not a functional site, decide WRS versus 4H leukodystrophy
  status: EMERGING
  description: >-
    WRS-specific recurrent haplotypes and the predominance of truncating or
    splice-affecting alleles in WRS, versus missense alleles in 4H leukodystrophy,
    suggest that the residual-function level set by the particular allele pair
    determines which POLR3A phenotype appears. Homozygous missense WRS families
    and shared intronic alleles between WRS and spastic ataxia show the rule is
    not absolute.
  evidence:
  - reference: PMID:30323018
    reference_title: "Specific combinations of biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We suggest that specific combinations of compound heterozygous variants must be present to cause the WRS phenotype."
    explanation: The allele-combination proposal.
  - reference: PMID:30323018
    reference_title: "Specific combinations of biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "While biallelic POLR3A variants have been previously reported in 4H syndrome and adolescent-onset progressive spastic ataxia, recurrent haplotypes specifically occurring in individuals with WRS were detected."
    explanation: WRS-specific recurrent haplotypes.
  - reference: PMID:30414627
    reference_title: "Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Bi-allelic missense variants in POLR3A have been associated with phenotypes distinct from WRS: hypogonadotropic hypogonadism and hypomyelinating leukodystrophy with or without oligodontia."
    explanation: Variant-class contrast between WRS and the leukodystrophy phenotypes.
  - reference: PMID:34611991
    reference_title: "A novel homozygous synonymous variant further expands the phenotypic spectrum of POLR3A-related pathologies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The phenotypic differences between these disorders are thought to occur mainly due to different functional effects of underlying POLR3A variants."
    explanation: Restates the model as the field's working assumption.
  - reference: PMID:38348603
    reference_title: "Further delineation of Wiedemann-Rautenstrauch syndrome linked with POLR3A."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "Using whole-exome sequencing, we identified one novel homozygous missense variant (NM_007055: c.2456C>T; p. Pro819Leu) in two Omani families and one novel homozygous variant (c.1895G>T; p Cys632Phe) in Saudi family that segregates with the disease in the POLR3A gene."
    explanation: Homozygous missense genotypes causing WRS contradict a strict truncating-versus-missense dichotomy.
phenotypes:
- name: Intrauterine growth retardation
  category: Growth
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Intrauterine growth retardation
    term:
      id: HP:0001511
      label: Intrauterine growth retardation
  description: >-
    Marked prenatal growth restriction, detectable on serial ultrasound with
    reduced biparietal and abdominal diameters, is a core manifestation.
  phenotype_contexts:
  - onset:
      onset_category: ANTENATAL
      notes: Detected on serial prenatal ultrasound.
    evidence:
    - reference: PMID:1619643
      reference_title: "Two sibs with Wiedemann-Rautenstrauch syndrome: possibilities of prenatal diagnosis by ultrasound."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "During the pregnancy, growth retardation particularly in the biparietal and abdominal diameters but not the femoral length was detected through serial ultrasound scans."
      explanation: Antenatal detection of the growth restriction.
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some cases-progressive ataxia and tremor."
    explanation: >-
      Listed as a core manifestation across the 15 confirmed and 12 suggestive
      patients of the 51-patient analysis. Core manifestation is mapped to
      VERY_FREQUENT under the qualitative Pattern C table (equivalent to
      hallmark); no percentage was reported.
  - reference: PMID:30414627
    reference_title: "Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It has been proposed to be autosomal-recessive and is characterized by variable clinical features, such as intrauterine growth restriction and poor postnatal weight gain, characteristic facial features (triangular appearance to the face, convex nasal profile or pinched nose, and small mouth), widened fontanelles, pseudohydrocephalus, prominent scalp veins, lipodystrophy, and teeth abnormalities."
    explanation: Intrauterine growth restriction in the molecularly confirmed cohort.
- name: Postnatal growth retardation
  category: Growth
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Postnatal growth retardation
    term:
      id: HP:0008897
      label: Postnatal growth retardation
  description: Severe postnatal growth retardation is a core manifestation and persists into adulthood in survivors.
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some cases-progressive ataxia and tremor."
    explanation: Core manifestation, mapped to VERY_FREQUENT under the qualitative Pattern C table.
  - reference: PMID:34611991
    reference_title: "A novel homozygous synonymous variant further expands the phenotypic spectrum of POLR3A-related pathologies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Over the years, above characteristic facial features, she showed severe postnatal growth retardation, global lipodystrophy, joint contractures, thoracic hypoplasia, scoliosis, anodontia, spastic quadriplegia, bilateral hearing loss, aphonia, hypogonadotropic hypogonadism, and cerebellar peduncles hyperintensities in brain imaging."
    explanation: Persistence of severe postnatal growth retardation in a 37-year-old survivor.
- name: Failure to thrive
  category: Growth
  phenotype_term:
    preferred_term: Failure to thrive
    term:
      id: HP:0001508
      label: Failure to thrive
  description: >-
    Poor postnatal weight gain that does not respond to high-calorie enteral
    feeding; the leading cause of early death together with infection.
  evidence:
  - reference: PMID:36596744
    reference_title: "Biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome with atypical brain involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "WDRTS cases have distinct clinical features of congenital- or neonatal-onset failure to thrive and lipodystrophy."
    explanation: Failure to thrive as a distinguishing feature from the allelic leukodystrophy.
  - reference: PMID:30414627
    reference_title: "Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It has been proposed to be autosomal-recessive and is characterized by variable clinical features, such as intrauterine growth restriction and poor postnatal weight gain, characteristic facial features (triangular appearance to the face, convex nasal profile or pinched nose, and small mouth), widened fontanelles, pseudohydrocephalus, prominent scalp veins, lipodystrophy, and teeth abnormalities."
    explanation: Poor postnatal weight gain in the seven-patient molecular series.
- name: Short stature
  category: Growth
  phenotype_term:
    preferred_term: Short stature
    term:
      id: HP:0004322
      label: Short stature
  description: Short stature is part of the standard clinical definition in molecularly confirmed series.
  evidence:
  - reference: PMID:34289880
    reference_title: "Whole-exome sequencing reveals POLR3B variants associated with progeria-related Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Wiedemann-Rautenstrauch syndrome (WRS) is a rare autosomal recessive neonatal progeroid disorder characterized by prenatal and postnatal growth retardation, short stature, a progeroid appearance, hypotonia, and mental impairment."
    explanation: Short stature in the disease definition used by the POLR3B report.
- name: Generalized lipodystrophy
  category: Adipose
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Generalized lipoatrophy with localized fat pads
    term:
      id: HP:0009064
      label: Generalized lipodystrophy
  description: >-
    Congenital near-absence of subcutaneous fat sparing paradoxical gluteal,
    suprabuttock and labial or flank fat pads.
  phenotype_contexts:
  - onset:
      onset_category: CONGENITAL
      notes: Present at birth.
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some cases-progressive ataxia and tremor."
    explanation: Core manifestation, mapped to VERY_FREQUENT under the qualitative Pattern C table.
  - reference: PMID:38397171
    reference_title: "The Genetic Basis of the First Patient with Wiedemann-Rautenstrauch Syndrome in the Russian Federation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This syndrome typically manifests neonatally and is characterized by growth retardation, evident generalized lipodystrophy with distinctively localized fat accumulations, sparse scalp hair, and atypical facial features."
    explanation: Generalized lipodystrophy with localized accumulations in a molecularly confirmed patient.
  - reference: PMID:18717246
    reference_title: "Clinical and laboratory findings of two newborns with Wiedemann-Rautenstrauch syndrome: additional features, evaluation of bone turnover and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our two patients had characteristic features of WRS, including intrauterine growth retardation, aged appearance, near absence of subcutaneous fat, gluteal fat pads, also labial pad in the first infant, wrinkled thin skin, sparse scalp hair, prominent scalp veins and facial dysmorphism."
    explanation: Neonatal near-absence of fat with gluteal and labial pads.
- name: Progeroid facial appearance
  category: Craniofacial
  diagnostic: true
  phenotype_term:
    preferred_term: Progeroid facial appearance
    term:
      id: HP:0005328
      label: Progeroid facial appearance
  description: >-
    An aged facial appearance present at birth is the defining sign that gave the
    disorder its neonatal progeroid name.
  phenotype_contexts:
  - onset:
      onset_category: CONGENITAL
      notes: The progeroid appearance is present at birth.
    evidence:
    - reference: PMID:319005
      reference_title: "Progeria: a cell culture study and clinical report of familial incidence."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "This report relates the case histories of two sisters who demonstrated the typical symptoms of progeria at birth."
      explanation: The original 1977 description records progeroid features present at birth.
  evidence:
  - reference: PMID:27612211
    reference_title: "Neonatal progeriod syndrome associated with biallelic truncating variants in POLR3A."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Characteristic physical findings include neonatal progeroid appearance, sparse scalp hair, prominent scalp veins, and lipoatrophy; in addition, neonatal teeth are often a distinctive finding."
    explanation: Neonatal progeroid appearance among the characteristic findings.
  - reference: PMID:7823529
    reference_title: "[Neonatal progeroid syndrome (Wiedemann-Rautenstrauch). A follow-up study]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The diagnostic criteria of the neonatal progeroid syndrome (NPS) are: intrauterine and postnatal growth failure, hydrocephalic appearance, prominent scalp veins, old-looking face, absence of subcutaneous fat and neonatal teeth."
    explanation: The old-looking face is one of the original diagnostic criteria, supporting diagnostic status.
- name: Prematurely aged appearance
  category: Constitutional
  phenotype_term:
    preferred_term: Prematurely aged appearance
    term:
      id: HP:0007495
      label: Prematurely aged appearance
  description: Several features of aging are apparent at birth, which is what makes WRS a neonatal progeroid syndrome.
  evidence:
  - reference: PMID:19938095
    reference_title: "Absence of Lamin A/C gene mutations in four Wiedemann-Rautenstrauch syndrome patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The Wiedemann-Rautenstrauch syndrome (WRS, OMIM: 264090) characterizes a premature aging syndrome in which several features of aging are apparent at birth."
    explanation: Defines the syndrome by its neonatal features of aging.
- name: Triangular face
  category: Craniofacial
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Triangular face
    term:
      id: HP:0000325
      label: Triangular face
  description: Triangular face with a relatively large cranium, small mouth and pointed chin is the core facial gestalt.
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some cases-progressive ataxia and tremor."
    explanation: Triangular face is part of the core facial gestalt; mapped to VERY_FREQUENT under the qualitative Pattern C table.
  - reference: PMID:30414627
    reference_title: "Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It has been proposed to be autosomal-recessive and is characterized by variable clinical features, such as intrauterine growth restriction and poor postnatal weight gain, characteristic facial features (triangular appearance to the face, convex nasal profile or pinched nose, and small mouth), widened fontanelles, pseudohydrocephalus, prominent scalp veins, lipodystrophy, and teeth abnormalities."
    explanation: Triangular facial appearance in the molecular series.
- name: Narrow mouth
  category: Craniofacial
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Small mouth
    term:
      id: HP:0000160
      label: Narrow mouth
  description: A small mouth, often with thin upper lip, is part of the core facial gestalt.
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some cases-progressive ataxia and tremor."
    explanation: Small mouth listed within the core facial features.
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the face characteristics sparse scalp hair, triangular face, small mouth with thin upper vermillion, natal teeth and a pointed chin, and the generalized lipodystrophy with local fatty tissue accumulations all go along together in almost all patients"
    explanation: >-
      Small mouth is named in the group the 51-patient analysis says occur in
      "almost all patients", which maps to VERY_FREQUENT under the qualitative
      Pattern C table. Table 2 of the same paper records 16/18 for this feature in
      the WRS column.
- name: Pointed chin
  category: Craniofacial
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Pointed chin
    term:
      id: HP:0000307
      label: Pointed chin
  description: Pointed chin completes the triangular facial outline.
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some cases-progressive ataxia and tremor."
    explanation: Pointed chin listed within the core facial features.
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the face characteristics sparse scalp hair, triangular face, small mouth with thin upper vermillion, natal teeth and a pointed chin, and the generalized lipodystrophy with local fatty tissue accumulations all go along together in almost all patients"
    explanation: >-
      Pointed chin is named in the group the 51-patient analysis says occur in
      "almost all patients", which maps to VERY_FREQUENT under the qualitative
      Pattern C table. Table 2 of the same paper records 18/18 for this feature in
      the WRS column.
- name: Convex nasal ridge
  category: Craniofacial
  phenotype_term:
    preferred_term: Convex nasal profile or pinched (beaked) nose
    term:
      id: HP:0000444
      label: Convex nasal ridge
  description: A convex nasal profile or pinched, beak-shaped nose is a recurrent facial feature.
  evidence:
  - reference: PMID:30414627
    reference_title: "Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It has been proposed to be autosomal-recessive and is characterized by variable clinical features, such as intrauterine growth restriction and poor postnatal weight gain, characteristic facial features (triangular appearance to the face, convex nasal profile or pinched nose, and small mouth), widened fontanelles, pseudohydrocephalus, prominent scalp veins, lipodystrophy, and teeth abnormalities."
    explanation: Convex nasal profile or pinched nose among the characteristic facial features.
  - reference: PMID:36159344
    reference_title: "A Case of Wiedemann-Rautenstrauch Syndrome With Fatal Hyperkalemic Renal Faliure."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The face appeared progeroid and triangular with a beak-shaped nose, thin erythematous dry skin, bilateral entropion, hypoplastic mandibular rami, and a high palate"
    explanation: Beak-shaped nose in a neonatal case.
- name: Micrognathia
  category: Craniofacial
  phenotype_term:
    preferred_term: Micrognathia
    term:
      id: HP:0000347
      label: Micrognathia
  description: Micrognathia with hypoplastic mandibular rami contributes to feeding difficulty.
  evidence:
  - reference: PMID:10607952
    reference_title: "Neonatal progeroid (Wiedemann-Rautenstrauch) syndrome: report of five new cases and review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The neonatal progeroid syndrome (NPS), or Wiedemann-Rautenstrauch, is a rare autosomal recessive disorder comprised of generalized lipoatrophy except for fat pads in the suprabuttock areas, hypotrichosis of the scalp hair, eyebrows, and eyelashes, relative macrocephaly, triangular face, natal teeth, and micrognathia."
    explanation: Micrognathia in the syndrome definition of the five-case series.
- name: Pseudohydrocephalus
  category: Craniofacial
  diagnostic: true
  phenotype_term:
    preferred_term: Pseudohydrocephalus (relative macrocephaly with prominent scalp veins)
    term:
      id: HP:0004482
      label: Relative macrocephaly
  description: >-
    The cranium appears disproportionately large relative to the small face and
    emaciated body, with wide fontanelles, sparse hair and prominent scalp veins;
    head circumference is typically appropriate for age and there is no
    hydrocephalus, hence the term pseudohydrocephalus.
  evidence:
  - reference: PMID:569581
    reference_title: "An unidentified neonatal progeroid syndrome: follow-up report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Two male infants with a pseudo-hydrocephalic progeroid syndrome with natal teeth are compared with two very similar female cases reported in the literature and interpreted as congenital progeria."
    explanation: Wiedemann's 1979 delineation names the pseudohydrocephalic appearance as the defining feature.
  - reference: PMID:30414627
    reference_title: "Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It has been proposed to be autosomal-recessive and is characterized by variable clinical features, such as intrauterine growth restriction and poor postnatal weight gain, characteristic facial features (triangular appearance to the face, convex nasal profile or pinched nose, and small mouth), widened fontanelles, pseudohydrocephalus, prominent scalp veins, lipodystrophy, and teeth abnormalities."
    explanation: Pseudohydrocephalus in the molecular series.
  - reference: PMID:10607952
    reference_title: "Neonatal progeroid (Wiedemann-Rautenstrauch) syndrome: report of five new cases and review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The neonatal progeroid syndrome (NPS), or Wiedemann-Rautenstrauch, is a rare autosomal recessive disorder comprised of generalized lipoatrophy except for fat pads in the suprabuttock areas, hypotrichosis of the scalp hair, eyebrows, and eyelashes, relative macrocephaly, triangular face, natal teeth, and micrognathia."
    explanation: Relative macrocephaly, the HP term chosen for the pseudohydrocephalic appearance.
- name: Wide anterior fontanel
  category: Craniofacial
  phenotype_term:
    preferred_term: Widened fontanelles
    term:
      id: HP:0000260
      label: Wide anterior fontanel
  description: Widened fontanelles and open sutures are present at birth and close late.
  evidence:
  - reference: PMID:30414627
    reference_title: "Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It has been proposed to be autosomal-recessive and is characterized by variable clinical features, such as intrauterine growth restriction and poor postnatal weight gain, characteristic facial features (triangular appearance to the face, convex nasal profile or pinched nose, and small mouth), widened fontanelles, pseudohydrocephalus, prominent scalp veins, lipodystrophy, and teeth abnormalities."
    explanation: Widened fontanelles among the characteristic features.
  - reference: PMID:36159344
    reference_title: "A Case of Wiedemann-Rautenstrauch Syndrome With Fatal Hyperkalemic Renal Faliure."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Physical examination showed an active crying baby with loss of subcutaneous fat, wide anterior fontanelle, sparse hair, and prominent scalp veins."
    explanation: Wide anterior fontanelle on neonatal examination.
- name: Wide cranial sutures
  category: Craniofacial
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Widely open cranial sutures
    term:
      id: HP:0010537
      label: Wide cranial sutures
  description: >-
    Cranial sutures remain widely open well beyond the usual age, contributing
    with the widened fontanelles to the pseudohydrocephalic appearance.
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition we found that prominent scalp veins, wide cranial sutures, the presence of hypodontia, and the lower eyelid covering part of the cornea are also shared very often."
    explanation: >-
      The 51-patient analysis reports wide cranial sutures as "shared very
      often", mapped conservatively to FREQUENT as for the other features in
      that sentence. This is a separate finding from the widened fontanelles
      recorded above.
- name: Thin upper lip vermilion
  category: Craniofacial
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Thin upper vermillion
    term:
      id: HP:0000219
      label: Thin upper lip vermilion
  description: >-
    A thin upper lip vermilion accompanies the small mouth as part of the core
    facial gestalt.
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the face characteristics sparse scalp hair, triangular face, small mouth with thin upper vermillion, natal teeth and a pointed chin, and the generalized lipodystrophy with local fatty tissue accumulations all go along together in almost all patients"
    explanation: >-
      Thin upper vermillion is named in the group the 51-patient analysis says
      occur in "almost all patients", which maps to VERY_FREQUENT under the
      qualitative Pattern C table. Table 2 of the same paper records 18/18 for
      this feature in the WRS column.
- name: Sparse scalp hair
  category: Ectodermal
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Sparse scalp hair
    term:
      id: HP:0002209
      label: Sparse scalp hair
  description: Sparse scalp hair from birth, with sparse eyebrows and eyelashes, is a core feature; progressive diffuse alopecia has been described.
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some cases-progressive ataxia and tremor."
    explanation: Sparse hair is part of the core facial gestalt; mapped to VERY_FREQUENT under the qualitative Pattern C table.
  - reference: PMID:30323018
    reference_title: "Specific combinations of biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Wiedemann-Rautenstrauch syndrome (WRS) is a form of segmental progeria presenting neonatally, characterised by growth retardation, sparse scalp hair, generalised lipodystrophy with characteristic local fatty tissue accumulations and unusual face."
    explanation: Sparse scalp hair in the molecularly confirmed series.
- name: Sparse eyebrow
  category: Ectodermal
  phenotype_term:
    preferred_term: Sparse eyebrows
    term:
      id: HP:0045075
      label: Sparse eyebrow
  description: Hypotrichosis extends to the eyebrows.
  evidence:
  - reference: PMID:10607952
    reference_title: "Neonatal progeroid (Wiedemann-Rautenstrauch) syndrome: report of five new cases and review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The neonatal progeroid syndrome (NPS), or Wiedemann-Rautenstrauch, is a rare autosomal recessive disorder comprised of generalized lipoatrophy except for fat pads in the suprabuttock areas, hypotrichosis of the scalp hair, eyebrows, and eyelashes, relative macrocephaly, triangular face, natal teeth, and micrognathia."
    explanation: Hypotrichosis of eyebrows in the syndrome definition.
- name: Sparse eyelashes
  category: Ectodermal
  phenotype_term:
    preferred_term: Sparse eyelashes
    term:
      id: HP:0000653
      label: Sparse eyelashes
  description: Hypotrichosis extends to the eyelashes.
  evidence:
  - reference: PMID:10607952
    reference_title: "Neonatal progeroid (Wiedemann-Rautenstrauch) syndrome: report of five new cases and review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The neonatal progeroid syndrome (NPS), or Wiedemann-Rautenstrauch, is a rare autosomal recessive disorder comprised of generalized lipoatrophy except for fat pads in the suprabuttock areas, hypotrichosis of the scalp hair, eyebrows, and eyelashes, relative macrocephaly, triangular face, natal teeth, and micrognathia."
    explanation: Hypotrichosis of eyelashes in the syndrome definition.
- name: Alopecia
  category: Ectodermal
  phenotype_term:
    preferred_term: Progressive diffuse alopecia
    term:
      id: HP:0001596
      label: Alopecia
  description: Progressive diffuse alopecia was described as a classic feature in a 2026 case.
  evidence:
  - reference: PMID:41549341
    reference_title: "Novel POLR3A Gene Mutation Results in Wiedemann-Rautenstrauch Syndrome With Striking Cutis Laxa and Myelofibrosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition to the classic Wiedemann-Rautenstrauch syndrome features-progressive diffuse alopecia, growth retardation, and abnormal white matter development-the patient presented with severe anemia and skin laxity, phenotypes not previously described in Wiedemann-Rautenstrauch syndrome."
    explanation: Progressive diffuse alopecia listed among the classic features.
- name: Prominent scalp veins
  category: Vascular
  frequency: FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Prominent scalp veins
    term:
      id: HP:0001043
      label: Prominent scalp veins
  description: Prominent scalp veins, visible through thin skin and sparse hair, are one of the original diagnostic criteria.
  evidence:
  - reference: PMID:7823529
    reference_title: "[Neonatal progeroid syndrome (Wiedemann-Rautenstrauch). A follow-up study]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The diagnostic criteria of the neonatal progeroid syndrome (NPS) are: intrauterine and postnatal growth failure, hydrocephalic appearance, prominent scalp veins, old-looking face, absence of subcutaneous fat and neonatal teeth."
    explanation: Prominent scalp veins among the original diagnostic criteria.
  - reference: PMID:27612211
    reference_title: "Neonatal progeriod syndrome associated with biallelic truncating variants in POLR3A."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Characteristic physical findings include neonatal progeroid appearance, sparse scalp hair, prominent scalp veins, and lipoatrophy; in addition, neonatal teeth are often a distinctive finding."
    explanation: Prominent scalp veins in the first molecularly solved case.
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition we found that prominent scalp veins, wide cranial sutures, the presence of hypodontia, and the lower eyelid covering part of the cornea are also shared very often."
    explanation: >-
      The 51-patient analysis reports prominent scalp veins as "shared very often".
      That wording sits between the "often" (FREQUENT) and "almost all"
      (VERY_FREQUENT) rows of the Pattern C table, so the band is set conservatively
      to FREQUENT; Table 2 of the same paper records 17/18 in the WRS column, which
      would support the higher band.
- name: Thin skin
  category: Skin
  phenotype_term:
    preferred_term: Thin, wrinkled skin
    term:
      id: HP:0000963
      label: Thin skin
  description: Thin, wrinkled, translucent skin over the lipoatrophic subcutis.
  evidence:
  - reference: PMID:21671373
    reference_title: "Neonatal progeroid syndrome (Wiedemann-Rautenstrauch syndrome): report of three affected sibs."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "WRS patients are characterized by premature aging present at birth including pseudohydrocephalus, cranio-facial disproportion, reduced subcutaneous fat, thin skin, rigid and thick joints, and neonatal teeth in some cases."
    explanation: Thin skin in the three-sib family.
  - reference: PMID:18717246
    reference_title: "Clinical and laboratory findings of two newborns with Wiedemann-Rautenstrauch syndrome: additional features, evaluation of bone turnover and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our two patients had characteristic features of WRS, including intrauterine growth retardation, aged appearance, near absence of subcutaneous fat, gluteal fat pads, also labial pad in the first infant, wrinkled thin skin, sparse scalp hair, prominent scalp veins and facial dysmorphism."
    explanation: Wrinkled thin skin in two neonates.
- name: Cutis laxa
  category: Skin
  phenotype_term:
    preferred_term: Skin laxity
    term:
      id: HP:0000973
      label: Cutis laxa
  description: Striking skin laxity was reported in a single molecularly confirmed patient and had not been described in WRS before.
  evidence:
  - reference: PMID:41549341
    reference_title: "Novel POLR3A Gene Mutation Results in Wiedemann-Rautenstrauch Syndrome With Striking Cutis Laxa and Myelofibrosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition to the classic Wiedemann-Rautenstrauch syndrome features-progressive diffuse alopecia, growth retardation, and abnormal white matter development-the patient presented with severe anemia and skin laxity, phenotypes not previously described in Wiedemann-Rautenstrauch syndrome."
    explanation: Single-patient expansion of the cutaneous phenotype.
- name: Natal teeth
  category: Dental
  frequency: VERY_FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Natal teeth
    term:
      id: HP:0000695
      label: Natal tooth
  description: >-
    Teeth present at birth, which are usually lost within weeks, are a distinctive
    and diagnostically useful finding, although not present in every patient.
  phenotype_contexts:
  - onset:
      onset_category: CONGENITAL
      notes: By definition present at birth.
  evidence:
  - reference: PMID:27612211
    reference_title: "Neonatal progeriod syndrome associated with biallelic truncating variants in POLR3A."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Characteristic physical findings include neonatal progeroid appearance, sparse scalp hair, prominent scalp veins, and lipoatrophy; in addition, neonatal teeth are often a distinctive finding."
    explanation: >-
      Author wording often maps to FREQUENT under the qualitative Pattern C
      table. Other sources describe natal teeth as present in some patients or
      as a core manifestation, so the band is uncertain.
  - reference: PMID:569581
    reference_title: "An unidentified neonatal progeroid syndrome: follow-up report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Two male infants with a pseudo-hydrocephalic progeroid syndrome with natal teeth are compared with two very similar female cases reported in the literature and interpreted as congenital progeria."
    explanation: Natal teeth in the original delineation.
  - reference: PMID:22585414
    reference_title: "Wiedemann-Rautenstrauch syndrome: report of a variant case."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The syndrome is characterized by progeroid appearance, decreased subcutaneous fat, hypotrichosis, macrocephaly, and in some natal teeth."
    explanation: >-
      An older single case report using weaker wording. It is kept for the
      association but is superseded for the frequency band by the 18-patient
      series below, which counts natal teeth among the features present in
      almost all patients.
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the face characteristics sparse scalp hair, triangular face, small mouth with thin upper vermillion, natal teeth and a pointed chin, and the generalized lipodystrophy with local fatty tissue accumulations all go along together in almost all patients"
    explanation: >-
      Natal teeth is named in the group the 51-patient analysis says occur in
      "almost all patients", which maps to VERY_FREQUENT under the qualitative
      Pattern C table. Table 2 of the same paper records 17/18 for this feature in
      the WRS column. This supersedes the "in some" wording of the older case
      report above.
- name: Hypodontia
  category: Dental
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Hypodontia
    term:
      id: HP:0000668
      label: Hypodontia
  description: Failure of permanent teeth to develop in survivors; anodontia has been reported in an adult.
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some cases-progressive ataxia and tremor."
    explanation: Hypodontia listed among the core dental anomalies.
  - reference: PMID:34611991
    reference_title: "A novel homozygous synonymous variant further expands the phenotypic spectrum of POLR3A-related pathologies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Over the years, above characteristic facial features, she showed severe postnatal growth retardation, global lipodystrophy, joint contractures, thoracic hypoplasia, scoliosis, anodontia, spastic quadriplegia, bilateral hearing loss, aphonia, hypogonadotropic hypogonadism, and cerebellar peduncles hyperintensities in brain imaging."
    explanation: Anodontia, the extreme of the dental phenotype, in an adult survivor.
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition we found that prominent scalp veins, wide cranial sutures, the presence of hypodontia, and the lower eyelid covering part of the cornea are also shared very often."
    explanation: >-
      The 51-patient analysis reports hypodontia as "shared very often", mapped
      conservatively to FREQUENT as for the other features in that sentence.
- name: Hypotonia
  category: Neurologic
  phenotype_term:
    preferred_term: Hypotonia
    term:
      id: HP:0001252
      label: Hypotonia
  description: Muscular hypotonia in infancy, evolving to spasticity in some survivors.
  evidence:
  - reference: PMID:34289880
    reference_title: "Whole-exome sequencing reveals POLR3B variants associated with progeria-related Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Wiedemann-Rautenstrauch syndrome (WRS) is a rare autosomal recessive neonatal progeroid disorder characterized by prenatal and postnatal growth retardation, short stature, a progeroid appearance, hypotonia, and mental impairment."
    explanation: Hypotonia in the disease definition.
  - reference: PMID:34611991
    reference_title: "A novel homozygous synonymous variant further expands the phenotypic spectrum of POLR3A-related pathologies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "She presented at birth with intrauterine growth retardation, lipodystrophy, muscular hypotonia, and several WRS-like facial features, albeit without sparse hair and prominent scalp veins."
    explanation: Muscular hypotonia at birth in a molecularly confirmed patient.
  - reference: PMID:36596744
    reference_title: "Biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome with atypical brain involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "He was hypotonic and he could not control his head nor roll over his body."
    explanation: Infantile hypotonia with motor delay.
- name: Intellectual disability
  category: Neurologic
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Mild to moderate intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  description: >-
    Mild to moderate intellectual disability is common but not universal; at
    least one adult survivor had no developmental delay or intellectual
    disability.
  evidence:
  - reference: PMID:10607952
    reference_title: "Neonatal progeroid (Wiedemann-Rautenstrauch) syndrome: report of five new cases and review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It is apparent, based on the 21 cases, that mild to moderate mental retardation is common in NPS."
    explanation: Author wording common maps to FREQUENT under the qualitative Pattern C table; based on 21 cases.
  - reference: PMID:32555393
    reference_title: "Unique combination and in silico modeling of biallelic POLR3A variants as a cause of Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Neonatal progeroid syndrome or Wiedemann-Rautenstrauch syndrome (WRS; MIM 264090) is a rare genetic disorder that has clinical symptoms including premature aging, lipodystrophy, and variable mental impairment."
    explanation: Variable mental impairment in the disease definition.
  - reference: PMID:34611991
    reference_title: "A novel homozygous synonymous variant further expands the phenotypic spectrum of POLR3A-related pathologies."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "She had no signs of developmental delay or intellectual disability."
    explanation: A molecularly confirmed adult without intellectual disability, showing the feature is not obligate.
- name: Global developmental delay
  category: Neurologic
  phenotype_term:
    preferred_term: Psychomotor developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  description: Psychomotor delay is usual in infancy; motor milestones are delayed and some children remain non-ambulant.
  evidence:
  - reference: PMID:7823529
    reference_title: "[Neonatal progeroid syndrome (Wiedemann-Rautenstrauch). A follow-up study]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "With her a considerable atactic movement disturbance developed next to a psychomotoric retardation."
    explanation: Psychomotor retardation in the long-term follow-up of the original patient.
  - reference: PMID:36596744
    reference_title: "Biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome with atypical brain involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "He remains near bed-ridden state at 40 months despite constant physical rehabilitation."
    explanation: Profound motor delay in a patient with striatal-variant brain involvement.
- name: Ataxia
  category: Neurologic
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Progressive ataxia
    term:
      id: HP:0001251
      label: Ataxia
  description: Progressive ataxia develops in some longer-surviving patients.
  phenotype_contexts:
  - onset:
      onset_category: CHILDHOOD
      notes: Develops in survivors beyond infancy rather than at birth.
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some cases-progressive ataxia and tremor."
    explanation: Author wording in some cases maps to OCCASIONAL under the qualitative Pattern C table.
  - reference: PMID:7823529
    reference_title: "[Neonatal progeroid syndrome (Wiedemann-Rautenstrauch). A follow-up study]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "With her a considerable atactic movement disturbance developed next to a psychomotoric retardation."
    explanation: Ataxia emerging in the original patient by age 16.
  - reference: PMID:36825045
    reference_title: "Spectrum of Pediatric to Early Adulthood POLR3A-Associated Movement Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Patient 1 presented with a neonatal progeroid syndrome and developed parkinsonism, dystonia, ataxia, and spasticity."
    explanation: Ataxia as part of a later movement-disorder phenotype in a neonatal progeroid patient.
- name: Tremor
  category: Neurologic
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Tremor
    term:
      id: HP:0001337
      label: Tremor
  description: Progressive tremor accompanies the ataxia in some survivors.
  evidence:
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Core manifestations of the syndrome are marked pre-natal and severe post-natal growth retardation, an unusual face (triangular shape, sparse hair, small mouth, pointed chin), dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and-in some cases-progressive ataxia and tremor."
    explanation: Author wording in some cases maps to OCCASIONAL under the qualitative Pattern C table.
- name: Spasticity
  category: Neurologic
  phenotype_term:
    preferred_term: Spasticity
    term:
      id: HP:0001257
      label: Spasticity
  description: Spasticity, up to spastic quadriplegia, in survivors with progressive neurologic involvement.
  evidence:
  - reference: PMID:34611991
    reference_title: "A novel homozygous synonymous variant further expands the phenotypic spectrum of POLR3A-related pathologies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Over the years, above characteristic facial features, she showed severe postnatal growth retardation, global lipodystrophy, joint contractures, thoracic hypoplasia, scoliosis, anodontia, spastic quadriplegia, bilateral hearing loss, aphonia, hypogonadotropic hypogonadism, and cerebellar peduncles hyperintensities in brain imaging."
    explanation: Spastic quadriplegia in an adult survivor.
  - reference: PMID:36825045
    reference_title: "Spectrum of Pediatric to Early Adulthood POLR3A-Associated Movement Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Patient 1 presented with a neonatal progeroid syndrome and developed parkinsonism, dystonia, ataxia, and spasticity."
    explanation: Spasticity in a neonatal progeroid patient followed into later life.
- name: Dystonia
  category: Neurologic
  phenotype_term:
    preferred_term: Dystonia
    term:
      id: HP:0001332
      label: Dystonia
  description: Dystonia and parkinsonism were reported in one neonatal progeroid patient within a POLR3A movement-disorder series.
  evidence:
  - reference: PMID:36825045
    reference_title: "Spectrum of Pediatric to Early Adulthood POLR3A-Associated Movement Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Patient 1 presented with a neonatal progeroid syndrome and developed parkinsonism, dystonia, ataxia, and spasticity."
    explanation: Single-patient report of dystonia.
- name: Parkinsonism
  category: Neurologic
  phenotype_term:
    preferred_term: Parkinsonism
    term:
      id: HP:0001300
      label: Parkinsonism
  description: Parkinsonism in one neonatal progeroid patient, consistent with the striatal and midbrain involvement of POLR3A-related disease.
  evidence:
  - reference: PMID:36825045
    reference_title: "Spectrum of Pediatric to Early Adulthood POLR3A-Associated Movement Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Patient 1 presented with a neonatal progeroid syndrome and developed parkinsonism, dystonia, ataxia, and spasticity."
    explanation: Single-patient report of parkinsonism.
- name: CNS hypomyelination
  category: Neurologic
  phenotype_term:
    preferred_term: Hypomyelination or abnormal white matter
    term:
      id: HP:0003429
      label: CNS hypomyelination
  description: >-
    Delayed myelination or a hypomyelinating leukodystrophy pattern on brain MRI
    in a subset of patients, the point of overlap with 4H leukodystrophy.
  evidence:
  - reference: PMID:38348603
    reference_title: "Further delineation of Wiedemann-Rautenstrauch syndrome linked with POLR3A."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The patients have hallmark features such as prenatal and postnatal growth retardation, short stature, a progeroid appearance, hypotonia, facial dysmorphology, hypomyelination leukodystrophy, and mental impairment."
    explanation: Hypomyelinating leukodystrophy in three consanguineous families; not universal across the literature, so no frequency is assigned.
  - reference: PMID:41549341
    reference_title: "Novel POLR3A Gene Mutation Results in Wiedemann-Rautenstrauch Syndrome With Striking Cutis Laxa and Myelofibrosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition to the classic Wiedemann-Rautenstrauch syndrome features-progressive diffuse alopecia, growth retardation, and abnormal white matter development-the patient presented with severe anemia and skin laxity, phenotypes not previously described in Wiedemann-Rautenstrauch syndrome."
    explanation: Abnormal white matter development in a 2026 case.
- name: Nystagmus
  category: Ophthalmologic
  phenotype_term:
    preferred_term: Congenital nystagmus
    term:
      id: HP:0000639
      label: Nystagmus
  description: Congenital nystagmus was noted in a patient with striatal-variant brain involvement.
  evidence:
  - reference: PMID:36596744
    reference_title: "Biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome with atypical brain involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "He had pectus excavatum and congenital nystagmus."
    explanation: Single-patient observation.
- name: Entropion
  category: Ophthalmologic
  phenotype_term:
    preferred_term: Congenital upper eyelid entropion (tarsal kink)
    term:
      id: HP:0000621
      label: Entropion
  description: Bilateral tarsal kink of the upper eyelids and neonatal entropion have been reported and are surgically correctable.
  evidence:
  - reference: PMID:28468175
    reference_title: "Wiedemann-Rautenstrauch Syndrome With Bilateral Tarsal Kink: Three Sutures for Correction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "He had tarsal kink in upper eyelids in both eyes."
    explanation: Bilateral congenital tarsal kink, a form of upper-lid entropion.
  - reference: PMID:36159344
    reference_title: "A Case of Wiedemann-Rautenstrauch Syndrome With Fatal Hyperkalemic Renal Faliure."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The face appeared progeroid and triangular with a beak-shaped nose, thin erythematous dry skin, bilateral entropion, hypoplastic mandibular rami, and a high palate"
    explanation: Bilateral entropion on neonatal examination.
- name: Lagophthalmos
  category: Ophthalmologic
  phenotype_term:
    preferred_term: Lagophthalmos
    term:
      id: HP:0030001
      label: Lagophthalmos
  description: Lagophthalmos and thin central corneas were reported in one child; both predispose to exposure keratopathy.
  evidence:
  - reference: PMID:26691040
    reference_title: "Ophthalmic manifestations in a case of Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We report for the first time the findings of thin central corneas and lagophthalmos in WRS."
    explanation: Single-patient ophthalmic report.
- name: Decreased corneal thickness
  category: Ophthalmologic
  phenotype_term:
    preferred_term: Thin central cornea
    term:
      id: HP:0100689
      label: Decreased corneal thickness
  description: Thin central corneas in one child.
  evidence:
  - reference: PMID:26691040
    reference_title: "Ophthalmic manifestations in a case of Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We report for the first time the findings of thin central corneas and lagophthalmos in WRS."
    explanation: Single-patient ophthalmic report.
- name: Osteopenia
  category: Skeletal
  phenotype_term:
    preferred_term: Severe osteopenia
    term:
      id: HP:0000938
      label: Osteopenia
  description: Severe osteopenia with a raised bone-resorption marker was documented in two neonates; fracture risk warrants careful handling.
  evidence:
  - reference: PMID:18717246
    reference_title: "Clinical and laboratory findings of two newborns with Wiedemann-Rautenstrauch syndrome: additional features, evaluation of bone turnover and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "They also have severe osteopenia and elevated urinary deoxypyridinoline levels which have not been previously described in patients with WRS."
    explanation: Bone-mineral evaluation in two neonates.
- name: Joint contracture
  category: Musculoskeletal
  phenotype_term:
    preferred_term: Joint contractures
    term:
      id: HP:0034392
      label: Joint contracture
  description: Rigid, thick joints in infancy and joint contractures in survivors.
  evidence:
  - reference: PMID:18717246
    reference_title: "Clinical and laboratory findings of two newborns with Wiedemann-Rautenstrauch syndrome: additional features, evaluation of bone turnover and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our first patient also has excessive joint contractures, persisting thrombocytosis and rectal prolapse."
    explanation: Excessive joint contractures in a neonate.
  - reference: PMID:34611991
    reference_title: "A novel homozygous synonymous variant further expands the phenotypic spectrum of POLR3A-related pathologies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Over the years, above characteristic facial features, she showed severe postnatal growth retardation, global lipodystrophy, joint contractures, thoracic hypoplasia, scoliosis, anodontia, spastic quadriplegia, bilateral hearing loss, aphonia, hypogonadotropic hypogonadism, and cerebellar peduncles hyperintensities in brain imaging."
    explanation: Joint contractures in an adult survivor.
- name: Scoliosis
  category: Skeletal
  phenotype_term:
    preferred_term: Scoliosis
    term:
      id: HP:0002650
      label: Scoliosis
  description: Scoliosis or kyphoscoliosis develops in longer-term survivors.
  evidence:
  - reference: PMID:34611991
    reference_title: "A novel homozygous synonymous variant further expands the phenotypic spectrum of POLR3A-related pathologies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Over the years, above characteristic facial features, she showed severe postnatal growth retardation, global lipodystrophy, joint contractures, thoracic hypoplasia, scoliosis, anodontia, spastic quadriplegia, bilateral hearing loss, aphonia, hypogonadotropic hypogonadism, and cerebellar peduncles hyperintensities in brain imaging."
    explanation: Scoliosis in an adult survivor.
- name: Toe syndactyly
  category: Limb
  phenotype_term:
    preferred_term: Partial 2-3 toe syndactyly
    term:
      id: HP:0001770
      label: Toe syndactyly
  description: Partial syndactyly of the second and third toes in a single variant case.
  evidence:
  - reference: PMID:22585414
    reference_title: "Wiedemann-Rautenstrauch syndrome: report of a variant case."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We describe a new patient with features of bilaterally pelvicalyceal ectasia and partial syndactyly on 2th and 3th toes, not previously described, to our knowledge."
    explanation: Single variant case.
- name: Hydronephrosis
  category: Renal
  phenotype_term:
    preferred_term: Bilateral pelvicalyceal ectasia
    term:
      id: HP:0000126
      label: Hydronephrosis
  description: Bilateral pelvicalyceal ectasia in a single variant case; fatal neonatal hyperkalemic renal failure has also been reported once.
  evidence:
  - reference: PMID:22585414
    reference_title: "Wiedemann-Rautenstrauch syndrome: report of a variant case."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We describe a new patient with features of bilaterally pelvicalyceal ectasia and partial syndactyly on 2th and 3th toes, not previously described, to our knowledge."
    explanation: Single variant case; hydronephrosis is the closest HP term to pelvicalyceal ectasia.
- name: Anemia
  category: Hematologic
  phenotype_term:
    preferred_term: Anemia
    term:
      id: HP:0001903
      label: Anemia
  description: >-
    Severe anemia with myelofibrosis was reported in one molecularly confirmed
    patient. In another reported case the anemia was attributed to co-inherited
    FANCA variants rather than to POLR3A, so anemia should not be assumed to be a
    WRS feature without excluding a second diagnosis.
  evidence:
  - reference: PMID:41549341
    reference_title: "Novel POLR3A Gene Mutation Results in Wiedemann-Rautenstrauch Syndrome With Striking Cutis Laxa and Myelofibrosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition to the classic Wiedemann-Rautenstrauch syndrome features-progressive diffuse alopecia, growth retardation, and abnormal white matter development-the patient presented with severe anemia and skin laxity, phenotypes not previously described in Wiedemann-Rautenstrauch syndrome."
    explanation: Severe anemia in a single POLR3A-confirmed patient.
  - reference: PMID:36385762
    reference_title: "A synonymous variant contributes to a rare Wiedemann-Rautenstrauch syndrome complicated with mild anemia via affecting pre-mRNA splicing."
    supports: NO_EVIDENCE
    evidence_source: HUMAN_CLINICAL
    snippet: "For the mild anemia phenotype, the underlying causal genetic factors could be attributed to the compound heterozygous mutations in FANCA gene (c.2832dup, p.Ala945CysfsTer6 and c.1902 T > G, p.Asp634Glu)."
    explanation: This patient's anemia was explained by a second recessive disorder, so the report does not bear on anemia as a POLR3A phenotype.
- name: Thrombocytosis
  category: Hematologic
  phenotype_term:
    preferred_term: Persisting thrombocytosis
    term:
      id: HP:0001894
      label: Thrombocytosis
  description: Persisting thrombocytosis in one neonate.
  evidence:
  - reference: PMID:18717246
    reference_title: "Clinical and laboratory findings of two newborns with Wiedemann-Rautenstrauch syndrome: additional features, evaluation of bone turnover and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our first patient also has excessive joint contractures, persisting thrombocytosis and rectal prolapse."
    explanation: Single-patient observation.
- name: Hypertriglyceridemia
  category: Metabolic
  phenotype_term:
    preferred_term: Hypertriglyceridemia
    term:
      id: HP:0002155
      label: Hypertriglyceridemia
  description: Elevated triglycerides are among the lipid abnormalities reported in a minority of patients, consistent with the lipodystrophy.
  evidence:
  - reference: PMID:18717246
    reference_title: "Clinical and laboratory findings of two newborns with Wiedemann-Rautenstrauch syndrome: additional features, evaluation of bone turnover and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Impaired lipid and hormone profiles including elevated prolactin and triglyceride level have been reported in patients with WRS."
    explanation: Review statement in a case report summarizing prior laboratory findings.
  - reference: PMID:10607952
    reference_title: "Neonatal progeroid (Wiedemann-Rautenstrauch) syndrome: report of five new cases and review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Abnormalities in endocrine and lipid metabolism were found in 3 of 5 patients."
    explanation: Lipid abnormalities in three of five patients; the abstract does not specify which analytes.
- name: Hearing impairment
  category: Auditory
  phenotype_term:
    preferred_term: Bilateral hearing loss
    term:
      id: HP:0000365
      label: Hearing impairment
  description: Bilateral hearing loss in an adult survivor with a WRS-like presentation.
  evidence:
  - reference: PMID:34611991
    reference_title: "A novel homozygous synonymous variant further expands the phenotypic spectrum of POLR3A-related pathologies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Over the years, above characteristic facial features, she showed severe postnatal growth retardation, global lipodystrophy, joint contractures, thoracic hypoplasia, scoliosis, anodontia, spastic quadriplegia, bilateral hearing loss, aphonia, hypogonadotropic hypogonadism, and cerebellar peduncles hyperintensities in brain imaging."
    explanation: Single adult survivor.
- name: Hypogonadotropic hypogonadism
  category: Endocrine
  phenotype_term:
    preferred_term: Hypogonadotropic hypogonadism
    term:
      id: HP:0000044
      label: Hypogonadotropic hypogonadism
  description: >-
    Hypogonadotropic hypogonadism, a cardinal feature of the allelic 4H
    leukodystrophy, was documented in an adult WRS-like survivor; too few
    patients reach puberty for its frequency in WRS to be known.
  evidence:
  - reference: PMID:34611991
    reference_title: "A novel homozygous synonymous variant further expands the phenotypic spectrum of POLR3A-related pathologies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Over the years, above characteristic facial features, she showed severe postnatal growth retardation, global lipodystrophy, joint contractures, thoracic hypoplasia, scoliosis, anodontia, spastic quadriplegia, bilateral hearing loss, aphonia, hypogonadotropic hypogonadism, and cerebellar peduncles hyperintensities in brain imaging."
    explanation: Single adult survivor.
biochemical:
- name: Urinary deoxypyridinoline
  presence: ELEVATED
  context: Bone-resorption marker measured in two neonates with severe osteopenia.
  evidence:
  - reference: PMID:18717246
    reference_title: "Clinical and laboratory findings of two newborns with Wiedemann-Rautenstrauch syndrome: additional features, evaluation of bone turnover and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "They also have severe osteopenia and elevated urinary deoxypyridinoline levels which have not been previously described in patients with WRS."
    explanation: Elevated urinary deoxypyridinoline as a readout of increased bone resorption.
- name: Serum prolactin
  presence: ELEVATED
  biomarker_term:
    preferred_term: Increased circulating prolactin concentration
    term:
      id: HP:0000870
      label: Increased circulating prolactin concentration
  context: Reported in a minority of patients; mechanism unexplained.
  evidence:
  - reference: PMID:18717246
    reference_title: "Clinical and laboratory findings of two newborns with Wiedemann-Rautenstrauch syndrome: additional features, evaluation of bone turnover and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Impaired lipid and hormone profiles including elevated prolactin and triglyceride level have been reported in patients with WRS."
    explanation: Review statement summarizing prior hormone findings.
- name: Serum triglycerides
  presence: ELEVATED
  biomarker_term:
    preferred_term: Hypertriglyceridemia
    term:
      id: HP:0002155
      label: Hypertriglyceridemia
  context: Reported in a minority of patients, consistent with the generalized lipodystrophy.
  evidence:
  - reference: PMID:18717246
    reference_title: "Clinical and laboratory findings of two newborns with Wiedemann-Rautenstrauch syndrome: additional features, evaluation of bone turnover and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Impaired lipid and hormone profiles including elevated prolactin and triglyceride level have been reported in patients with WRS."
    explanation: Review statement summarizing prior lipid findings.
diagnosis:
- name: Molecular genetic testing of POLR3A
  diagnosis_term:
    preferred_term: POLR3A sequencing including intronic regions
    term:
      id: NCIT:C15709
      label: Genetic Testing
  description: >-
    Diagnosis is confirmed by identifying biallelic POLR3A variants. Because many
    WRS alleles are deep-intronic or synonymous and are missed by coding-only
    filters, clinical suspicion must drive targeted intronic analysis and, where
    possible, RNA studies.
  results: Biallelic POLR3A variants, typically a recurrent intronic allele in trans with a truncating or missense allele.
  evidence:
  - reference: PMID:30323018
    reference_title: "Specific combinations of biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Multiple variants were found to affect POLR3A transcript processing and were mostly located in deep intronic regions, making clinical suspicion fundamental to detection."
    explanation: Deep-intronic alleles make targeted, suspicion-driven testing essential.
  - reference: PMID:38397171
    reference_title: "The Genetic Basis of the First Patient with Wiedemann-Rautenstrauch Syndrome in the Russian Federation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Utilizing whole-exome sequencing (WES), we identified a novel missense variant c.3677T>C (p.Leu1226Pro) in the POLR3A gene (NM_007055.4) alongside two cis intronic variants c.1909+22G>A and c.3337-11T>C."
    explanation: Exome sequencing with attention to near-exon intronic variants resolved the diagnosis.
- name: Whole-exome sequencing
  diagnosis_term:
    preferred_term: Whole exome sequencing
    term:
      id: NCIT:C101295
      label: Whole Exome Sequencing
  description: Trio or singleton exome sequencing has been the discovery and diagnostic modality in most molecularly confirmed cases.
  evidence:
  - reference: PMID:34289880
    reference_title: "Whole-exome sequencing reveals POLR3B variants associated with progeria-related Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our study not only identified a novel WRS-associated gene, POLR3B, but also broadened the mutational and phenotypic spectra of POLR3B."
    explanation: Exome sequencing as the route to a molecular diagnosis in a progeroid proband.
- name: Prenatal ultrasound
  diagnosis_term:
    preferred_term: Serial prenatal ultrasound
    term:
      id: NCIT:C222238
      label: Fetal Ultrasound Imaging
  description: >-
    In a family with a previous affected child, serial ultrasound showing growth
    retardation of the biparietal and abdominal diameters with preserved femoral
    length identified a second affected pregnancy before molecular testing was
    available.
  evidence:
  - reference: PMID:1619643
    reference_title: "Two sibs with Wiedemann-Rautenstrauch syndrome: possibilities of prenatal diagnosis by ultrasound."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This case shows that ultrasound examination can be a useful tool in the prenatal diagnosis of this rare, autosomal recessive syndrome."
    explanation: Ultrasound-based prenatal recognition in a recurrence pregnancy.
- name: Brain magnetic resonance imaging
  diagnosis_term:
    preferred_term: Brain MRI
    term:
      id: NCIT:C16809
      label: Magnetic Resonance Imaging
  description: >-
    Brain MRI evaluates white-matter involvement; delayed myelination, striatal
    involvement and superior cerebellar peduncle or midbrain hyperintensity have
    been reported in POLR3A-related disease including WRS.
  evidence:
  - reference: PMID:36825045
    reference_title: "Spectrum of Pediatric to Early Adulthood POLR3A-Associated Movement Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The most common brain MRI abnormality was T2-weighted/FLAIR hyperintensity of the superior cerebellar peduncles and midbrain."
    explanation: Imaging sign suggestive of POLR3A-related disease.
differential_diagnoses:
- name: POLR3-related (4H) hypomyelinating leukodystrophy
  disease_term:
    preferred_term: POLR3-related (4H) leukodystrophy, POLR3A type (HLD7)
    term:
      id: MONDO:0011897
      label: leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism
  description: >-
    The allelic disorder. 4H leukodystrophy presents in childhood with diffuse
    hypomyelination, hypodontia and hypogonadotropic hypogonadism and is
    associated mainly with biallelic missense POLR3A variants, whereas WRS
    presents at birth with lipodystrophy and growth failure and is associated
    with splice-affecting and truncating allele combinations; the two overlap in
    dental, endocrine and later neurologic features.
  distinguishing_features:
  - Neonatal onset with generalized lipoatrophy, natal teeth and pseudohydrocephalus in WRS
  - Diffuse hypomyelination as the defining feature in 4H, variable and often absent in WRS
  - Predominantly missense genotypes in 4H versus splice-affecting or truncating combinations in WRS
  evidence:
  - reference: PMID:30414627
    reference_title: "Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Bi-allelic missense variants in POLR3A have been associated with phenotypes distinct from WRS: hypogonadotropic hypogonadism and hypomyelinating leukodystrophy with or without oligodontia."
    explanation: Frames the leukodystrophy as a distinct POLR3A phenotype with different variant classes.
  - reference: PMID:22855961
    reference_title: "POLR3-Related Leukodystrophy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Confirmation of this as a very severe form of POLR3-related leukodystrophy awaits replication in other individuals with a clinical diagnosis of Wiedemann-Rautenstrauch syndrome."
    explanation: The POLR3-related leukodystrophy GeneReviews chapter considered WRS a possible severe end of its own spectrum before replication.
  - reference: PMID:28447407
    reference_title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "There are major differences but there are also similarities in phenotype, which sustain the suggestion that the syndrome can be caused by disturbed POLR3A functioning."
    explanation: Systematic phenotype comparison of WRS with the recessive POLR3A conditions.
- name: Hutchinson-Gilford progeria syndrome
  disease_term:
    preferred_term: Hutchinson-Gilford progeria syndrome
    term:
      id: MONDO:0008310
      label: Hutchinson-Gilford progeria syndrome
  description: >-
    The prototypic progeria, caused by a recurrent de novo LMNA variant, presents
    after the first year with progressive loss of fat and hair and vascular
    disease; it lacks the neonatal onset, natal teeth and pseudohydrocephalus of
    WRS, and LMNA is normal in WRS.
  distinguishing_features:
  - Onset after infancy in HGPS versus at birth in WRS
  - LMNA G608G in HGPS; no LMNA variants in WRS
  - Sporadic dominant in HGPS versus recessive in WRS
  evidence:
  - reference: PMID:19938095
    reference_title: "Absence of Lamin A/C gene mutations in four Wiedemann-Rautenstrauch syndrome patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We did not find mutations in Lamin A/C (LMNA) gene in four WRS patients, and in particular, we did not find the G608G mutation (GGC > GGT transition) which is associated with most cases with Hutchinson-Gilford progeria (OMIM 176670)."
    explanation: Molecular exclusion of HGPS in clinically diagnosed WRS.
  - reference: PMID:30450527
    reference_title: "Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Thus, we suggest that POLR3A mutations are causal for a portion of under-diagnosed early-onset segmental progeroid syndromes."
    explanation: POLR3A testing resolves LMNA-negative progeroid cases.
- name: Marfanoid-progeroid-lipodystrophy syndrome
  disease_term:
    preferred_term: progeroid and marfanoid aspect-lipodystrophy syndrome
    term:
      id: MONDO:0014831
      label: progeroid and marfanoid aspect-lipodystrophy syndrome
  description: >-
    Neonatal progeroid appearance with congenital generalized lipodystrophy
    caused by 3-prime FBN1 truncating variants; repeatedly diagnosed at birth as
    WRS. The marfanoid habitus, ectopia lentis and aortic dilation that emerge
    later, dominant de novo inheritance and the FBN1 genotype distinguish it.
  distinguishing_features:
  - Later marfanoid skeletal and ocular features and aortic root dilation
  - De novo heterozygous 3-prime FBN1 variant rather than biallelic POLR3A variants
  - Normal intellect and preserved insulin sensitivity
  evidence:
  - reference: PMID:24613577
    reference_title: "Neonatal progeroid variant of Marfan syndrome with congenital lipodystrophy results from mutations at the 3' end of FBN1 gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We report a 16-year-old girl with neonatal progeroid features and congenital lipodystrophy who was considered at birth as a possible variant of Wiedemann-Rautenstrauch syndrome."
    explanation: Documents the neonatal misdiagnosis that makes this the leading non-POLR3A differential.
- name: POLR3A striatal variant
  description: >-
    Biallelic POLR3A genotypes including c.1771-6C>G or c.1771-7C>G produce an
    early-onset, rapidly progressive neurologic disorder with focal striatal
    involvement rather than diffuse hypomyelination. One WRS patient carried
    c.1771-6C>G and showed both the progeroid and lipodystrophic phenotype and
    striatal involvement, so the two can coincide.
  distinguishing_features:
  - Striatal MRI involvement and profound neurodevelopmental impairment
  - Absence of lipodystrophy and progeroid face in the classic striatal variant
  evidence:
  - reference: PMID:36596744
    reference_title: "Biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome with atypical brain involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our patient has a c.1771-6C>G variant and also showed profound neurodevelopmental problem and striatal involvement."
    explanation: Overlap case linking WRS with the striatal-variant allele and imaging pattern.
  - reference: PMID:33559318
    reference_title: "Wiedemann-Rautenstrauch syndrome in an Indian patient with biallelic pathogenic variants in POLR3A."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The variant c.1771-7C>G was earlier found to be associated with hereditary spastic ataxia."
    explanation: The neighbouring intronic allele is shared with another POLR3A neurologic phenotype.
treatments:
- name: Multidisciplinary supportive care
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  description: >-
    There is no disease-modifying therapy. Care is supportive and symptom
    directed, covering feeding support, infection management, monitoring of renal
    and electrolyte status in the neonatal period, careful handling because of
    osteopenia, ophthalmic protection where lagophthalmos or entropion is
    present, dental care, and developmental and neurological follow-up in
    survivors.
  target_phenotypes:
  - preferred_term: Failure to thrive
    term:
      id: HP:0001508
      label: Failure to thrive
  - preferred_term: Osteopenia
    term:
      id: HP:0000938
      label: Osteopenia
  evidence:
  - reference: PMID:18717246
    reference_title: "Clinical and laboratory findings of two newborns with Wiedemann-Rautenstrauch syndrome: additional features, evaluation of bone turnover and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We evaluated bone mineral findings in our two patients with WRS and recommend caution when handling children with WRS."
    explanation: Handling precautions because of severe neonatal osteopenia.
  - reference: PMID:36159344
    reference_title: "A Case of Wiedemann-Rautenstrauch Syndrome With Fatal Hyperkalemic Renal Faliure."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We reported a case of a three-days old male neonate with features of WRS presented with fatal hyperkalemic renal failure which is a unique presentation not reported before in the cases affected with this syndrome."
    explanation: Justifies neonatal renal and electrolyte surveillance as part of supportive care.
- name: Nutritional support
  action_category: THERAPEUTIC
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: High-calorie enteral nutritional support
    term:
      id: NCIT:C15433
      label: Nutritional Support
  description: >-
    High-calorie formula and enteral tube feeding are used for failure to thrive,
    but weight gain is often poor because the growth failure is intrinsic and
    vomiting and aspiration complicate feeding.
  notes: >-
    therapeutic_modality BEHAVIORAL is used here because the intervention is a
    feeding regimen, not a supplement compound; see the CLAUDE.md caution about
    NCIT:C15433.
  target_phenotypes:
  - preferred_term: Failure to thrive
    term:
      id: HP:0001508
      label: Failure to thrive
  evidence:
  - reference: PMID:36596744
    reference_title: "Biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome with atypical brain involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Nutritional support using high calorie milk and enteral tube was ineffective to gain weight due to frequent vomiting and aspiration."
    explanation: Documents the intervention and its limited effectiveness in one patient.
- name: Physical rehabilitation
  action_category: THERAPEUTIC
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Physical therapy
    term:
      id: NCIT:C15302
      label: Physical Therapy
  description: Physiotherapy for hypotonia, motor delay and contractures; benefit is limited in patients with progressive neurological involvement.
  target_phenotypes:
  - preferred_term: Hypotonia
    term:
      id: HP:0001252
      label: Hypotonia
  - preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:36596744
    reference_title: "Biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome with atypical brain involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "He remains near bed-ridden state at 40 months despite constant physical rehabilitation."
    explanation: Documents use of rehabilitation and its limited effect in a severely affected patient.
- name: Eyelid surgery for congenital tarsal kink
  action_category: THERAPEUTIC
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: Everting-suture correction of upper eyelid tarsal kink
    term:
      id: NCIT:C15331
      label: Ophthalmologic Surgical Procedure
  description: Bilateral upper-lid tarsal kink was corrected with everting sutures via a transconjunctival approach under local anesthesia.
  target_phenotypes:
  - preferred_term: Entropion
    term:
      id: HP:0000621
      label: Entropion
  evidence:
  - reference: PMID:28468175
    reference_title: "Wiedemann-Rautenstrauch Syndrome With Bilateral Tarsal Kink: Three Sutures for Correction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The authors treated bilateral tarsal kink with an everting suture via a transconjunctival approach under local anesthesia."
    explanation: Single-patient surgical report.
- name: Genetic counseling and prenatal diagnosis
  action_category: COUNSELING_INFORMATIONAL
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  description: >-
    Autosomal recessive inheritance gives a 25% recurrence risk per pregnancy.
    Molecular prenatal diagnosis is possible when both familial POLR3A variants
    are known; serial ultrasound detected growth restriction in a recurrence
    pregnancy before the gene was identified.
  evidence:
  - reference: PMID:1619643
    reference_title: "Two sibs with Wiedemann-Rautenstrauch syndrome: possibilities of prenatal diagnosis by ultrasound."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "When the woman became pregnant again, in spite of having been assessed as having a 25% risk of recurrence, the prenatal findings seen in her previous pregnancy led us to suggest sequential echography and a similar pattern of growth retardation was shown."
    explanation: Recurrence-risk counseling and ultrasound-based prenatal diagnosis in a second pregnancy.
experimental_models:
- name: WRS patient primary dermal fibroblasts
  experimental_model_type: PRIMARY_CELL_CULTURE
  description: >-
    Primary skin fibroblasts from one WRS patient carrying the truncating allele
    c.3772_3773delCT (p.Leu1258Glyfs*12), compared with a control line.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  cell_types:
  - preferred_term: skin fibroblast
    term:
      id: CL:0002620
      label: skin fibroblast
  publication: PMID:32976914
  evidence:
  - reference: PMID:32976914
    reference_title: "Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann-Rautenstrauch syndrome fibroblasts."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "We aim to describe the cellular and molecular features of WRS fibroblasts."
    explanation: "The study's stated purpose is to characterize patient-derived WRS fibroblasts, which is what this model is."
  modeled_mechanisms:
  - target: Reduced Wild-Type POLR3A Expression
    relationship: MEASURES
    fidelity: MODERATE
    model_scale: MOLECULAR
    description: Quantifies wild-type versus mutant POLR3A transcript and protein in patient cells.
    limitations: >-
      A single patient; only one allele was characterized in the report, so the
      contribution of the second allele to the residual wild-type pool is unknown.
    readouts:
    - name: Wild-type POLR3A mRNA and protein
      target: Reduced Wild-Type POLR3A Expression
      direction: DECREASED
      interpretation: Less wild-type catalytic subunit is available for Pol III assembly.
      evidence:
      - reference: PMID:32976914
        reference_title: "Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann-Rautenstrauch syndrome fibroblasts."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "The mutation caused a decrease in the expression of wildtype POLR3A mRNA and POLR3A protein and a sharp increase in mutant protein expression."
        explanation: The measurement behind this readout.
    evidence:
    - reference: PMID:32976914
      reference_title: "Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann-Rautenstrauch syndrome fibroblasts."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "The mutation caused a decrease in the expression of wildtype POLR3A mRNA and POLR3A protein and a sharp increase in mutant protein expression."
      explanation: Establishes that this model measures the wild-type POLR3A level that defines the target node.
  - target: Nucleolar Disruption, p53 Activation and Premature Senescence
    relationship: RECAPITULATES
    fidelity: MODERATE
    model_scale: CELLULAR
    description: Patient fibroblasts show the nucleolar, p53 and senescence phenotype that defines this node.
    limitations: >-
      Cultured fibroblasts from one patient; in vitro passaging itself induces
      senescence, and the phenotype has not been shown in the affected tissues
      such as adipose, bone or brain.
    readouts:
    - name: Nucleolar number and area
      target: Nucleolar Disruption, p53 Activation and Premature Senescence
      direction: INCREASED
      interpretation: Nucleolar stress readout.
      evidence:
      - reference: PMID:32976914
        reference_title: "Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann-Rautenstrauch syndrome fibroblasts."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "These changes were associated with an increase in the number and area of nucleoli and to a high increase in the expression of pP53 and pH2AX."
        explanation: Reports the nucleolar measurement.
    - name: Phospho-p53 and phospho-H2AX expression
      target: Nucleolar Disruption, p53 Activation and Premature Senescence
      direction: INCREASED
      interpretation: DNA-damage-response and p53 activation readout.
      evidence:
      - reference: PMID:32976914
        reference_title: "Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann-Rautenstrauch syndrome fibroblasts."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "These changes were associated with an increase in the number and area of nucleoli and to a high increase in the expression of pP53 and pH2AX."
        explanation: Reports the pP53 and pH2AX measurement.
    - name: Premature senescence
      target: Nucleolar Disruption, p53 Activation and Premature Senescence
      direction: INCREASED
      interpretation: Cellular outcome of the nucleolar and p53 response.
      evidence:
      - reference: PMID:32976914
        reference_title: "Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann-Rautenstrauch syndrome fibroblasts."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "All these changes were associated with premature senescence."
        explanation: Reports the senescence outcome.
    evidence:
    - reference: PMID:32976914
      reference_title: "Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann-Rautenstrauch syndrome fibroblasts."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "The present observations add to our understanding of the differences between Hutchinson-Gilford progeria syndrome and WRS and opens new alternatives to study cell senesce and human aging."
      explanation: The authors position the fibroblast model as informative for WRS senescence biology.
- name: WRS patient-derived induced pluripotent stem cells
  experimental_model_type: IPSC_DERIVED_MODEL
  description: >-
    iPSCs reprogrammed by a non-integrating episomal method from fibroblasts of a
    WRS patient with biallelic POLR3A variants, alongside an HGPS iPSC line.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  publication: PMID:41081995
  evidence:
  - reference: PMID:41081995
    reference_title: "POLR3A mutations cause nucleolus abnormalities and aberrant telomerase RNA metabolism in induced pluripotent stem cells from Wiedemann-Rautenstrauch premature aging syndrome patient."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "using a non-integrative episomal approach we reprogrammed iPSCs from cells of a patient suffering from Wiedemann-Rautenstrauch Syndrome (WRS), which is caused by bi-allelic pathogenic mutations of the RNA polymerase III subunit A gene (POLR3A)"
    explanation: "Establishes the derivation and genotype of this patient iPSC model."
  modeled_mechanisms:
  - target: Nucleolar Disruption, p53 Activation and Premature Senescence
    relationship: PARTIALLY_RECAPITULATES
    fidelity: LOW
    model_scale: CELLULAR
    description: Reproduces nucleolar abnormality and adds TERC sequestration, but in a pluripotent state that overexpresses POLR3A.
    limitations: >-
      POLR3A is upregulated during reprogramming, so mutant POLR3A is expressed
      above the level found in differentiated patient cells; pluripotent cells do
      not senesce, so the senescence limb of the node cannot be modelled here.
    readouts:
    - name: Nucleolar morphology and TERC localization
      target: Nucleolar Disruption, p53 Activation and Premature Senescence
      direction: ALTERED
      interpretation: Nucleolar abnormality with telomerase RNA sequestration.
      evidence:
      - reference: PMID:41081995
        reference_title: "POLR3A mutations cause nucleolus abnormalities and aberrant telomerase RNA metabolism in induced pluripotent stem cells from Wiedemann-Rautenstrauch premature aging syndrome patient."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "Enhanced expression of mutant POLR3A in WRS iPSCs led to nucleolus abnormalities and telomerase RNA component (TERC) sequestration in the nucleoli in WRS iPSCs."
        explanation: Reports the nucleolar and TERC measurement.
    evidence:
    - reference: PMID:41081995
      reference_title: "POLR3A mutations cause nucleolus abnormalities and aberrant telomerase RNA metabolism in induced pluripotent stem cells from Wiedemann-Rautenstrauch premature aging syndrome patient."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "Whereas lamin A is downregulated in iPSCs, allowing for regeneration of HGPS iPSCs, we found that POLR3A is upregulated during reprogramming."
      explanation: Explains why the model exaggerates mutant POLR3A expression.
- name: WRS bone-marrow-derived progenitor differentiation culture
  experimental_model_type: PRIMARY_CELL_CULTURE
  description: >-
    Bone-marrow-derived stem cells from a 16-year-old WRS patient, stimulated
    toward osteoblastic and chondroblastic differentiation with dexamethasone,
    ascorbic acid and beta-glycerophosphate over 21 days, compared with a healthy
    donor.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  cell_types:
  - preferred_term: mesenchymal stem cell
    term:
      id: CL:0000134
      label: mesenchymal stem cell
  publication: PMID:16097434
  evidence:
  - reference: PMID:16097434
    reference_title: "In vitro osteogenic differentiation is affected in Wiedemann-Rautenstrauch-Syndrome (WRS)."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "To elucidate the osteoblastic and chondroblastic regeneration potential in WRS, a progenitor cell culture system was used."
    explanation: "States what the progenitor culture system was built to measure."
  modeled_mechanisms:
  - target: Impaired Mesenchymal Progenitor Proliferation and Differentiation
    relationship: RECAPITULATES
    fidelity: MODERATE
    model_scale: CELLULAR
    description: The only direct measurement of progenitor differentiation capacity in WRS.
    limitations: >-
      A single patient predating molecular diagnosis, so the POLR3A genotype is
      unknown; one control donor; an in vitro differentiation assay rather than
      tissue formation.
    readouts:
    - name: Osteoblastic differentiation response
      target: Impaired Mesenchymal Progenitor Proliferation and Differentiation
      direction: DECREASED
      interpretation: Reduced osteogenic capacity of patient progenitors.
      evidence:
      - reference: PMID:16097434
        reference_title: "In vitro osteogenic differentiation is affected in Wiedemann-Rautenstrauch-Syndrome (WRS)."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "It was shown, for the first time, that WRS cells showed a highly significant lower in vitro response to osteoblastic differentiation stimulus."
        explanation: Reports the osteoblastic readout.
    - name: Chondrocyte and hematopoietic cell induction
      target: Impaired Mesenchymal Progenitor Proliferation and Differentiation
      direction: DECREASED
      interpretation: Reduced chondrogenic and hematopoietic output.
      evidence:
      - reference: PMID:16097434
        reference_title: "In vitro osteogenic differentiation is affected in Wiedemann-Rautenstrauch-Syndrome (WRS)."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "Furthermore, significantly fewer chondrocytes and hematopoietic cells were induced in WRS progenitors compared to the control group."
        explanation: Reports the chondrocyte and hematopoietic readouts.
    evidence:
    - reference: PMID:16097434
      reference_title: "In vitro osteogenic differentiation is affected in Wiedemann-Rautenstrauch-Syndrome (WRS)."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "Bone marrow-derived stem cells of a 16-year-old WRS patient were cultivated and stimulated by dexamethasone, ascorbic acid and beta-glycerolphosphate (DAG) over 21 days."
      explanation: Describes the progenitor culture system.
- name: POLR3A c.3342C>T minigene splicing reporter
  experimental_model_type: CELL_LINE
  description: >-
    A pEGFP-N1 minigene spanning POLR3A exons 25 to 27 carrying the synonymous
    c.3342C>T (p.Ser1114=) variant, transfected into HEK293 or HeLa cells to test
    the effect on pre-mRNA splicing.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  publication: PMID:36385762
  evidence:
  - reference: PMID:36385762
    reference_title: "A synonymous variant contributes to a rare Wiedemann-Rautenstrauch syndrome complicated with mild anemia via affecting pre-mRNA splicing."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "for minigene splicing reporter assays to test their effects on pre-mRNA splicing"
    explanation: "Establishes the minigene reporter as the assay system used for this variant."
  modeled_mechanisms:
  - target: Aberrant POLR3A Transcript Processing
    relationship: RECAPITULATES
    fidelity: MODERATE
    model_scale: MOLECULAR
    description: Shows that a synonymous WRS allele produces aberrant splice isoforms.
    limitations: >-
      A minigene reports splicing of a three-exon fragment in heterologous cells,
      not the full POLR3A transcript in patient tissue; isoform proportions may
      differ in vivo.
    readouts:
    - name: Aberrant splice isoforms from the c.3342C>T minigene
      target: Aberrant POLR3A Transcript Processing
      direction: INCREASED
      interpretation: The synonymous variant disrupts normal splicing.
      evidence:
      - reference: PMID:36385762
        reference_title: "A synonymous variant contributes to a rare Wiedemann-Rautenstrauch syndrome complicated with mild anemia via affecting pre-mRNA splicing."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "For POLR3A, the synonymous mutation (c.3342C > T, p.Ser1114=) generated three types of aberrant isoforms."
        explanation: Reports the isoform readout.
- name: POLR3A p.M852V CRISPR-edited HEK293 and oligodendroglial cells
  experimental_model_type: CELL_LINE
  description: >-
    HEK293 clones carrying the leukodystrophy-causing POLR3A c.2554A>G (p.M852V)
    allele, homozygous or in trans with a frameshift, plus MO3.13 oligodendroglial
    cells, profiled for Pol III transcript output.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  publication: PMID:30898877
  evidence:
  - reference: PMID:30898877
    reference_title: "Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "we used CRISPR-Cas9 to introduce the POLR3A mutation"
    explanation: "Establishes the CRISPR-edited cell lines as the model system."
  modeled_mechanisms:
  - target: RNA Polymerase III Transcriptional Hypofunction
    relationship: PARTIALLY_RECAPITULATES
    fidelity: LOW
    model_scale: MOLECULAR
    description: Demonstrates that a hypomorphic POLR3A allele lowers tRNA and BC200 output, the step assumed but not measured in WRS.
    limitations: >-
      The allele studied causes 4H leukodystrophy, not WRS; WRS allele
      combinations have not been profiled, so the magnitude and transcript
      selectivity of Pol III hypofunction in WRS is extrapolated.
    divergences:
    - divergence_type: POPULATION_MISMATCH
      materiality: QUALIFYING
      description: >-
        The genotype modelled (p.M852V with a null allele) is a leukodystrophy
        genotype; WRS genotypes pair a splice-affecting intronic allele with a
        null or missense allele and have not been profiled.
    readouts:
    - name: Precursor and mature tRNA levels
      target: RNA Polymerase III Transcriptional Hypofunction
      direction: DECREASED
      interpretation: Global reduction of tRNA output from hypomorphic Pol III.
      evidence:
      - reference: PMID:30898877
        reference_title: "Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "Transcriptomic profiling uncovered a subset of transcripts vulnerable to Pol III hypofunction, including a global reduction in tRNA levels."
        explanation: Reports the tRNA measurement.
    evidence:
    - reference: PMID:30898877
      reference_title: "Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: IN_VITRO
      snippet: "The brain cytoplasmic BC200 RNA (BCYRN1), involved in translation regulation, was consistently affected in all our cellular models, including patient-derived fibroblasts."
      explanation: Supports Pol III hypofunction as a consequence of pathogenic POLR3A variants; patients here have leukodystrophy, not WRS.
animal_models:
- name: Polr3a G672E knock-in mouse
  species: Mouse
  genotype: Polr3a c.2015G>A (p.G672E) homozygous knock-in, and knock-in over null
  genes:
  - preferred_term: POLR3A
    term:
      id: hgnc:30074
      label: POLR3A
  publication: PMID:28407788
  evidence:
  - reference: PMID:28407788
    reference_title: "Absence of neurological abnormalities in mice homozygous for the Polr3a G672E hypomyelinating leukodystrophy mutation."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "we introduced the French Canadian founder Polr3a mutation c.2015G > A (p.G672E) in mice, generating homozygous knock-in (KI/KI) as well as compound heterozygous mice for one Polr3a KI and one null allele (KI/KO)."
    explanation: "Establishes the genotypes of the two mouse lines described here."
  description: >-
    Mice carrying the French-Canadian founder 4H-leukodystrophy allele, either
    homozygous or over a null allele, are viable and fertile with normal motor
    behaviour, normal myelin staining and protein levels, and no significant
    change in brain Pol III transcripts. No mouse model of WRS exists; this
    leukodystrophy model is recorded because it is the closest available and
    because its negative result bears on what a WRS model would need.
  modeled_mechanisms:
  - target: Central Nervous System Hypomyelination
    relationship: FAILS_TO_RECAPITULATE
    fidelity: LOW
    model_scale: TISSUE
    description: A homozygous leukodystrophy allele does not produce hypomyelination in mouse.
    limitations: >-
      Leukodystrophy allele rather than a WRS genotype; the G672E allele may be
      too mild in mouse, and rodent oligodendrogenesis may tolerate Pol III
      perturbation better than human. The absence of a phenotype in this model is
      not evidence against Pol III-dependent hypomyelination in humans.
    readouts:
    - name: Luxol Fast Blue myelin staining and myelin protein levels
      target: Central Nervous System Hypomyelination
      direction: UNCHANGED
      interpretation: Myelination not overtly impaired.
      evidence:
      - reference: PMID:28407788
        reference_title: "Absence of neurological abnormalities in mice homozygous for the Polr3a G672E hypomyelinating leukodystrophy mutation."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Cerebral and cerebellar Luxol Fast Blue staining and measurement of levels of myelin proteins showed no significant differences between the three groups, suggesting that myelination is not overtly impaired in Polr3a KI/KI and KI/KO mice."
        explanation: Reports the myelin measurement.
    evidence:
    - reference: PMID:28407788
      reference_title: "Absence of neurological abnormalities in mice homozygous for the Polr3a G672E hypomyelinating leukodystrophy mutation."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "We conclude that the first transgenic mice with a leukodystrophy-causing Polr3a mutation do not recapitulate the childhood-onset HLD observed in the majority of human patients with POLR3A mutations, and provide essential information to guide selection of Polr3a mutations for developing future mouse models of the disease."
      explanation: The authors' own statement that the model fails to recapitulate the human disease.
- name: Oligodendrocyte-lineage conditional Polr3a mutant mouse
  species: Mouse
  genotype: Pathogenic Polr3a alleles expressed conditionally in Olig2-expressing cells
  genes:
  - preferred_term: POLR3A
    term:
      id: hgnc:30074
      label: POLR3A
  publication: PMID:34583988
  evidence:
  - reference: PMID:34583988
    reference_title: "Defective myelination in an RNA polymerase III mutant leukodystrophic mouse."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Our results show that disease pathogenesis in the mice involves defects that reduce both the number of mature myelinating oligodendrocytes and the ability of these cells to produce a myelin sheath of normal thickness."
    explanation: "States the cellular defect this conditional mouse model demonstrates."
  description: >-
    Conditional expression of pathogenic Polr3a mutations in the Olig2 lineage
    produces impaired growth, developmental delay, cognitive and sensorimotor
    deficits and cerebral and spinal hypomyelination, with fewer mature
    oligodendrocytes and thinner myelin; cerebellar hypomyelination and gross
    motor deficits are absent.
  modeled_mechanisms:
  - target: Central Nervous System Hypomyelination
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    model_scale: TISSUE
    description: Establishes that Pol III perturbation restricted to the oligodendrocyte lineage is sufficient for hypomyelination.
    limitations: >-
      Leukodystrophy alleles restricted to one lineage; the systemic WRS
      phenotype of lipodystrophy, craniofacial dysmorphogenesis and growth
      failure cannot be assessed, and cerebellar hypomyelination is not
      reproduced.
    readouts:
    - name: Myelination of cerebrum and spinal cord
      target: Central Nervous System Hypomyelination
      direction: DECREASED
      interpretation: Hypomyelination from lineage-restricted Pol III perturbation.
      evidence:
      - reference: PMID:34583988
        reference_title: "Defective myelination in an RNA polymerase III mutant leukodystrophic mouse."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Here we show that mice expressing pathogenic mutations in the largest Pol III subunit, Polr3a, specifically in Olig2-expressing cells, have impaired growth and developmental delay, deficits in cognitive, sensory, and fine sensorimotor function, and hypomyelination in multiple regions of the cerebrum and spinal cord."
        explanation: Reports the hypomyelination measurement.
    evidence:
    - reference: PMID:34583988
      reference_title: "Defective myelination in an RNA polymerase III mutant leukodystrophic mouse."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "In contrast, the gross motor defects and cerebellar hypomyelination that are common features of severely affected patients are absent in the mice, suggesting a relatively mild form of the disease in this conditional model."
      explanation: The authors' own account of what the model does and does not reproduce.
discussions:
- discussion_id: wrs_adipose_mechanism_gap
  prompt: >-
    How does partial loss of RNA polymerase III function abolish subcutaneous
    adipose tissue while sparing gluteal and labial fat pads?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Impaired Mesenchymal Progenitor Proliferation and Differentiation
  - pathophysiology#Generalized Subcutaneous Lipoatrophy with Localized Fat Pads
  rationale: >-
    Congenital generalized lipoatrophy is the defining tissue phenotype, yet no
    study has examined adipocyte differentiation, adipose progenitor number or
    lipid handling in WRS cells; the only differentiation data are osteogenic,
    chondrogenic and hematopoietic. The regional sparing of specific fat depots
    is unexplained by any global Pol III model and suggests depot-specific
    progenitor biology.
  evidence:
  - reference: PMID:16097434
    reference_title: "In vitro osteogenic differentiation is affected in Wiedemann-Rautenstrauch-Syndrome (WRS)."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "To date, there are no data about the differentiation capacity of WRS progenitor cells available in the literature."
    explanation: States the gap that the osteogenic study only partly filled; adipogenic differentiation remains unassayed.
  - reference: PMID:10607952
    reference_title: "Neonatal progeroid (Wiedemann-Rautenstrauch) syndrome: report of five new cases and review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The neonatal progeroid syndrome (NPS), or Wiedemann-Rautenstrauch, is a rare autosomal recessive disorder comprised of generalized lipoatrophy except for fat pads in the suprabuttock areas, hypotrichosis of the scalp hair, eyebrows, and eyelashes, relative macrocephaly, triangular face, natal teeth, and micrognathia."
    explanation: The depot-sparing pattern that a mechanism must explain.
- discussion_id: wrs_pol3_output_unmeasured
  prompt: >-
    Is Pol III transcript output actually reduced in WRS cells, and does the WRS
    allele combination affect a different subset of Pol III transcripts than
    leukodystrophy alleles?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#RNA Polymerase III Transcriptional Hypofunction
  - mechanistic_hypotheses#allele_combination_determines_wrs_versus_4h
  rationale: >-
    Reduced tRNA and BC200 levels have been shown for a leukodystrophy allele,
    and WRS fibroblasts show reduced wild-type POLR3A, but no study has profiled
    Pol III transcripts in WRS cells. Whether WRS and 4H alleles differ in the
    magnitude or transcript selectivity of Pol III hypofunction is the testable
    core of the allele-combination hypothesis.
  evidence:
  - reference: PMID:30323018
    reference_title: "Specific combinations of biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "No isolated functional sites in POLR3A explain the phenotype variability in POLR3A-related disorders."
    explanation: Structural position alone does not explain which phenotype a genotype produces.
- discussion_id: wrs_no_animal_model
  prompt: >-
    Can a mouse model of the WRS allele combination be built, given that the
    homozygous G672E leukodystrophy allele produces no phenotype and only
    lineage-restricted conditional alleles produce hypomyelination?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Central Nervous System Hypomyelination
  - pathophysiology#Generalized Subcutaneous Lipoatrophy with Localized Fat Pads
  - animal_models#Mouse
  rationale: >-
    No animal model of WRS exists. The available Polr3a mice model the allelic
    leukodystrophy instead: a homozygous founder missense allele gives no
    neurological or myelin phenotype, and conditional Olig2-lineage expression of
    pathogenic alleles gives a mild hypomyelination without the systemic
    features. A WRS model would need a germline compound-heterozygous genotype
    with a splice-affecting allele whose leakiness in mouse is unknown, so the
    mouse negative results should not be read as evidence about the human
    mechanism.
  evidence:
  - reference: PMID:28407788
    reference_title: "Absence of neurological abnormalities in mice homozygous for the Polr3a G672E hypomyelinating leukodystrophy mutation."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We conclude that the first transgenic mice with a leukodystrophy-causing Polr3a mutation do not recapitulate the childhood-onset HLD observed in the majority of human patients with POLR3A mutations, and provide essential information to guide selection of Polr3a mutations for developing future mouse models of the disease."
    explanation: Direct evidence of a human-mouse mismatch for the closest available allele.
  - reference: PMID:34583988
    reference_title: "Defective myelination in an RNA polymerase III mutant leukodystrophic mouse."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "These phenotypes reflect a subset of clinical features seen in patients."
    explanation: Even the conditional model reproduces only part of the human leukodystrophy.
references:
- reference: PMID:30414627
  title: "Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome."
- reference: PMID:30323018
  title: "Specific combinations of biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome."
- reference: PMID:27612211
  title: "Neonatal progeriod syndrome associated with biallelic truncating variants in POLR3A."
- reference: PMID:28447407
  title: "Wiedemann-Rautenstrauch syndrome: A phenotype analysis."
- reference: PMID:30450527
  title: "Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations."
- reference: PMID:32976914
  title: "Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann-Rautenstrauch syndrome fibroblasts."
- reference: PMID:41081995
  title: "POLR3A mutations cause nucleolus abnormalities and aberrant telomerase RNA metabolism in induced pluripotent stem cells from Wiedemann-Rautenstrauch premature aging syndrome patient."
- reference: PMID:32555393
  title: "Unique combination and in silico modeling of biallelic POLR3A variants as a cause of Wiedemann-Rautenstrauch syndrome."
- reference: PMID:38397171
  title: "The Genetic Basis of the First Patient with Wiedemann-Rautenstrauch Syndrome in the Russian Federation."
- reference: PMID:36385762
  title: "A synonymous variant contributes to a rare Wiedemann-Rautenstrauch syndrome complicated with mild anemia via affecting pre-mRNA splicing."
- reference: PMID:41549341
  title: "Novel POLR3A Gene Mutation Results in Wiedemann-Rautenstrauch Syndrome With Striking Cutis Laxa and Myelofibrosis."
- reference: PMID:31695177
  title: "A variant of neonatal progeroid syndrome, or Wiedemann-Rautenstrauch syndrome, is associated with a nonsense variant in POLR3GL."
- reference: PMID:34289880
  title: "Whole-exome sequencing reveals POLR3B variants associated with progeria-related Wiedemann-Rautenstrauch syndrome."
- reference: PMID:33559318
  title: "Wiedemann-Rautenstrauch syndrome in an Indian patient with biallelic pathogenic variants in POLR3A."
- reference: PMID:38348603
  title: "Further delineation of Wiedemann-Rautenstrauch syndrome linked with POLR3A."
- reference: PMID:40912518
  title: "Clinical and molecular insights into Wiedemann-Rautenstrauch syndrome: A case report and genetic analysis of the c.2707G>A variant in the POLR3A gene."
- reference: PMID:36596744
  title: "Biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome with atypical brain involvement."
- reference: PMID:34611991
  title: "A novel homozygous synonymous variant further expands the phenotypic spectrum of POLR3A-related pathologies."
- reference: PMID:36825045
  title: "Spectrum of Pediatric to Early Adulthood POLR3A-Associated Movement Disorders."
- reference: PMID:10607952
  title: "Neonatal progeroid (Wiedemann-Rautenstrauch) syndrome: report of five new cases and review."
- reference: PMID:16097434
  title: "In vitro osteogenic differentiation is affected in Wiedemann-Rautenstrauch-Syndrome (WRS)."
- reference: PMID:18717246
  title: "Clinical and laboratory findings of two newborns with Wiedemann-Rautenstrauch syndrome: additional features, evaluation of bone turnover and review of the literature."
- reference: PMID:1619643
  title: "Two sibs with Wiedemann-Rautenstrauch syndrome: possibilities of prenatal diagnosis by ultrasound."
- reference: PMID:26691040
  title: "Ophthalmic manifestations in a case of Wiedemann-Rautenstrauch syndrome."
- reference: PMID:28468175
  title: "Wiedemann-Rautenstrauch Syndrome With Bilateral Tarsal Kink: Three Sutures for Correction."
- reference: PMID:21671373
  title: "Neonatal progeroid syndrome (Wiedemann-Rautenstrauch syndrome): report of three affected sibs."
- reference: PMID:19938095
  title: "Absence of Lamin A/C gene mutations in four Wiedemann-Rautenstrauch syndrome patients."
- reference: PMID:36159344
  title: "A Case of Wiedemann-Rautenstrauch Syndrome With Fatal Hyperkalemic Renal Faliure."
- reference: PMID:569581
  title: "An unidentified neonatal progeroid syndrome: follow-up report."
- reference: PMID:319005
  title: "Progeria: a cell culture study and clinical report of familial incidence."
- reference: PMID:7823529
  title: "[Neonatal progeroid syndrome (Wiedemann-Rautenstrauch). A follow-up study]."
- reference: PMID:22585414
  title: "Wiedemann-Rautenstrauch syndrome: report of a variant case."
- reference: PMID:22855961
  title: "POLR3-Related Leukodystrophy."
- reference: PMID:30898877
  title: "Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200."
- reference: PMID:34583988
  title: "Defective myelination in an RNA polymerase III mutant leukodystrophic mouse."
- reference: PMID:28407788
  title: "Absence of neurological abnormalities in mice homozygous for the Polr3a G672E hypomyelinating leukodystrophy mutation."
- reference: PMID:24613577
  title: "Neonatal progeroid variant of Marfan syndrome with congenital lipodystrophy results from mutations at the 3' end of FBN1 gene."
notes: >-
  Scope and lump/split decision. WRS (MONDO:0009910) is curated as ONE Disease
  entry, a single clinically recognizable neonatal progeroid syndrome with one
  established gene. It is deliberately kept separate from the allelic
  POLR3A-related leukodystrophy entries (POLR-Related_Leukodystrophy,
  Hypomyelinating_Leukodystrophy_7), which share the gene but differ in onset,
  defining features and predominant variant classes; that relationship is
  recorded as a differential diagnosis and as the allele-combination hypothesis
  rather than as a subtype of either entry. The POLR3GL and POLR3B reports (one
  patient and one family respectively, the latter with ACMG variants of
  uncertain significance) are recorded as candidate loci in the genetic section
  with no relationship_type, not as subtypes, because neither has been
  replicated.

  Grouping follow-up. kb/groupings/Progeroid_Syndromes.yaml lists WRS as a known
  curation gap among MONDO:0015333 descendants; that grouping should add
  Wiedemann-Rautenstrauch_Syndrome as a DISEASE member in a follow-up PR. It is
  not edited here.

  Evidence policy. No GeneReviews chapter exists for WRS; the POLR3-Related
  Leukodystrophy chapter (PMID:22855961) is cited only for its single sentence
  about WRS and is deliberately not tagged as a phenotype baseline. Orphanet
  ORPHA:3455 has no structured cache entry (just fetch-reference ORPHA:3455
  reports no source for the reference type), so its prevalence class and
  phenotype frequencies are not cited. Several quotes come from cached full text
  rather than a PubMed abstract, because those records carry no abstract or the
  needed sentence sits in the body. Frequency bands follow the qualitative
  Pattern C mapping of docs/frequency-evidence-guidelines.md, treating core
  manifestation and "almost all patients" as hallmark (VERY_FREQUENT), often,
  common and "very often" as FREQUENT, and in some cases as OCCASIONAL. The
  51-patient analysis (PMID:28447407) is cached as full text and its Table 2
  does report per-feature counts for the WRS column (for example 18/18 pointed
  chin, 17/18 natal teeth and prominent scalp veins, 3/16 tremor, 7/10
  intellectual disability). Bands here are taken from that paper's own prose
  summary of those counts rather than from the table cells, because the
  extracted PDF text interleaves the WRS column with the three comparison
  cohorts on one line and a single-feature cell cannot be quoted unambiguously;
  where the two differ the prose is the more conservative, and the count is
  named in the explanation.
  Myelofibrosis appears only in the title of PMID:41549341, so it is mentioned
  in the anemia description but is not curated as a phenotype with a title-only
  snippet.

  Progression and prognosis. Both are curated from cached full text:
  PMID:28447407 supplies the age-at-death distribution and the late-infancy
  onset of the progressive neurological signs, and PMID:36159344 supplies the
  reported average survival and the usual causes of death. What the caches do
  not contain is any formal survival analysis, life table or cause-of-death
  series: the figures are counts from an 18-patient descriptive series and a
  narrative statement in a single case report, so no rate or median is asserted
  here. Genotype-specific prognosis is likewise unavailable, and PMID:28447407
  states that whether the spread in life expectancy is caused by specific
  variants or by other factors remains uncertain.

  Deep research. A Perplexity sonar-deep-research report
  (research/Wiedemann-Rautenstrauch_Syndrome-deep-research-perplexity.md) was
  used as a lead source only. Of its seven resolved references, PMID:1026530 is
  a mis-parsed DOI fragment that resolves to a 1976 disopyramide
  pharmacokinetics paper and was rejected, and its DOI-keyed Frontiers citation
  was replaced by that paper's PMID (36385762). Its suggested terms HP:0008106
  and HP:0001077 do not exist, GO:0006379 is obsolete, and GO:0009306,
  UBERON:0002371, UBERON:0008897 and three NCIT codes name unrelated concepts;
  every CURIE used here was re-derived with OAK against the configured
  ontologies.
📚

References & Deep Research

References

37
PMID:30414627
Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome.
No top-level findings curated for this source.
PMID:30323018
Specific combinations of biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome.
No top-level findings curated for this source.
PMID:27612211
Neonatal progeriod syndrome associated with biallelic truncating variants in POLR3A.
No top-level findings curated for this source.
PMID:28447407
Wiedemann-Rautenstrauch syndrome: A phenotype analysis.
No top-level findings curated for this source.
PMID:30450527
Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations.
No top-level findings curated for this source.
PMID:32976914
Nucleolar disruption, activation of P53 and premature senescence in POLR3A-mutated Wiedemann-Rautenstrauch syndrome fibroblasts.
No top-level findings curated for this source.
PMID:41081995
POLR3A mutations cause nucleolus abnormalities and aberrant telomerase RNA metabolism in induced pluripotent stem cells from Wiedemann-Rautenstrauch premature aging syndrome patient.
No top-level findings curated for this source.
PMID:32555393
Unique combination and in silico modeling of biallelic POLR3A variants as a cause of Wiedemann-Rautenstrauch syndrome.
No top-level findings curated for this source.
PMID:38397171
The Genetic Basis of the First Patient with Wiedemann-Rautenstrauch Syndrome in the Russian Federation.
No top-level findings curated for this source.
PMID:36385762
A synonymous variant contributes to a rare Wiedemann-Rautenstrauch syndrome complicated with mild anemia via affecting pre-mRNA splicing.
No top-level findings curated for this source.
PMID:41549341
Novel POLR3A Gene Mutation Results in Wiedemann-Rautenstrauch Syndrome With Striking Cutis Laxa and Myelofibrosis.
No top-level findings curated for this source.
PMID:31695177
A variant of neonatal progeroid syndrome, or Wiedemann-Rautenstrauch syndrome, is associated with a nonsense variant in POLR3GL.
No top-level findings curated for this source.
PMID:34289880
Whole-exome sequencing reveals POLR3B variants associated with progeria-related Wiedemann-Rautenstrauch syndrome.
No top-level findings curated for this source.
PMID:33559318
Wiedemann-Rautenstrauch syndrome in an Indian patient with biallelic pathogenic variants in POLR3A.
No top-level findings curated for this source.
PMID:38348603
Further delineation of Wiedemann-Rautenstrauch syndrome linked with POLR3A.
No top-level findings curated for this source.
PMID:40912518
Clinical and molecular insights into Wiedemann-Rautenstrauch syndrome: A case report and genetic analysis of the c.2707G>A variant in the POLR3A gene.
No top-level findings curated for this source.
PMID:36596744
Biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome with atypical brain involvement.
No top-level findings curated for this source.
PMID:34611991
A novel homozygous synonymous variant further expands the phenotypic spectrum of POLR3A-related pathologies.
No top-level findings curated for this source.
PMID:36825045
Spectrum of Pediatric to Early Adulthood POLR3A-Associated Movement Disorders.
No top-level findings curated for this source.
PMID:10607952
Neonatal progeroid (Wiedemann-Rautenstrauch) syndrome: report of five new cases and review.
No top-level findings curated for this source.
PMID:16097434
In vitro osteogenic differentiation is affected in Wiedemann-Rautenstrauch-Syndrome (WRS).
No top-level findings curated for this source.
PMID:18717246
Clinical and laboratory findings of two newborns with Wiedemann-Rautenstrauch syndrome: additional features, evaluation of bone turnover and review of the literature.
No top-level findings curated for this source.
PMID:1619643
Two sibs with Wiedemann-Rautenstrauch syndrome: possibilities of prenatal diagnosis by ultrasound.
No top-level findings curated for this source.
PMID:26691040
Ophthalmic manifestations in a case of Wiedemann-Rautenstrauch syndrome.
No top-level findings curated for this source.
PMID:28468175
Wiedemann-Rautenstrauch Syndrome With Bilateral Tarsal Kink: Three Sutures for Correction.
No top-level findings curated for this source.
PMID:21671373
Neonatal progeroid syndrome (Wiedemann-Rautenstrauch syndrome): report of three affected sibs.
No top-level findings curated for this source.
PMID:19938095
Absence of Lamin A/C gene mutations in four Wiedemann-Rautenstrauch syndrome patients.
No top-level findings curated for this source.
PMID:36159344
A Case of Wiedemann-Rautenstrauch Syndrome With Fatal Hyperkalemic Renal Faliure.
No top-level findings curated for this source.
PMID:569581
An unidentified neonatal progeroid syndrome: follow-up report.
No top-level findings curated for this source.
PMID:319005
Progeria: a cell culture study and clinical report of familial incidence.
No top-level findings curated for this source.
PMID:7823529
[Neonatal progeroid syndrome (Wiedemann-Rautenstrauch). A follow-up study].
No top-level findings curated for this source.
PMID:22585414
Wiedemann-Rautenstrauch syndrome: report of a variant case.
No top-level findings curated for this source.
PMID:22855961
POLR3-Related Leukodystrophy.
No top-level findings curated for this source.
PMID:30898877
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200.
No top-level findings curated for this source.
PMID:34583988
Defective myelination in an RNA polymerase III mutant leukodystrophic mouse.
No top-level findings curated for this source.
PMID:28407788
Absence of neurological abnormalities in mice homozygous for the Polr3a G672E hypomyelinating leukodystrophy mutation.
No top-level findings curated for this source.
PMID:24613577
Neonatal progeroid variant of Marfan syndrome with congenital lipodystrophy results from mutations at the 3' end of FBN1 gene.
No top-level findings curated for this source.

Deep Research

1
Perplexity ▸
1. Disease Information
sonar-deep-research 17 citations 2026-09-05T06:52:55.956461

1. Disease Information

1.1 Definition and Clinical Overview

Wiedemann–Rautenstrauch syndrome is a neonatal-onset progeroid syndrome in which affected infants display features reminiscent of premature aging from birth, including a paucity of subcutaneous fat, thin translucent skin with prominent veins, sparse scalp hair, and a characteristic triangular facial configuration with a large appearing head.[1][3][7][8][9] MedlinePlus Genetics describes WRS as “a type of progeria” in which “the signs and symptoms … begin before birth as affected individuals do not grow and gain weight at the expected rate (intrauterine growth restriction)” and in which distinctive facial features, natal teeth, lipodystrophy, and neurologic problems may co-occur.[1][9] Orphanet defines WRS as a rare multiple congenital anomalies/dysmorphic syndrome characterized by “marked prenatal and postnatal growth retardation, decreased subcutaneous fat, hypotrichosis, relative macrocephaly and an unusual face,” with mild to moderate intellectual disability commonly observed.[3] OMIM similarly describes WRS (MIM #264090) as “a rare autosomal recessive neonatal progeroid disorder characterized by intrauterine growth retardation, failure to thrive, short stature, a progeroid appearance, hypotonia, and variable mental impairment.”[4] Taken together, these authoritative disease-level resources provide a concise conceptualization of WRS as a congenital, Mendelian, lipodystrophic progeroid syndrome driven by POLR3A dysfunction and manifesting with multi-system involvement centered on growth, craniofacial, adipose, neurologic, and dental phenotypes.[1][3][4][7][8]

From a nosologic perspective, WRS is situated within the broader category of progeroid syndromes, which are defined by clinical features of premature aging, often involving defects in genome maintenance, nuclear architecture, or key transcriptional machineries.[7][10] Unlike classic Hutchinson–Gilford progeria, which typically presents in early childhood with vascular aging and LMNA mutations, WRS has onset in utero and neonatally, exhibits a striking lack of subcutaneous fat rather than predominant vascular pathology, and is rooted in RNA polymerase III dysfunction rather than nuclear envelope abnormalities.[1][3][7][10] NORD emphasizes that “several features of aging are evident at birth, so it is referred to as a neonatal progeroid condition,” underscoring the temporal and morphological distinctiveness of WRS within the progeroid spectrum.[7] The clinical heterogeneity is considerable, however, with some patients showing relatively mild cognitive impairment and survival into the third decade, while others succumb within the first year of life due to complications of severe failure to thrive, infections, or multi-organ compromise.[3][4][7][8] This variability complicates diagnosis, necessitating careful phenotypic assessment and molecular testing to distinguish WRS from overlapping entities such as other progeroid syndromes, congenital lipodystrophies, and POLR3A-related leukodystrophies.[3][8][15][16]

1.2 Nosology, Identifiers, and Classification

WRS is catalogued across several major biomedical terminologies and disease databases, supporting its integration into structured knowledge systems. OMIM lists WRS under entry 264090, with a number sign indicating that the phenotype is caused by compound heterozygous mutation in the POLR3A gene (MIM #614258) located at 10q22.3.[4] Orphanet assigns WRS the identifier ORPHA:3455 and classifies it under “multiple congenital anomalies/dysmorphic syndromes,” with inheritance specified as autosomal recessive and age of onset as antenatal and neonatal.[3] MedlinePlus and NORD treat WRS as a distinct genetic condition within the category of progeroid syndromes.[1][7] The German-language Wikipedia page similarly notes its ICD-10 classification as E34.8, which corresponds to “Other specified endocrine disorders,” reflecting historic coding conventions rather than a precise etiologic classification.[5] Orphanet and MedlinePlus also reference ICD-11 code LD2B for WRS, aligning it with congenital malformation syndromes affecting growth and morphology.[3][9] MeSH, UMLS, and SNOMED CT include descriptors mapped to WRS, such as UMLS C0406586 and SNOMEDCT 238874008.[3][4][5]

In ontological frameworks, the disease is represented as MONDO:0009910 (Wiedemann–Rautenstrauch syndrome), placed under Mendelian disease classes and linked to underlying genetic etiology (POLR3A, HGNC:9177) and to phenotype ontologies such as HPO terms for intrauterine growth retardation (HP:0001511), generalized lipodystrophy (HP:0009125), and progeroid facial appearance (HP:0008106). Although MONDO identifiers are not explicitly mentioned in the provided textual sources, they follow from the integration of OMIM, Orphanet, and other disease ontologies, and the user’s query specifies MONDO:0009910 as the canonical identifier. The disease is also indexed in GARD and in various rare disease registries, further supporting its recognition as a distinct nosologic entity.[3][7]

1.3 Synonyms and Historical Notes

Several synonyms and alternative names for WRS have been used in the literature and reference resources, reflecting evolving clinical understanding and historical priority of its descriptors. MedlinePlus lists alternative names including “congenital pseudohydrocephalic progeroid syndrome,” “neonatal progeroid syndrome,” “neonatal pseudo-hydrocephalic progeroid syndrome,” “neonatal pseudohydrocephalic progeroid syndrome,” and the abbreviation “WRS.”[1][9] Orphanet similarly notes “neonatal progeroid syndrome” as a synonym.[3] Wikipedia and the German-language sources emphasize “neonatal progeroid syndrome” and “neonatales progeroides Syndrom,” as well as “pseudo-hydrocephalic progeroid syndrome,” underscoring the characteristic pseudohydrocephalus—a head that appears unusually large due to sparse hair and prominent scalp veins, despite head circumference often being within normal limits.[2][5][9] The term “pseudohydrocephalic” reflects historical misinterpretation of the large fontanelles and enlarged skull as hydrocephalus, which subsequent imaging clarified as an absence of increased intracranial pressure.

Historically, the syndrome was first reported by Thomas Rautenstrauch in 1977 as a “progeria” in a newborn with premature aging features, and later recognized as a distinct syndrome by Hans-Rudolf Wiedemann in 1979.[2][5] Subsequent early case reports by Devos (1981) and Rudin (1988) further delineated the phenotype, leading to its current eponymous designation as Wiedemann–Rautenstrauch syndrome.[2][5] For decades, the etiology remained unknown, and WRS was described as a “rare autosomal recessive progeroid syndrome of unknown etiology.”[16] It was only in the mid-2010s that exome sequencing and careful genotype–phenotype analysis implicated POLR3A as the causal gene.[15][16] Jay et al. (2016, as summarized by the Washington University profile) reported bi-allelic truncating and splicing variants in POLR3A in eight individuals with WRS, thereby confirming the genetic basis and shifting the nosologic framing of WRS to a POLR3A-related disorder.[16] More recent reports have broadened the mutational spectrum to include missense, synonymous, and intronic variants that alter splicing or expression, further emphasizing the molecular heterogeneity underlying the clinical entity.[11][12][13][15]

1.4 Nature of Information and Data Sources

The information summarized here is derived predominantly from aggregated disease-level resources (OMIM, Orphanet, MedlinePlus Genetics, NORD) and from peer-reviewed clinical and molecular studies compiling data across multiple patients, rather than from individual EHR-derived datasets.[1][3][4][7][8][9][15][16] Orphanet’s summary indicates that more than 30 patients have been reported, with a prevalence estimated at <1 per 1,000,000, while NORD notes approximately 40 patients documented in the literature between the first case in 1977 and 2022.[3][7] MedlinePlus states that fewer than 100 affected individuals have been described in the scientific literature, highlighting the small but growing case pool.[1][9] The most systematic clinical phenotyping to date is provided by Paolacci et al. (2018, PMID:28447407), who performed a literature-based analysis of 51 reported patients and synthesized core and variable manifestations of the syndrome.[8] Jay et al. (2016, as summarized in [16]) and subsequent POLR3A-focused series provide genotype–phenotype correlations and confirm the etiologic role of POLR3A through molecular genetic analyses, including exome sequencing and functional assays.[11][12][15][16]

Individual case reports, such as the variant case with partial toe syndactyly and pelvicalyceal ectasia (PMID:22585414), the synonymous variant case reported by Frontiers in Molecular Neuroscience (PMID:1026530), the multi-family consanguineous series from Oman and Saudi Arabia, and the recent case with cutis laxa and myelofibrosis (PMID:41549341), add detail to the phenotypic spectrum and highlight clinical heterogeneity.[6][11][12][13] These are human clinical data, often supported by molecular diagnostic methods and occasionally by functional in vitro studies of RNA polymerase III. Importantly, there are no large population-based epidemiologic datasets or randomized clinical trials for WRS; evidence is primarily observational, derived from case series, case reports, and curated rare disease resources.[3][4][7][8][15][16]

2. Etiology

2.1 Genetic Causal Factors

The primary etiologic factor in Wiedemann–Rautenstrauch syndrome is biallelic pathogenic variation in POLR3A (RNA polymerase III subunit A), inherited in an autosomal recessive manner.[3][4][11][14][15][16] POLR3A, located on chromosome 10q22.3, encodes the largest subunit of RNA polymerase III (Pol III), which is a DNA-directed RNA polymerase responsible for transcription of 5S ribosomal RNA, transfer RNAs (tRNAs), and various other small noncoding RNAs involved in regulation of transcription, RNA processing, and translation.[14][15][16] MedlinePlus Genetics notes that “Wiedemann-Rautenstrauch syndrome is caused by variants … in the POLR3A gene” and that these variants “lead to the production of abnormal subunits… [which] may not be able to form the RNA polymerase III enzyme, or they may create an enzyme that is unable to produce RNA,” leading to reduced Pol III function and impaired development.[1][9][14] OMIM explicitly associates WRS (MIM #264090) with compound heterozygous mutations in POLR3A (MIM #614258) on 10q22.3.[4] Orphanet similarly states that the syndrome “is caused by bi-allelic variants in POLR3A located at 10q22.3, which encodes a subunit of RNA polymerase III,” and notes that the condition is allelic with 4H leukodystrophy and adolescent-onset progressive spastic ataxia.[3]

Jay et al. (2016, summarized in [16]) provided pivotal evidence that bi-allelic loss-of-function variants in POLR3A cause autosomal recessive WRS, identifying seven additional infants, children, and adults with WRS carrying truncating and/or splicing variants in POLR3A, on top of an earlier single patient report.[16] The article emphasized that “bi-allelic missense variants in POLR3A have been associated with phenotypes distinct from WRS: hypogonadotropic hypogonadism and hypomyelinating leukodystrophy,” thereby suggesting that specific variant types (truncating/splicing vs missense) may drive divergent phenotypes within the POLR3A-related disease spectrum.[15][16] Paolacci et al. (2018, as in [12]) and Wambach et al. (2018, cited in [11][15]) further confirmed the association of biallelic POLR3A variants—often truncating or splicing with predicted loss-of-function—with WRS, expanding the phenotypic range and documenting additional families. Frontiers in Molecular Neuroscience reported a Chinese female patient with WRS carrying compound-heterozygous POLR3A variants, including a synonymous variant (c.3342C>T, p.Ser1114=) and a missense variant (c.3718G>A, p.Gly1240Ser), and used trio-based whole-exome sequencing and functional RNA analyses to demonstrate the pathogenicity of the synonymous variant via splicing or regulatory effects.[11]

More recently, a Korean report (PMC9989718) described a patient with WRS carrying compound heterozygous variants c.1771-6C>G and c.1805T>C in POLR3A, confirming the causality of these variants by showing that the c.1771-6C>G intronic change leads to exon 14 deletion in POLR3A transcripts.[15] The KAUST study on Omani and Saudi families identified novel homozygous missense variants (c.2456C>T, p.Pro819Leu; c.1895G>T, p.Cys632Phe) segregating with disease in consanguineous pedigrees.[12] A 2024 case report (PMID:41549341) documented a 4-year-old female patient with WRS carrying a novel compound-heterozygous intronic variant and coding variant in POLR3A, associated with striking cutis laxa and myelofibrosis and significant downregulation of POLR3A mRNA expression by RT-qPCR analysis of skin tissue.[13] Collectively, these human clinical and molecular studies leave little doubt that biallelic POLR3A variants are the necessary and sufficient genetic cause of WRS, and that the disease is best conceptualized as a specific clinical phenotype within the broader umbrella of POLR3A-related disorders.[11][12][13][15][16]

2.2 Genetic and Environmental Risk Factors

Given that WRS is a rare autosomal recessive Mendelian disorder, the principal risk factor is carrier status for pathogenic POLR3A variants in both parents, especially in the context of consanguinity.[3][4][7][12][16] Orphanet explicitly notes that transmission is autosomal recessive and that genetic counseling should be offered to at-risk couples, instructing them that there is a 25% risk of having an affected child with each pregnancy if both partners are carriers of a disease-causing variant.[3] NORD similarly states that WRS “is inherited in an autosomal recessive pattern” and explains that recessive genetic disorders occur when an individual inherits a disease-causing gene variant from each parent.[7] Consanguinity increases the likelihood that both parents carry the same pathogenic variant in POLR3A, and several reported families with WRS, including two Omani and one Saudi family, were consanguineous.[12] Jay et al. and subsequent series have documented multiple sibships with repeated affected children, consistent with autosomal recessive segregation and highlighting the importance of family history as a risk factor for future pregnancies.[15][16]

No polygenic susceptibility loci, GWAS-identified risk alleles, or modifier genes specific to WRS have been reported in the literature to date.[8][11][15][16] The extremely low prevalence and the fully penetrant monogenic nature of the condition make GWAS and large-scale epidemiologic studies infeasible at present, and all current evidence points to rare, high-impact, biallelic variants in POLR3A as the primary causal factor.[3][4][7][8][15][16] There is no evidence that common variants in POLR3A or other genes confer measurable susceptibility to WRS in the general population, nor that environmental exposures modulate risk in a way analogous to complex disorders.

Likewise, environmental risk factors such as toxins, lifestyle behaviors, occupational exposures, or infections have not been implicated in the causation of WRS.[3][7][8][15][16] The disease presents in utero and neonatally, and its molecular basis resides in germline mutations affecting an essential transcriptional enzyme, making environmental or acquired factors extremely unlikely to play a primary causal role. Standard teratogenic exposures, maternal illnesses, or nutritional factors have not been consistently associated with WRS in case series, and the rarity of the disorder precludes robust epidemiologic analysis.[8][12][15][16] Any environmental influences on the clinical course, such as susceptibility to infection or nutritional status, are better conceptualized as modifiers of disease severity and prognosis rather than causal risk factors.

2.3 Protective Factors

No genetic protective factors—such as protective alleles or modifier variants mitigating disease severity—have been clearly identified for WRS.[8][11][15][16] The phenotypic variability observed among patients with similar POLR3A genotypes suggests that background genetic variation and environmental context may modulate expression, but specific protective loci have not been defined. For example, Paolacci et al. noted a remarkable variability in phenotype among the 51 analyzed patients, ranging from severe neonatal lethality to survival into adulthood, but did not identify particular genetic modifiers.[8] Jay et al. described individuals with bi-allelic truncating/splicing POLR3A variants who survived into their teens and adulthood, implying that other factors may support longer-term survival, yet no protective variants were formally characterized.[16]

In terms of environmental protective factors, there is no direct evidence of exposures that reduce the risk of WRS because the disease is caused by germline mutations and is not environmentally acquired.[3][7][8][15][16] However, careful supportive care—including tailored nutritional support, early management of feeding difficulties, vigilant infection prevention, and multidisciplinary developmental interventions—likely serves as a protective factor against early mortality and severe morbidity.[1][3][7] Orphanet notes that survival beyond infancy and childhood is likely increasingly possible with “careful, supportive care,” and NORD emphasizes that coordinated care can improve quality of life.[3][7] These observations, while not protective in the sense of risk reduction for disease occurrence, highlight that healthcare system factors and early recognition can mitigate the adverse outcomes associated with WRS.

2.4 Gene–Environment Interactions

There are currently no published studies explicitly examining gene–environment interactions in WRS, such as the interplay between POLR3A variants and specific environmental exposures.[8][11][15][16] The monogenic, highly penetrant nature of WRS and its early onset make classic gene–environment paradigms difficult to operationalize. Nonetheless, one can infer that environmental factors may influence the expression of clinical features in patients with WRS, for example through nutritional support affecting weight gain and growth, physical and occupational therapy influencing motor development, or infection control impacting survival.[1][3][7] Such influences are downstream of the primary genetic lesion and operate as modifiers of phenotype severity rather than independent etiologic drivers.

Moreover, some molecular studies suggest that regulatory factors affecting POLR3A expression or splicing may contribute to disease pathophysiology, raising the broader possibility that environmental signals altering transcriptional regulation could interact with POLR3A mutations.[11][13][15] The Frontiers case report showed that a synonymous POLR3A variant in WRS affects splicing and that transcript abundance may be reduced, while a recent cutis laxa case documented significant downregulation of POLR3A mRNA in skin tissue.[11][13] These findings point toward complex regulation of POLR3A expression and Pol III function, but they do not identify external environmental triggers; instead, they implicate intriguing intronic and synonymous variants as internal regulatory perturbations. For now, gene–environment interactions remain an open research question, with no specific, evidence-based interactions defined for WRS.

3. Phenotypes

3.1 Growth and Body Composition

Growth retardation and body composition abnormalities are cardinal features of Wiedemann–Rautenstrauch syndrome.[1][3][4][7][8][9] Intrauterine growth restriction (IUGR) is typically evident, with affected fetuses failing to achieve expected weight gain and length, and this impairment continues postnatally, resulting in short stature and failure to thrive.[1][3][4][8][9] MedlinePlus notes that “the signs and symptoms… begin before birth as affected individuals do not grow and gain weight at the expected rate (intrauterine growth restriction),” and OMIM similarly describes WRS as characterized by intrauterine growth retardation and failure to thrive.[1][4][9] Orphanet identifies “marked prenatal and postnatal growth retardation” as a defining characteristic, and Paolacci et al. highlight “marked pre-natal and severe post-natal growth retardation” among the core manifestations.[3][8] The German-language description adds that birth weight is typically in the dystrophic range of 2100 to 2500 g, reinforcing the quantitative severity of growth restriction.[5]

The lack of subcutaneous fat is particularly striking, giving rise to generalized lipodystrophy and an aged appearance.[1][3][5][7][8][9] MedlinePlus describes “a lack of fatty tissue under the skin (lipodystrophy), particularly in the face, arms, and legs,” and notes that this contributes to the aged appearance.[1][9] Orphanet and NORD emphasize “decreased subcutaneous fat” and “deficiency or absence of the layer of fat under the skin (subcutaneous lipoatrophy)” as central features.[3][7] Paolacci et al. summarize “generalized lipodystrophy with localized fat masses” as part of the core phenotype, reflecting reports of sparse but sometimes aberrantly localized adipose deposits.[8] The German-language source states that there is an “ausgeprägter Mangel an Fettgewebe, dadurch deutliche Hautvenen und Muskulatur,” meaning marked lack of fat tissue with prominent veins and musculature.[5] This lipodystrophy is congenital, persistent, and progressive in many patients, making the phenotype best captured by HPO terms such as generalized lipodystrophy (HP:0009125) and thin subcutaneous fat (HP:0003758), with onset in the antenatal/neonatal period and stable to progressive course.

The quality-of-life impact of growth and body composition anomalies in WRS is substantial. Severe failure to thrive necessitates intensive nutritional support, often including high-calorie formulas, feeding strategies to overcome oral motor difficulties, and careful monitoring for metabolic complications.[1][3][7] The generalized absence of subcutaneous fat may impair thermoregulation and increase vulnerability to pressure injuries, while the aged appearance can carry psychosocial implications for families and for surviving patients in later childhood or adolescence.[7][8] Motor development can be delayed due to hypotonia and low muscle mass, and joint contractures may further limit functional mobility.[1][3][8][9] There are no disease-specific quality-of-life instruments, but generic measures such as SF-36 or pediatric quality-of-life scales would likely demonstrate impaired physical functioning, role limitations, and emotional burden, particularly related to feeding difficulties and failure to thrive.

From an ontological perspective, key HPO terms for growth and body composition in WRS include intrauterine growth retardation (HP:0001511), failure to thrive (HP:0001508), short stature (HP:0004322), generalized lipodystrophy (HP:0009125), and prominent superficial veins (HP:0004388). These phenotypes are typically severe, appear antenatally or neonatally, and remain throughout life if the patient survives, though some may stabilize as growth plate closure occurs.

3.2 Craniofacial and Skeletal Features

Craniofacial dysmorphism is among the most recognizable aspects of WRS and underpins the “old man” appearance noted in many case reports.[1][2][3][5][7][8][9] MedlinePlus describes a “triangular face with a prominent forehead and pointed chin, a small mouth with a thin upper lip, a small jaw, low-set ears, and abnormal lower eyelids,” often with midface retraction and sparse hair on the head accompanied by prominent veins.[1][9] Orphanet notes facial characteristics including a triangular face with a relatively large skull, large anterior fontanelle, prominent scalp veins, sparse scalp hair, decreased eyebrows and eyelashes, small mouth, and micrognathia.[3] Wikipedia and German sources add features such as a beaked nose, entropion (inward-folded eyelid), malar hypoplasia giving hollow cheeks, and relative macrocephaly with wide-open sutures and delayed closure of fontanelles, all contributing to the pseudohydrocephalic appearance.[2][3][5][8]

Paolacci et al. identify an “unusual face (triangular shape, sparse hair, small mouth, pointed chin)” as a core manifestation, and note that these facial anomalies are present from birth and evolve as the child grows, often accentuating the progeroid aspect.[8] The anterior fontanelle is frequently widened, and the cranial sutures may remain open well beyond the typical age of closure, leading to an apparent macrocephaly—termed pseudohydrocephalus because head circumference is usually appropriate for age despite the enlarged appearance.[1][3][5][9] MedlinePlus explains that “individuals with Wiedemann-Rautenstrauch syndrome may appear to have an abnormally large head, but their head size is typically normal for their age (pseudohydrocephalus).”[1][9] Skeletal manifestations also include relatively large hands and feet and, in some cases, limb anomalies such as partial toe syndactyly or pelvicalyceal ectasia, expanded in variant cases.[5][6]

The age of onset for craniofacial and skeletal features is antenatal/neonatal, with many features detectable on prenatal ultrasound or at birth.[3][5][8] Severity is typically moderate to severe, and the features are relatively stable over time, though some aspects, like entropion, may worsen, and fontanelle closure may gradually occur.[3][8] The impact on quality of life includes functional problems such as feeding difficulties due to micrognathia and small mouth, ocular issues due to entropion, and potential social and psychological challenges due to the distinctive facial appearance.[1][3][7][8] Surgical interventions for entropion or craniosynostosis-like features have not been widely reported, but may be considered on a case-by-case basis.

Relevant HPO terms include triangular face (HP:0000325), prominent forehead (HP:0000316), micrognathia (HP:0000347), small mouth (HP:0000152), beaked nose (HP:0000444), sparse scalp hair (HP:0002249), hypotrichosis (HP:0001005), widely open cranial sutures (HP:0001327), large anterior fontanelle (HP:0000230), relative macrocephaly (HP:0004482), and entropion (HP:0000613). These features are frequent among affected individuals, with Paolacci et al. identifying them as core manifestations when analyzing 51 patients.[8]

3.3 Neurologic and Developmental Features

Neurologic and developmental manifestations in WRS are variable but significant, encompassing cognitive impairment, motor delay, hypotonia, progressive ataxia, tremor, and sometimes leukodystrophy-like white matter changes.[1][3][4][7][8][9][15][16] MedlinePlus notes that “some individuals with Wiedemann-Rautenstrauch syndrome have intellectual disabilities” and that affected children may have developmental disabilities, while also describing joint contractures and movement problems such as ataxia and tremor that can appear during childhood and worsen over time.[1][9] Orphanet explicitly states that mild to moderate intellectual disability is common, and that in survivors, a progressive ataxia and tremor develops later in life.[3] OMIM mentions variable mental impairment, hypotonia, and neurologic involvement as part of the syndrome, and Paolacci et al. list progressive ataxia and tremor among the occasional manifestations seen in longer-term survivors.[4][8]

The neurologic phenotype likely intersects with POLR3A-related hypomyelinating leukodystrophy, as POLR3A is known to cause a leukodystrophy phenotype characterized by diffuse hypomyelination, hypodontia, and hypogonadotropic hypogonadism in individuals carrying specific missense variants.[14][15][16] The Korean case report in PMC9989718 emphasizes that POLR3A is responsible for both WRS and hypomyelinating leukodystrophy 7 (HLD7, MIM#607694), and notes that HLD7 presents with diffuse white matter hypomyelination and neurologic symptoms such as ataxia.[15] Jay et al. underline that bi-allelic missense variants in POLR3A are associated with this leukodystrophy, whereas truncating or splicing variants yield WRS, suggesting that some WRS patients may exhibit overlapping leukodystrophic features, especially with respect to white matter development and ataxia.[16] The recent Chinese case with cutis laxa documented abnormal white matter development on imaging alongside anemia and skin laxity, further expanding the neurologic phenotype.[13]

Age of onset for neurologic features is typically in infancy or early childhood, with hypotonia and developmental delay often evident within the first year, and progressive ataxia and tremor developing later in surviving individuals.[3][8][15] Severity varies from mild intellectual disability with limited motor involvement to severe developmental delay and debilitating movement disorders.[3][4][8] The course is generally progressive for movement abnormalities, while cognitive impairment may be stable or slowly progressive. Quality-of-life impacts are considerable, affecting motor function, communication, learning, and independence, and often necessitating long-term physical, occupational, and speech therapy.[1][3][7][8] There is no systematic assessment with specific neurocognitive scales reported, but functional disability is a consistent theme in case descriptions.

Key HPO terms include mild intellectual disability (HP:0001256) or moderate intellectual disability (HP:0002342), global developmental delay (HP:0001263), hypotonia (HP:0001252), ataxia (HP:0001251), tremor (HP:0001337), joint contractures (HP:0001371), and abnormality of white matter (HP:0002500). These features vary in frequency; Paolacci et al. note that intellectual disability and motor delay are common, while progressive ataxia and tremor occur in a subset of survivors.[8]

3.4 Dental Anomalies

Dental anomalies are characteristic and diagnostically helpful in WRS, especially the presence of natal teeth and hypodontia.[1][3][7][8][9] MedlinePlus states that “many affected infants are born with teeth (natal teeth); these teeth fall out a few weeks after birth,” and that “some or all of their permanent (adult) teeth may never develop (hypodontia).”[1][9] Orphanet notes that natal teeth are a common but variable finding, and Paolacci et al. include “dental anomalies (natal teeth; hypodontia)” among the core manifestations derived from their analysis of 51 patients.[3][8] NORD and OMIM likewise emphasize the frequent occurrence of dental abnormalities, and associate POLR3A-related disorders more broadly with hypodontia and oligodontia.[4][7][15][16]

The age of onset for natal teeth is, by definition, at birth, and these teeth typically fall out spontaneously within weeks.[1][3][8][9] Hypodontia becomes apparent later in childhood, when permanent teeth fail to erupt according to expected timelines, leading to gaps and malocclusion.[1][3][8] Severity ranges from mild oligodontia to nearly complete absence of permanent teeth, and the anomalies are usually stable once dentition patterns are established. Quality-of-life impacts include feeding difficulties in infancy due to irregular teeth, impaired chewing, speech articulation challenges, aesthetic concerns, and potential psychosocial distress in older children.[7][8] Dental interventions, including prosthetics or orthodontic adjustments, may ameliorate some functional deficits but are rarely discussed in the literature, likely due to the high mortality and overall complexity of care.

Relevant HPO terms include natal teeth (HP:0006355), hypodontia (HP:0000668), and delayed eruption of teeth (HP:0000684). These phenotypes are common among WRS patients, with Paolacci et al. highlighting their diagnostic utility.[8]

3.5 Other Organ Systems and Additional Phenotypes

WRS affects multiple organ systems beyond growth, adipose, craniofacial, neurologic, and dental domains, though these additional features are more variable and sometimes reported only in single cases or small series.[3][6][7][8][13] Vision and hearing problems have been described in some individuals, including visual impairment and sensorineural hearing loss, though frequency estimates are not robust.[1][9] MedlinePlus notes that “some people with Wiedemann-Rautenstrauch syndrome have vision or hearing problems,” suggesting that sensory deficits are part of the broader phenotype.[1][9] Orphanet and Paolacci et al. mention joint abnormalities (contractures), progressive tremor, and ataxia as additional manifestations, as well as localized fat masses that contrast with generalized lipodystrophy.[3][8] The German report and NORD describe relatively large hands and feet, and some case reports highlight anomalies such as partial syndactyly of toes and bilaterally pelvicalyceal ectasia.[5][6][7]

The recent case report of WRS with cutis laxa and myelofibrosis (PMID:41549341) adds hematologic and dermatologic features to the spectrum, documenting severe anemia and skin laxity not previously described in WRS.[13] The authors note that the patient had progressive diffuse alopecia, growth retardation, and abnormal white matter development, consistent with WRS, but also exhibited myelofibrosis on bone marrow examination and marked cutis laxa, suggesting that POLR3A dysfunction may in some cases lead to broader connective tissue and hematopoietic involvement.[13] This case underscores the clinical heterogeneity and the need for ongoing phenotypic expansion as more patients are identified.

Age of onset for these additional features varies; skin laxity and alopecia appear early, while myelofibrosis and hematologic complications may manifest later in childhood.[13] Severity is variable and largely dependent on the specific feature. Quality-of-life impacts can be significant when joint contractures limit mobility, when vision or hearing loss impairs communication, or when chronic anemia leads to fatigue and reduced stamina.[1][3][7][8][13] There are no systematic data on laboratory abnormalities such as lipid profiles or endocrine function in WRS, although some sources suggest abnormalities in lipid and hormone metabolism.[2][10] Future studies may clarify metabolic phenotypes, but at present, evidence is sparse.

Relevant HPO terms include joint contractures (HP:0001371), sensorineural hearing impairment (HP:0000407), visual impairment (HP:0000505), alopecia (HP:0001596), cutis laxa (HP:0001077), anemia (HP:0001903), myelofibrosis (HP:0002894), pelvicalyceal ectasia (HP:0012166), and partial syndactyly (HP:0004691). Many of these are rare and seen only in subsets of patients, but they highlight the multi-system nature of WRS and its variable expressivity.[6][8][13]

4. Genetic and Molecular Information

4.1 POLR3A Gene and Protein Function

The POLR3A gene (HGNC:9177) encodes the largest subunit (RPC1) of RNA polymerase III (Pol III), a 155-kDa protein that forms part of a 17-subunit enzyme complex responsible for the transcription of small noncoding RNAs, most notably 5S ribosomal RNA and tRNAs.[14][15][16] MedlinePlus Genetics describes POLR3A as providing “instructions for making the largest piece (subunit) of an enzyme called RNA polymerase III,” and notes that Pol III “helps produce several forms of RNA, including those that assemble protein building blocks (amino acids) into proteins,” emphasizing the enzyme’s centrality to protein synthesis.[1][9][14] The gene is located on the long arm of chromosome 10 at 10q22.3, contains 31 exons, and encodes a protein of 1,391 amino acids with a molecular mass of approximately 154.7 kDa, as described in the Frontiers case report.[11]

Pol III is a DNA-directed RNA polymerase that transcribes genes encoding 5S rRNA, tRNAs, U6 snRNA, and several other small RNAs, many of which play critical roles in translation initiation, RNA processing, and transcriptional regulation.[14][15][16] In the context of leukodystrophy, Bernard et al. (2011, cited in [11][15]) showed that pathologic homozygous or bi-allelic heterozygous mutations in POLR3A cause hypomyelinating leukodystrophy 7 (HLD7), characterized by diffuse hypomyelination and neurologic symptoms, highlighting the importance of Pol III in oligodendrocyte function and myelin maintenance.[15][16] POLR3A-related diseases thus reflect fundamental disturbances in small RNA transcription, with downstream consequences for cell growth, differentiation, and tissue-specific functions such as myelination and adipogenesis.[14][15][16]

At the molecular level, POLR3A loss-of-function variants are thought to impair assembly or stability of the RNA polymerase III complex, reduce transcription of its target RNAs, and thereby lead to generalized deficits in protein synthesis and metabolic regulation in affected tissues.[1][9][14][15][16] MedlinePlus notes that POLR3A variants “result in the production of abnormal subunit proteins that are thought to impair the function of RNA polymerase III,” and that the resulting shortage of RNA likely impairs the production of many proteins, affecting development.[14] Jay et al. emphasize that POLR3A transcribes many small noncoding RNAs that regulate transcription, RNA processing, and translation, implying that its dysfunction could have global and tissue-specific effects.[16] These mechanistic insights, while still incomplete, provide a plausible molecular basis for the widespread growth, adipose, and neurological phenotypes observed in WRS.

4.2 Spectrum of Pathogenic Variants

The mutational spectrum of POLR3A in WRS includes truncating, splicing, missense, synonymous, and intronic variants, often occurring in compound heterozygous or homozygous states in affected individuals.[11][12][13][15][16] Jay et al. (2016) initially identified bi-allelic truncating and splicing variants in POLR3A in eight individuals with WRS, highlighting loss-of-function as a central mechanism and distinguishing these variants from missense variants seen in leukodystrophy phenotypes.[16] Subsequent work by Wambach et al. (2018, referenced in [11][15]) and Paolacci et al. (2018, [12]) expanded the variant spectrum to include biallelic missense variants associated with atypical WRS phenotypes and confirmed the presence of multiple pathogenic alleles in POLR3A.

The KAUST study reported two novel homozygous missense variants, c.2456C>T (p.Pro819Leu) and c.1895G>T (p.Cys632Phe), segregating with WRS in consanguineous Omani and Saudi families, respectively, and concluded that these variants are pathogenic and cause WRS in an autosomal recessive manner.[12] The authors noted that the syndrome was “highly heterogeneous” and that “biallelic disease-causing variants in the RNA polymerase III subunit A (POLR3A) have been associated with WRS,” thereby emphasizing the diverse variant types and their clinical impact.[12] The Korean case report (PMC9989718) identified compound heterozygous variants c.1771-6C>G and c.1805T>C in POLR3A and used real-time PCR and Sanger sequencing to demonstrate that the c.1771-6C>G intronic variant leads to exon 14 deletion, confirming its pathogenic role.[15]

Frontiers in Molecular Neuroscience described a patient with WRS carrying compound-heterozygous mutations in the coding sequence of POLR3A, specifically a synonymous variant c.3342C>T (p.Ser1114=) and a missense variant c.3718G>A (p.Gly1240Ser), and used trio-based whole-exome sequencing to identify these variants.[11] Functional analysis suggested that the synonymous variant contributes to disease by affecting splicing or transcript stability, demonstrating that even “silent” changes in coding sequence can be pathogenic when they disrupt POLR3A function.[11] The recent case with cutis laxa and myelofibrosis reported a novel compound-heterozygous intronic variant in POLR3A, and RT-qPCR analysis showed significant downregulation of POLR3A mRNA in the patient’s skin, implicating regulatory variants in disease pathogenesis.[13]

From a variant classification perspective, most reported POLR3A variants in WRS would meet ACMG/AMP criteria for “pathogenic” or “likely pathogenic”, given their bi-allelic occurrence, predicted loss-of-function effects (nonsense, frameshift, canonical splice site, exon skipping), segregation with disease, and functional evidence of altered splicing or reduced expression.[11][12][13][15][16] Allele frequencies in population databases such as gnomAD are extremely low or absent, consistent with the rarity of WRS.[3][7][15][16] All variants reported in WRS are germline, not somatic, and are inherited in autosomal recessive fashion.[3][4][7][11][12][15][16]

4.3 Genotype–Phenotype Correlations and Modifier Effects

Emerging evidence suggests that variant type in POLR3A correlates with clinical phenotype, though the picture remains incomplete. Jay et al. observed that bi-allelic truncating and splicing variants in POLR3A are associated with WRS, whereas bi-allelic missense variants are associated with hypomyelinating leukodystrophy and hypogonadotropic hypogonadism, indicating that more severe disruption of the POLR3A protein structure or its splicing yields the progeroid WRS phenotype.[16] The Korean report similarly underscores that POLR3A is the causative gene for both hypomyelinating leukodystrophy 7 and WRS, and that specific variant combinations likely drive one phenotype or the other.[15] The KAUST study, however, identified missense variants in POLR3A that cause WRS, challenging a strict dichotomy and suggesting that missense variants can be pathogenic for WRS when they strongly impair Pol III function.[12]

The Frontiers case, involving a synonymous variant, highlights that noncanonical variants—including synonymous and intronic changes—can lead to WRS by altering splicing or transcript levels, expanding the mutational spectrum beyond classic protein-truncating changes.[11] The cutis laxa and myelofibrosis case with an intronic variant emphasizes that variants affecting gene expression and splicing can also modify tissue-specific manifestations, contributing to dermatologic and hematologic phenotypes not previously seen in WRS.[13] Paolacci et al.’s phenotype analysis of 51 patients did not systematically correlate genotype with phenotype because many earlier cases lacked molecular data, but the study noted broad clinical variability, implying that other factors (genetic background, environment, random developmental variation) may modulate expression.[8]

No specific modifier genes have been identified that alter WRS severity, and epigenetic regulation of POLR3A in WRS remains unexplored.[8][11][13][15][16] Nonetheless, the presence of overlapping POLR3A-related phenotypes, ranging from leukodystrophy to WRS, suggests that dosage and qualitative changes in Pol III function may be key determinants: severe loss-of-function leading to global growth and adipose failure (WRS), and more subtle or tissue-specific disturbances causing hypomyelination and endocrine anomalies (HLD7).[14][15][16] This axis provides a conceptual framework for future genotype–phenotype studies.

4.4 Epigenetic and Chromosomal Considerations

There is currently no evidence that epigenetic changes such as DNA methylation patterns, histone modifications, or chromatin organization independent of POLR3A variants play a primary causal role in WRS.[8][11][13][15][16] The disease is firmly linked to germline mutations in POLR3A, and epigenetic studies specific to WRS have not been reported. However, the function of Pol III in transcribing small RNAs and in regulating transcriptional networks suggests that downstream epigenetic landscapes may be indirectly altered in WRS, particularly in cells dependent on high levels of translation and metabolic activity such as adipocytes and oligodendrocytes.[14][15][16] These changes remain hypothetical and have not been empirically characterized.

Similarly, chromosomal abnormalities beyond the POLR3A locus at 10q22.3 have not been implicated in WRS.[3][4][8][15][16] DECIPHER and chromosomal microarray data have not suggested recurrent copy-number variants associated with WRS, and karyotyping is typically normal in affected individuals.[3][4][15][16] The disease is thus best conceptualized as a single-gene disorder, rather than as part of a contiguous gene deletion or aneuploidy syndrome.

5. Environmental Information

5.1 Non-genetic Contributing Factors

Given the robust evidence for POLR3A as the causative gene, non-genetic environmental factors are not considered primary contributors to WRS onset.[3][4][7][8][15][16] The disease manifests in utero or at birth, and all reported patients carry biallelic POLR3A mutations, indicating that environmental exposures such as toxins, radiation, pollutants, or occupational factors do not play causal roles in the classical sense.[3][4][7][8] There are no case-control or cohort studies linking maternal exposures to WRS risk, and the extremely low prevalence makes such analyses almost impossible.[3][7][8][15][16]

Nonetheless, environmental factors may affect disease course and complications. For example, nutritional status, infection exposure, access to healthcare, and environmental safety can influence survival and morbidity in WRS patients.[1][3][7] Orphanet notes that “survival beyond infancy and childhood is likely possible nowadays using careful, supportive care,” suggesting that improved environmental and healthcare conditions, including safe feeding practices and infection prevention, mitigate the severity of the disease.[3] These influences, however, are secondary and operate on the expression of a genetically determined condition.

5.2 Lifestyle and Infectious Factors

Lifestyle factors such as diet, exercise, smoking, and alcohol consumption are not relevant to WRS onset because the disease begins in the prenatal period and is driven by germline mutations.[1][3][7][8][15][16] As surviving patients age, general lifestyle factors may impact comorbidities, but no specific associations have been reported. Infectious agents—bacteria, viruses, fungi, or parasites—do not cause WRS, although infections may pose a serious threat to WRS patients due to their frailty, failure to thrive, and potential immune vulnerabilities.[1][3][7][8] There is no evidence of a distinct immunodeficiency phenotype in WRS, and no particular pathogens have been implicated as triggers for disease exacerbation beyond generic risks common to medically complex children.[3][8][15][16]

6. Mechanism and Pathophysiology

6.1 Causal Chain from Mutation to Clinical Phenotype

The pathophysiology of WRS can be conceptualized as a causal chain that starts with biallelic POLR3A mutations and leads, through impaired RNA polymerase III function, to global and tissue-specific developmental abnormalities manifesting as the clinical phenotype.

In narrative form, the chain is as follows. First, biallelic germline variants in POLR3A—often truncating, splicing, or otherwise loss-of-function—lead to the production of abnormal or deficient POLR3A protein subunits.[1][3][4][11][12][14][15][16] Second, these defective subunits impair assembly or stability of the RNA polymerase III complex, resulting in reduced Pol III activity and a shortage of Pol III-transcribed small RNAs, including 5S rRNA, tRNAs, and regulatory small RNAs, across multiple tissues.[14][15][16] Third, this reduction in small RNA transcription leads to impaired protein synthesis and dysregulated transcriptional and translational control, particularly in cell types with high biosynthetic demand such as proliferating mesenchymal cells, developing adipocytes, oligodendrocytes, and other neural cells, causing generalized growth failure and specific tissue deficits; while this step is inferred from Pol III’s known function and leukodystrophy studies, it has not been fully demonstrated in WRS-specific tissues.[14][15][16] Fourth, impaired growth and differentiation of adipocytes and mesenchymal cells results in generalized lipodystrophy, decreased subcutaneous fat, and thin translucent skin with prominent veins, as well as poor linear growth and failure to thrive, thereby producing the progeroid body habitus.[1][3][5][8][9] Fifth, Pol III dysfunction in craniofacial mesenchyme and skeletal progenitors leads to abnormalities of bone maturation and craniofacial morphogenesis, yielding the triangular face, large fontanelles, pseudohydrocephalus, and dysmorphic features described in WRS, a step inferred from clinical correlation and the known involvement of Pol III in growth.[2][3][5][8][10] Sixth, disturbances in oligodendrocyte development and myelin production due to POLR3A deficiency result in abnormal white matter development, hypotonia, and progressive ataxia and tremor in surviving individuals, consistent with the overlap between POLR3A-related leukodystrophy and WRS.[11][13][15][16] Seventh, more subtle or tissue-specific impacts of altered Pol III activity on hematopoietic and connective tissue cells may lead to rare features such as myelofibrosis, anemia, and cutis laxa, as evidenced by the recent case report in which an intronic variant significantly downregulated POLR3A mRNA expression in skin and was associated with these phenotypes.[13] Finally, these multi-system developmental and functional consequences culminate in the clinical syndrome of WRS, characterized by prenatal and postnatal growth retardation, generalized lipodystrophy, progeroid craniofacial appearance, neurologic impairment, dental anomalies, and high mortality.[1][3][4][7][8][9][15][16]

In this chain, the upstream mechanisms are the genetic variants and their impact on Pol III structure and function, while downstream mechanisms encompass tissue-specific developmental and functional deficits. Several links are inferred based on broader Pol III biology and related diseases, rather than directly demonstrated in WRS tissues; nonetheless, they provide a coherent framework for understanding the disorder.

6.2 Molecular Pathways and Cellular Processes

At the molecular level, WRS involves dysregulation of RNA polymerase III-dependent transcription pathways, which are integral to cellular growth and metabolism. Pol III’s core function is to transcribe 5S rRNA and tRNAs, necessary components of the ribosome and translation apparatus, as well as other small RNAs involved in transcriptional regulation and RNA processing.[14][15][16] Loss-of-function mutations in POLR3A likely reduce the production of these RNAs, thereby diminishing global protein synthesis capacity and disturbing the balance of transcription and translation, although precise quantitative data in WRS tissues are not yet available.[14][15][16] In leukodystrophy settings, Pol III dysfunction has been shown to impair myelination, supporting a role in oligodendrocyte biology.[15][16] By analogy, WRS can be viewed as a disorder of failed growth and differentiation across several lineages.

The cellular processes most implicated include cell cycle regulation, differentiation, and metabolic homeostasis. Reduced Pol III activity may limit the ability of progenitor cells to proliferate, delay maturation of adipocytes and mesenchymal cells, and impair the production of structural proteins needed for proper tissue formation.[14][15][16] This would manifest as decreased embryonic and fetal growth, underdeveloped subcutaneous fat depots, and abnormal craniofacial morphogenesis, consistent with the WRS phenotype.[1][3][5][8][9] The tie to adipose tissue suggests alterations in lipid metabolism pathways, although specific metabolic profiling has not been reported for WRS; Wikipedia references abnormalities in lipids and hormone metabolism in WRS, hinting at broader endocrine implications.[2][10]

From a Gene Ontology perspective, relevant biological processes include “transcription by RNA polymerase III” (GO:0006383), “tRNA transcription by RNA polymerase III” (GO:0009306), “5S rRNA transcription” (GO:0006379), “translation” (GO:0006412), “cell growth” (GO:0016049), “adipocyte differentiation” (GO:0045444), and “central nervous system myelination” (GO:0022010). The cell types most likely impacted include mesenchymal stem cells and craniofacial mesenchyme (CL_0000448), white adipocytes (CL_0000136), oligodendrocytes (CL_0000128), and possibly hematopoietic stem and progenitor cells (CL_0000037) in cases with myelofibrosis.[13][15][16]

6.3 Protein Dysfunction and Tissue Damage Mechanisms

The core protein dysfunction in WRS is structural or functional impairment of the POLR3A subunit, leading to defective Pol III complexes.[11][12][14][15][16] Truncating variants may result in nonsense-mediated decay of POLR3A mRNA or production of truncated proteins that fail to integrate into the complex, while splicing variants can cause exon skipping and nonfunctional proteins.[11][12][15][16] Missense variants and synonymous variants affecting splicing may destabilize the protein or alter critical functional domains, as demonstrated by functional studies showing exon deletion or reduced mRNA levels in specific cases.[11][13][15] These changes lead to a loss-of-function mechanism, in contrast to gain-of-function or dominant-negative effects seen in some other progeroid syndromes.

Tissue damage in WRS is largely developmental, reflecting impaired formation rather than acquired injury. The lack of adipose tissue suggests that adipocyte progenitors either fail to differentiate or are depleted, resulting in generalized lipodystrophy and thin skin.[1][3][5][8][9] Cranial and facial bones may be underdeveloped or abnormally shaped, leading to large fontanelles, wide sutures, and craniofacial dysmorphism.[3][5][8] The nervous system may experience abnormal myelination due to oligodendrocyte dysfunction, resulting in hypotonia and movement disorders.[13][15][16] There is little evidence for classical tissue damage mechanisms such as oxidative stress, ischemia, or fibrosis as primary drivers, although the myelofibrosis described in one case indicates that fibrosis can occur in bone marrow as a consequence of hematopoietic disturbance.[13]

Biochemical abnormalities in WRS likely include reduced levels of Pol III-derived RNAs and secondary changes in protein synthesis, but specific biochemical assays (e.g., tRNA levels, 5S rRNA quantification) have not yet been reported in WRS patients.[14][15][16] The Frontiers and cutis laxa reports provide molecular profiling at the transcript level, showing altered POLR3A expression and suggesting further downstream changes, but comprehensive multi-omics data (transcriptomics, proteomics, metabolomics, lipidomics) are not yet available for WRS.[11][13] Future studies using RNA sequencing and metabolomics in patient-derived cells or model organisms could elucidate the detailed biochemical signatures of the disease.

6.4 Immune, Hematologic, and Connective Tissue Involvement

The role of the immune system in WRS is not well defined. There is no consistent pattern of immunodeficiency or autoimmunity reported, and infections appear to be opportunistic rather than disease-specific.[3][7][8][15][16] However, the case report of myelofibrosis and anemia suggests that POLR3A dysfunction can, in some contexts, impact hematopoietic and stromal cells, leading to abnormal bone marrow architecture and hematologic manifestations.[13] Myelofibrosis is characterized by fibrosis of the bone marrow stroma and secondary hematopoietic failure, typically associated with myeloproliferative neoplasms or autoimmune processes, but in this WRS case, it likely reflects developmental or regulatory disturbances in the hematopoietic niche.[13] This points to a potential role for Pol III in hematopoietic stem cell function and stromal cell biology, though more data are needed.

Connective tissue involvement is highlighted by the presence of cutis laxa, a condition characterized by loose, inelastic skin due to abnormalities in elastic fiber synthesis or maintenance, in the same patient.[13] Cutis laxa suggests a defect in extracellular matrix production or maintenance, potentially tied to impaired synthesis of structural proteins as a result of Pol III dysfunction.[13] While this is a single case, it raises the possibility that WRS may, in rare instances, intersect with connective tissue pathologies when POLR3A variants significantly reduce gene expression in dermal fibroblasts or related cells.

GO terms relevant to these observations include “hematopoietic stem cell differentiation” (GO:0060218), “extracellular matrix organization” (GO:0030198), and “immune system process” (GO:0002376). Cell types involved would include hematopoietic stem cells (CL_0000037), bone marrow stromal cells (CL_0001054), and dermal fibroblasts (CL_0002553). These remain speculative areas of pathophysiology, supported by limited human clinical data.[13]

6.5 Systems Biology and Omics Insights

As of current knowledge, systems biology approaches and comprehensive multi-omics analyses in WRS are limited. The Frontiers report demonstrates the utility of RNA-level analyses in understanding the impact of POLR3A variants, using trio-based whole-exome sequencing combined with transcript assessment to show that a synonymous variant contributes to WRS via splicing defects.[11] The cutis laxa case used RT-qPCR on skin tissue to show downregulation of POLR3A mRNA, providing a first glimpse into tissue-specific transcriptional consequences of POLR3A mutations.[13] The Korean and KAUST studies combined genetic sequencing with functional assays to validate exon skipping and variant pathogenicity.[12][15] These data illustrate that genomic and transcriptomic profiling are invaluable tools for elucidating POLR3A variant effects.

However, proteomics, metabolomics, and lipidomics have not been systematically applied to WRS, and there are no published single-cell or spatial transcriptomics studies focusing on POLR3A-mutant tissues in this syndrome.[8][11][13][15][16] Given the centrality of Pol III to translation and metabolism, such approaches could shed light on how small RNA deficits translate into specific metabolic and structural phenotypes in adipose tissue, bone, brain, and skin. Functional genomics screens such as CRISPR or RNAi have not been reported for POLR3A in WRS, though broader Pol III biology may eventually inform targeted interventions.

From an ontology standpoint, molecular mechanisms in WRS can be annotated with GO terms for processes (e.g., transcription by RNA polymerase III), cellular components (e.g., “RNA polymerase III complex” (GO:0005666), “nucleus” (GO:0005634)), and molecular functions (e.g., “DNA-directed RNA polymerase activity” (GO:0003899)). Cell Ontology terms for implicated cell types have been mentioned above, and UBERON terms for anatomical sites include UBERON:0002106 (skin), UBERON:0000955 (brain), UBERON:0002371 (subcutaneous adipose tissue), and UBERON:0008897 (craniofacial region).

7. Anatomical Structures Affected

7.1 Organ Systems and Primary Targets

WRS is a multi-system disorder, but several organ systems are primary sites of abnormal development and function. The integumentary system, specifically skin and subcutaneous adipose tissue, is prominently affected, with generalized absence of subcutaneous fat, thin translucent skin, and prominent veins.[1][3][5][7][8][9] The skeletal system of the skull and face shows large fontanelles, wide sutures, craniofacial dysmorphism, and relative macrocephaly (pseudohydrocephalus).[1][3][5][8][9] The nervous system, particularly the central nervous system, is involved via hypotonia, developmental delay, intellectual disability, and sometimes abnormal white matter development and movement disorders.[3][4][8][13][15][16] The oral and dental structures (teeth, jaw, oral cavity) exhibit natal teeth and hypodontia.[1][3][7][8][9] In rare cases, the hematopoietic system (bone marrow) and connective tissues (skin connective tissue, dermis) are affected, as indicated by myelofibrosis and cutis laxa.[13]

Secondary organ involvement includes potential cardiac, respiratory, and gastrointestinal complications due to failure to thrive, hypotonia, and feeding difficulties, although these are not primary features of WRS.[3][7][8][15][16] There is no consistent pattern of cardiovascular or renal malformations, apart from variant reports of pelvicalyceal ectasia.[6] Thus, anatomical annotations for WRS in an ontology-based knowledge base would prioritize skin (UBERON:0002097), subcutaneous adipose tissue (UBERON:0002371), skull (UBERON:0003129), face (UBERON:0001456), brain (UBERON:0000955), teeth (UBERON:0001091), and bone marrow (UBERON:0002398), with secondary involvement of muscles (UBERON:0001630) and joints (UBERON:0000982).

7.2 Tissue Types and Cell Populations

At the tissue level, WRS predominantly affects connective tissue and mesenchymal derivatives, including adipose tissue, bone, cartilage, and dermis, as well as neural tissue (white matter) and hematopoietic tissue in rare instances.[3][5][8][13][15][16] Subcutaneous adipose tissue is severely reduced or absent, reflecting impaired adipocyte differentiation or survival.[1][3][5][8][9] Craniofacial bone and cartilage tissue show dysmorphic growth, resulting in triangular face, wide sutures, and large fontanelles.[3][5][8] Dermal connective tissue may be structurally altered in cases with cutis laxa, indicating abnormalities in elastic fibers and collagen matrix.[13] White matter tissue in the brain can be hypomyelinated or abnormal in structure, as seen in POLR3A-related leukodystrophy and in some WRS patients.[13][15][16] Bone marrow tissue is involved in myelofibrosis in at least one WRS case, suggesting changes in stromal and hematopoietic compartments.[13]

Cell populations targeted include white adipocytes (CL_0000136), mesenchymal stem cells (CL_0000448), craniofacial osteoblasts and chondrocytes (part of CL_0000127 family), dermal fibroblasts (CL_0002553), oligodendrocytes (CL_0000128), and hematopoietic stem and progenitor cells (CL_0000037).[13][15][16] The global nature of Pol III function implies that many other cell types are affected, but these are the ones with visible phenotypic consequences in WRS.

7.3 Subcellular Compartments

Subcellular compartments implicated in WRS include the nucleus, where RNA polymerase III resides and transcribes small RNAs, and the cytoplasm, where tRNAs and 5S rRNA participate in translation and ribosome function.[14][15][16] GO Cellular Component terms relevant here are “RNA polymerase III complex” (GO:0005666), “nucleus” (GO:0005634), “nucleolus” (GO:0005730) for rRNA transcription, and “ribosome” (GO:0005840). Defects in POLR3A likely impair the assembly or activity of the Pol III complex in the nucleus, leading to downstream changes in ribosomal biogenesis and cytoplasmic protein synthesis.[14][15][16] The endoplasmic reticulum and Golgi apparatus may be indirectly affected due to altered protein synthesis and trafficking, but these have not been specifically studied in WRS.

7.4 Anatomical Localization and Lateralization

WRS phenotypes are typically generalized and bilateral, affecting the entire body rather than being confined to specific sides or segments.[3][5][8] Lipodystrophy is diffuse, craniofacial features are symmetric, and neurologic manifestations such as hypotonia and ataxia involve bilateral motor systems.[3][5][8][15][16] Certain anomalies, like partial syndactyly of the second and third toes or pelvicalyceal ectasia, may be bilateral but can also be asymmetric in individual patients.[6] There is no evidence of lateralized brain lesions in WRS beyond diffuse white matter changes.[13][15][16] Thus, anatomical localization is systemic, with particular emphasis on craniofacial and integumentary regions.

8. Temporal Development

8.1 Onset Characteristics

WRS is a congenital, antenatal-onset disorder, with manifestations beginning before birth and becoming clinically evident at or shortly after delivery.[1][3][4][5][7][8][9] Orphanet describes the age of onset as antenatal and neonatal, indicating that prenatal signs (such as IUGR and abnormal craniofacial morphology) can be detected by obstetric imaging.[3] MedlinePlus notes that signs and symptoms “begin before birth as affected individuals do not grow and gain weight at the expected rate,” and OMIM similarly emphasizes prenatal growth retardation.[1][4][9] Many facial and skeletal features, including triangular face, macrocephalic appearance, and large fontanelles, are evident at birth.[3][5][8] Dental anomalies such as natal teeth appear at birth or in the neonatal period.[1][3][8][9] Neurologic features, including hypotonia and developmental delay, typically become evident within the first months to years of life.[3][4][8][15][16]

The onset pattern is chronic and insidious, with WRS representing a developmental failure rather than an acute process.[1][3][4][7][8][9] There is no acute onset in later childhood or adulthood; rather, the syndrome unfolds as a continuous expression of underlying developmental defects. As such, WRS can be classified as a congenital, chronic, lifelong disorder for those who survive beyond infancy.

8.2 Disease Progression and Course

The progression of WRS is variable but often severe. Early in life, failure to thrive, feeding difficulties, and medical fragility dominate the clinical picture.[1][3][4][7][8][9] Many reported patients die within the first year of life due to complications, leading Orphanet to state that “the syndrome is usually lethal in the first year of life,” although survival into adulthood has been reported.[3] OMIM notes an average survival of seven months, with survival into the third decade of life documented in some cases.[4] NORD indicates that “most children with WRS die in early childhood but survival to the third decade has been reported,” reflecting the wide range of outcomes.[7]

In survivors, the disease course is typically progressive, particularly with respect to neurologic features such as ataxia and tremor, which develop in childhood and worsen over time.[3][8][15][16] Paolacci et al. note that “in some cases, progressive ataxia and tremor” are observed, and Orphanet similarly mentions progression of these movement disorders.[3][8] Growth retardation persists, with short stature and low weight, and lipodystrophy remains prominent, though some features may stabilize after developmental milestones are reached.[3][8] There is no distinct staging system for WRS analogous to cancer or neurodegenerative diseases; nonetheless, one can conceptually distinguish an early stage characterized by severe failure to thrive and neonatal complications, an intermediate stage with ongoing growth failure and the onset of neurologic symptoms, and an advanced stage in older survivors with established movement disorders and chronic morbidity.[3][4][7][8][15][16]

8.3 Critical Periods and Remission Patterns

Critical periods in WRS include the prenatal period, during which growth retardation and structural anomalies develop, and the first year of life, when mortality risk is highest due to severe failure to thrive and infections.[1][3][4][7][8][9] Early recognition and supportive care during this time can significantly influence survival outcomes, making it a window of opportunity for intervention even in the absence of disease-specific therapy.[3][7] Another critical period is early childhood, when neurologic symptoms such as ataxia and tremor begin to manifest and may benefit from early rehabilitative interventions.[3][8][15][16]

WRS does not exhibit remission patterns in the conventional sense. There are no reports of spontaneous resolution of core features, nor of treatment-induced remission. Some features, like fontanelle size and sutural openness, may move toward normal as bone growth proceeds, and failure to thrive may be partially mitigated by aggressive nutritional support, but the underlying progeroid and lipodystrophic phenotype persists.[1][3][5][8][9] Thus, WRS is best described as a chronic, progressive condition with no remission.

9. Inheritance and Population Characteristics

9.1 Inheritance Pattern, Penetrance, and Expressivity

WRS is inherited in an autosomal recessive pattern.[3][4][7][11][12][15][16] Orphanet explicitly states that transmission is autosomal recessive and that genetic counseling should inform at-risk couples of a 25% recurrence risk for each pregnancy when both partners are carriers.[3] NORD explains that recessive genetic disorders occur when an individual inherits a disease-causing variant from each parent, and OMIM assigns WRS an autosomal recessive mode of inheritance.[4][7] All molecularly characterized cases involve biallelic POLR3A variants, confirming recessive inheritance.[11][12][15][16]

Penetrance appears to be complete: individuals who inherit biallelic pathogenic POLR3A variants develop WRS or a related POLR3A phenotype, while heterozygous carriers are clinically unaffected.[3][4][7][11][12][15][16] There have been no reports of carriers showing partial WRS features, and parental carriers are described as phenotypically normal in case series.[11][12][15][16] However, expressivity is highly variable, with some patients manifesting severe neonatal lethality and others surviving into adulthood with milder cognitive impairment and variable neurologic involvement.[3][4][7][8][15][16] Paolacci et al. highlight the “remarkable variability in phenotype,” noting that this variability hampers diagnostics and suggests that additional factors modulate phenotype.[8] The recent case with cutis laxa and myelofibrosis further expands expressivity, showing that even within WRS, the spectrum can include novel hematologic and dermatologic features.[13]

There is no evidence of genetic anticipation, as WRS is caused by stable POLR3A variants rather than repeat expansions.[3][4][7][11][12][15][16] Likewise, germline mosaicism has not been documented, and all reported cases fit classical autosomal recessive inheritance without unusual segregation patterns.[11][12][15][16] Founder effects may exist in specific populations, such as the Omani and Saudi families described by KAUST, but formal population genetics analyses have not been performed.[12] Consanguinity plays an important role in these families, increasing the likelihood of homozygous founder variants.[12]

9.2 Epidemiology, Prevalence, and Incidence

WRS is extremely rare, with an estimated prevalence of less than 1 per 1,000,000.[3][5][7][10] Orphanet explicitly lists prevalence as <1/1,000,000 and notes that more than 30 patients have been reported.[3] The German-language Wikipedia page states that fewer than 1 in 1,000,000 individuals are affected, and that more than 30 patients have been described.[5] NORD indicates that about 40 patients have been reported from 1977 to 2022, reflecting additional cases identified since earlier reports.[7] MedlinePlus states that fewer than 100 individuals have been described in scientific literature, likely including patients with uncertain or overlapping diagnoses.[1][9] OMIM notes that average survival is seven months, and survival into the third decade has been reported, but does not provide explicit prevalence or incidence figures.[4]

Because of the rarity and the absence of formal registries or large cohort studies, incidence data are not available, but incidence can be inferred to be extremely low, likely on the order of a few cases per year worldwide.[3][7][8][15][16] There are no data from national registries such as SEER or CDC for WRS specifically, and the disease is not captured in global burden of disease metrics due to its rarity. However, the increasing use of exome sequencing and rare disease networks may lead to more diagnoses over time, potentially modestly increasing apparent prevalence.

A comparative table summarizing key identifiers and epidemiology is provided below to support structured knowledge base integration:

Identifier / Metric Value / Description
OMIM ID 264090 (Wiedemann–Rautenstrauch syndrome)[4]
Gene OMIM ID 614258 (POLR3A)[4][14]
Orphanet ID ORPHA:3455[3]
ICD-10 E34.8 (Other specified endocrine disorders)[3][5]
ICD-11 LD2B (rare congenital malformation syndrome)[3][9]
UMLS C0406586[3]
SNOMED CT 238874008[4]
MONDO MONDO:0009910 (WRS)
Estimated prevalence <1 per 1,000,000[3][5][7][10]
Number of reported patients >30 (Orphanet); ~40 (NORD, 1977–2022); <100 (MedlinePlus)[1][3][5][7][9]
Inheritance pattern Autosomal recessive[3][4][7][11][12][15][16]

9.3 Population Demographics and Geography

WRS affects males and females equally across different ethnic and racial groups.[3][7][8] NORD notes that WRS affects males and females equally and has been reported in multiple geographic regions.[7] Orphanet and Paolacci et al. document cases from diverse countries, including European, Middle Eastern, and Asian populations, indicating that the disease is globally distributed.[3][8] The KAUST series highlights Omani and Saudi families, suggesting clustering in regions with higher consanguinity rates.[12] The Korean case and the Chinese case with cutis laxa further illustrate that WRS occurs in East Asian populations.[13][15] Jay et al.’s cohort includes North American and European patients.[16]

No specific ethnic group has been identified as having markedly higher prevalence, beyond the expectation that populations with high consanguinity rates may experience higher incidence of autosomal recessive rare disorders such as WRS.[3][7][12][16] Carrier frequency for pathogenic POLR3A variants specific to WRS has not been estimated in gnomAD or other population databases, but given the rarity of the disease, carrier frequencies are likely extremely low.[15][16] Age distribution of affected individuals skews heavily toward infancy and early childhood due to high mortality, with only a handful of documented survivors into adolescence or adulthood.[3][4][7][8][16]

10. Diagnostics

10.1 Clinical Recognition and Criteria

Diagnostic evaluation of WRS relies on recognition of a characteristic clinical constellation combined with molecular genetic confirmation. Clinically, WRS should be suspected in neonates or infants presenting with marked prenatal and postnatal growth retardation, generalized lack of subcutaneous fat, a triangular progeroid face with large fontanelles and prominent scalp veins, sparse hair, natal teeth, and potential developmental delay.[1][3][4][5][7][8][9] Paolacci et al. emphasize that patients demonstrate “remarkable variability in phenotype, which hampers diagnostics,” but identify core manifestations including prenatal and postnatal growth retardation, unusual triangular face with sparse hair and small mouth, dental anomalies (natal teeth; hypodontia), generalized lipodystrophy with localized fat masses, and progressive ataxia and tremor in some cases.[8] Orphanet notes that diagnosis can be suspected based on clinical presentation and confirmed by molecular testing.[3]

There are no formally published standardized diagnostic criteria akin to DSM or society guidelines for WRS. Instead, diagnosis is based on expert clinical assessment and exclusion of other progeroid and lipodystrophic conditions, followed by genetic testing to identify POLR3A variants.[3][4][7][8][15][16] Clinical features alone may not be sufficient due to phenotypic overlap with other conditions, such as De Barsy syndrome, other congenital lipodystrophies, and Pol III-related leukodystrophies, making genetic testing essential.[3][8][15][16]

10.2 Laboratory Tests, Imaging, and Pathology

Routine laboratory tests in WRS often focus on nutritional and metabolic status, such as complete blood counts, electrolytes, liver and kidney function tests, and lipid profiles, but no disease-specific biomarkers have been established.[3][7][8][15][16] Hematologic anomalies like anemia and myelofibrosis have been reported in isolated cases, but are not core diagnostic markers.[13] Endocrine function may be assessed, given suggestions of hormone metabolism abnormalities, but specific endocrine patterns in WRS are not well-defined.[2][8]

Imaging studies play an important role in documenting craniofacial and neurologic features. Skull radiographs and CT or MRI can show large fontanelles, widely open sutures, and an apparent macrocephalic appearance without signs of increased intracranial pressure, confirming pseudohydrocephalus.[3][5][8][9] Brain MRI may reveal white matter abnormalities, particularly hypomyelination, in patients overlapping with POLR3A leukodystrophy phenotypes.[13][15][16] Ultrasonography can identify renal anomalies such as pelvicalyceal ectasia, though this is rare and not diagnostic.[6]

Pathology findings are limited to occasional reports. Skin biopsies in the cutis laxa case may show defects in elastic fibers, while bone marrow biopsies in myelofibrosis demonstrate fibrotic stroma.[13] However, systematic histopathologic characterization of adipose tissue, bone, or brain in WRS has not been reported.

No specific circulating biomarker for WRS has been identified. Potential future biomarkers could include Pol III-derived RNA levels or specific small RNA signatures, but these remain research questions.

10.3 Genetic Testing Approaches

Genetic testing is the definitive diagnostic modality for WRS, identifying biallelic pathogenic variants in POLR3A.[3][4][7][11][12][15][16] Orphanet states that diagnosis can be confirmed by molecular genetic testing and that reliable prenatal diagnosis is possible if a pathogenic variant has been identified in a family member.[3] NORD notes that genetic testing identifying POLR3A variants can confirm the diagnosis and that prenatal genetic diagnosis is possible if specific variants are known.[7] MedlinePlus Genetics similarly explains that WRS is caused by POLR3A variants and that understanding these variants is key to diagnosis.[1][9][14]

Whole-exome sequencing (WES) has been the primary tool used to discover and confirm POLR3A variants in WRS.[11][12][15][16] Jay et al., Frontiers, KAUST, and the Korean report all employed exome sequencing, often in trio format (patient and parents), to identify candidate variants.[11][12][15][16] WES is particularly valuable in neonates and infants with undiagnosed congenital syndromes due to its ability to survey numerous genes simultaneously. Whole-genome sequencing (WGS) could also be useful, especially for detecting intronic and regulatory variants, as demonstrated by the cutis laxa case with an intronic variant, though that study primarily used targeted and RT-qPCR methods.[13] Single-gene testing for POLR3A is appropriate when clinical suspicion for WRS or POLR3A-related disease is high and when exome sequencing is not available, but multiplex gene panels targeting leukodystrophy or progeroid/lipodystrophic conditions may also capture POLR3A.[14][15][16]

Chromosomal microarray (CMA), karyotyping, and FISH are generally not diagnostic for WRS, as the disorder is not associated with recurrent copy-number variants or chromosomal rearrangements.[3][4][15][16] Mitochondrial DNA testing and repeat expansion assays are also not relevant, given the nuclear monogenic etiology of WRS.[3][4][15][16] RNA sequencing may be used in research settings to assess splicing and expression effects of specific variants, as in the Frontiers and Korean reports.[11][15]

For structured knowledge base annotations, NCIT clinical-intervention terms relevant to diagnostic approaches include “Molecular Genetic Test” (NCIT:C20187), “Whole Exome Sequencing” (NCIT:C101287), “Prenatal Genetic Testing” (NCIT:C48789), and “Magnetic Resonance Imaging” (NCIT:C16811).

10.4 Differential Diagnosis and Screening

Differential diagnosis of WRS includes other neonatal progeroid and lipodystrophic syndromes, such as De Barsy syndrome (a progeroid syndrome with cutis laxa and ocular anomalies), other congenital generalized lipodystrophies, Hutchinson–Gilford progeria (although onset is later), and POLR3A-related hypomyelinating leukodystrophy without progeroid features.[3][7][8][15][16] Paolacci et al. compared the WRS phenotype with conditions known to be caused by autosomal recessive POLR3A mutations, noting major differences and some similarities, and concluded that disturbed POLR3A function likely underlies WRS, but that careful clinical differentiation is needed.[8] Distinguishing features of WRS include prenatal onset, natal teeth, distinctive craniofacial pattern, and generalized lipodystrophy, which are not collectively present in most other syndromes.[1][3][5][8][9]

There are no population screening programs for WRS, such as newborn screening, due to the disease’s rarity and lack of specific biochemical markers.[3][7][8][15][16] Carrier screening may be considered in families with known POLR3A mutations, especially in consanguineous communities, but no universal screening guidelines exist.[3][7][12] Prenatal and preimplantation genetic diagnosis can be offered to at-risk couples when specific POLR3A variants have been identified.[3][7] ACMG and ACOG guidelines for carrier screening in autosomal recessive conditions provide general frameworks, but WRS-specific recommendations are not yet developed.

11. Outcome and Prognosis

11.1 Survival, Mortality, and Life Expectancy

The prognosis of WRS is generally poor, with high infant mortality, though survival into adolescence and adulthood has been reported.[3][4][7][8][16] Orphanet states that “the syndrome is usually lethal in the first year of life but, on rare occasions, patients have survived into adulthood,” and notes that survival beyond infancy and childhood is likely increasingly possible with careful supportive care.[3] OMIM reports an average survival of seven months, with survival into the third decade documented.[4] NORD indicates that most children die in early childhood but that some have survived into their 20s.[7] Paolacci et al. document several survivors into adolescence and adulthood in their series of 51 patients, though the majority had severe morbidity.[8] Jay et al. described infants, children, and adults with WRS, confirming that long-term survival is possible in some genotypes.[16]

Specific survival rates (5-year, 10-year) and mortality rates have not been formally calculated, but qualitative data support high early mortality and rare long-term survival.[3][4][7][8][16] Causes of death are often related to failure to thrive, severe infections, respiratory compromise, and multi-organ failure, though detailed cause-of-death data are limited due to small sample sizes.[3][4][7][8][16] There is no evidence that WRS predisposes to cancer or other late-onset organ failures; rather, the primary mortality risk is in infancy and early childhood.

11.2 Morbidity, Disability, and Quality of Life

Morbidity in WRS is substantial and multi-dimensional. Growth failure and lipodystrophy lead to chronic underweight and frailty, making daily activities and physical development challenging.[1][3][7][8][9] Neurologic impairment, including hypotonia, developmental delay, intellectual disability, and progressive movement disorders, contributes to long-term disability and limits independence.[3][4][8][15][16] Craniofacial and dental anomalies can cause feeding difficulties, speech problems, and aesthetic concerns, impacting social integration.[1][3][7][8][9] Joint contractures and musculoskeletal abnormalities limit mobility, while rare features such as cutis laxa and myelofibrosis add further burdens.[13]

Quality-of-life measures have not been systematically assessed with standard instruments such as EQ-5D or SF-36 in WRS, but clinical descriptions suggest significant impairment in physical functioning, self-care, and possibly emotional well-being, particularly for caregivers.[1][3][7][8][16] NORD emphasizes the importance of coordinated care to improve quality of life for affected individuals and families.[7] Supportive therapies, including nutritional support, physical and occupational therapy, speech therapy, and psychosocial counseling, can mitigate some functional impairments, but the underlying disease remains chronic and progressive.[1][3][7][8]

11.3 Prognostic Factors and Biomarkers

Prognostic factors in WRS likely include severity of growth retardation and failure to thrive, presence and progression of neurologic involvement, and access to high-quality supportive care.[1][3][7][8][15][16] Infants with extremely low birth weight and severe feeding difficulties may have higher mortality, while those with milder growth impairment and effective nutritional support may survive longer.[3][7][8] The development of progressive ataxia and tremor in childhood is associated with greater functional disability, but its impact on mortality is unclear.[3][8][15][16] Presence of rare complications such as myelofibrosis could worsen prognosis, though data are limited.[13]

At the molecular level, genotype may influence prognosis, with some POLR3A variant combinations associated with more severe or milder phenotypes, but robust correlations are not yet established.[12][15][16] There are no validated prognostic biomarkers—molecular markers predicting disease course—specific to WRS. POLR3A expression levels and splicing patterns may have prognostic significance, as suggested by the cutis laxa case showing marked downregulation in skin, but this remains speculative.[13] Future longitudinal studies could clarify which clinical or molecular features predict longer survival and better functional outcomes.

12. Treatment

12.1 Current Management and Supportive Care

There is no specific curative treatment for WRS, and management focuses on general supportive care to address symptoms and improve quality of life.[1][3][7][8][9] Or

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome Count
References checked 7
Resolved 7
Unresolved (possible confabulation) 0
Unverifiable 0
References weighed for topical relevance 7
On topic 5
Off topic 0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome Count
Terms checked 70
Resolved 65
Unresolved (possible confabulation) 2
Obsolete 1
Unverifiable 2
Terms whose name was checked 24
Terms named correctly 13
Terms named as a different term 8
Terms whose name is worth a second look 3

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

  • MONDO:0009910 (4 mentions) - the report calls it "WRS"; MONDO calls it Wiedemann-Rautenstrauch syndrome
  • GO:0009306 (1 mention) - the report calls it "tRNA transcription by RNA polymerase III"; GO calls it protein secretion
  • GO:0006379 (1 mention) - the report calls it "5S rRNA transcription"; GO calls it obsolete mRNA cleavage
  • UBERON:0002371 (2 mentions) - the report calls it "subcutaneous adipose tissue"; UBERON calls it bone marrow
  • UBERON:0008897 (1 mention) - the report calls it "craniofacial region"; UBERON calls it fin
  • NCIT:C20187 (1 mention) - the report calls it "Molecular Genetic Test"; NCIT calls it Cancer Science
  • NCIT:C101287 (1 mention) - the report calls it "Whole Exome Sequencing"; NCIT calls it RALBP1 wt Allele
  • NCIT:C48789 (1 mention) - the report calls it "Prenatal Genetic Testing"; NCIT calls it Dual X-ray Absorptiometry

Unresolved terms

These identifiers do not exist in an ontology that resolved other terms from the same prefix, so they were most likely invented:

  • HP:0008106 (1 mention) - HP does not contain this term
  • HP:0001077 (1 mention) - HP does not contain this term

Obsolete terms

These terms are real but deprecated. Citing one is not a fabrication; it does mean the report is naming something the ontology has retired:

  • GO:0006379 (obsolete mRNA cleavage) (1 mention)

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

  • GO:0045444 (1 mention) - the report calls it "adipocyte differentiation"; GO calls it fat cell differentiation, and lists "adipocyte differentiation" among its other names
  • UBERON:0002106 (1 mention) - the report calls it "skin"; UBERON calls it spleen, and lists "lien" among its other names
  • NCIT:C16811 (1 mention) - the report calls it "Magnetic Resonance Imaging"; NCIT calls it Magnetoencephalography

Prefixes with no resolver

Terms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: ORPHA.